====== NO.1protein ======
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In allele GC*1S; dbSNP:rs7041.
type:sequence variant  description:In allele GC*2, allele GC*2A9; dbSNP:rs4588.
type:sequence variant  description:In allele GC*2A9; requires 2 nucleotide substitutions.
type:sequence variant  description:In allele GC*1F, allele GC*2 and allele GC*1S; dbSNP:rs9016.
type:sequence conflict  description:In Ref. 1; AAA52173.
type:sequence conflict  description:In Ref. 5; AK309595.
type:sequence conflict  description:In Ref. 1; AAA52173.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2protein ======
type:initiator methionine  description:Removed
type:chain  description:Vitamin D3 dihydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Vitamin D3
type:binding site  description:Heme
type:binding site  description:Heme
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3; via carbonyl oxygen
type:binding site  description:Heme
type:binding site  description:Heme
type:mutagenesis site  description:Increase of the hydroxylase activity and decrease of affinity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3. Increase of the hydroxylase activity; when associated with A-84 and F-84.
type:mutagenesis site  description:Increase of the hydroxylase activity and decrease of affinity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3. Increase of the hydroxylase activity; when associated with A-73 and V-73.
type:mutagenesis site  description:Alters the substrate specificity that gives preference to the 1-alpha-hydroxylation of 25-hydroxyvitamin D3 over the 25-hydroxylation of 1-alpha-hydroxyvitamin D3. Increase of the hydroxylase activity and decrease of affinity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3.
type:mutagenesis site  description:Decrease of the hydroxylase activity for both 25-hydroxyivitamin D3 and 1-alpha-hydroxyvitamin D3.
type:mutagenesis site  description:Decrease of the hydroxylase activity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3.
type:mutagenesis site  description:Decrease of the hydroxylase activity for both 25-hydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3.
type:mutagenesis site  description:Decrease of the hydroxylase activity.
type:mutagenesis site  description:Slight increase of the hydroxylase activity.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.3protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 1
type:region of interest  description:Interaction with the Mediator complex and THRA
type:region of interest  description:Interaction with ESR1
type:region of interest  description:Interaction with the Mediator complex
type:region of interest  description:Interaction with the Mediator complex
type:region of interest  description:Interaction with THRA
type:region of interest  description:Interaction with VDR
type:region of interest  description:Interaction with PPARGC1A and THRA
type:region of interest  description:Interaction with ESR1
type:region of interest  description:Interaction with GATA1
type:region of interest  description:Interaction with TP53
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:Integrase domain-binding motif (IBM)
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Lys-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by MAPK1 or MAPK3
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine; by MAPK1 or MAPK3
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1139825.
type:sequence variant  description:In dbSNP:rs35668211.
type:mutagenesis site  description:Enhances interaction with ESR1.
type:mutagenesis site  description:Enhances interaction with ESR1.
type:mutagenesis site  description:Impairs interaction with ESR2; when associated with A-607; A-645 and A-648.
type:mutagenesis site  description:Impairs interaction with ESR1, PPARG, RXRA and THRB. Impairs interaction with THRA; when associated with 648-A-A-649.
type:mutagenesis site  description:Impairs interaction with ESR2; when associated with A-604; A-645 and A-648.
type:mutagenesis site  description:Enhances interaction with ESR1.
type:mutagenesis site  description:Impairs interaction with ESR2; when associated with A-604; A-607 and A-648.
type:mutagenesis site  description:Impairs interaction with ESR1, PPARG, THRB and VDR. Impairs interaction with THRA; when associated with 607-A-A-608.
type:mutagenesis site  description:Impairs interaction with ESR2; when associated with A-604; A-607 and A-645.
type:mutagenesis site  description:Increased interaction with PSIP1; when associated with D-887 or D-887 and D-889.
type:mutagenesis site  description:Phosphomimetic mutant. Increased interaction with PSIP1; when associated with D-886 or D-886 and D-889.
type:mutagenesis site  description:Increased interaction with PSIP1; when associated with D-886 and D-887.
type:mutagenesis site  description:Enhances protein stability; when associated with A-1457.
type:mutagenesis site  description:Enhances protein stability; when associated with A-1032.
type:sequence conflict  description:In Ref. 1; CAA73867.
type:sequence conflict  description:In Ref. 1; CAA73867.
type:sequence conflict  description:In Ref. 1; CAA73867.
type:sequence conflict  description:In Ref. 1; CAA73867 and 7; AAF98352.
type:sequence conflict  description:In Ref. 1; CAA73867 and 7; AAF98352.
type:sequence conflict  description:In Ref. 5; AAH06517.
type:sequence conflict  description:In Ref. 9; AAC41736.
type:sequence conflict  description:In Ref. 9; AAC41736.
type:sequence conflict  description:In Ref. 2; AAC39854.
type:sequence conflict  description:In Ref. 7; AAF98352.
type:sequence conflict  description:In Ref. 5; AAH06517.
type:sequence conflict  description:In Ref. 2; AAC39854.
type:helix  description:None
type:helix  description:None
====== NO.4protein ======
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 2; AAA41082.
type:sequence conflict  description:In Ref. 1; AAA41080.
type:sequence conflict  description:In Ref. 2; AAA41082.
====== NO.5protein ======
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
====== NO.6protein ======
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:modified residue  description:N-acetylthreonine
====== NO.7protein ======
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
type:sequence conflict  description:In Ref. 5; AAA40852.
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.8protein ======
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:domain  description:EF-hand 6
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
type:sequence conflict  description:In Ref. 2; AA sequence.
type:sequence conflict  description:In Ref. 2; AA sequence.
====== NO.9protein ======
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
type:splice variant  description:In isoform 2.
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.10protein ======
type:chain  description:Vitamin D3 receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:splice variant  description:In isoform 2.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909790.
type:sequence variant  description:In VDDR2A.
type:sequence variant  description:In VDDR2A.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909797.
type:sequence variant  description:In VDDR2A.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909794.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909791.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909793.
type:sequence variant  description:In VDDR2A; loss of calcitriol receptor activity; loss of affinity for calcitriol; no effect on ligand-independent localization to the nucleus; dbSNP:rs121909795.
type:sequence variant  description:In dbSNP:rs11574090.
type:sequence variant  description:In VDDR2A; loss of calcitriol receptor activity; decreased affinity for calcitriol by a factor of 1000; no effect on interaction with RXRA; changed interaction with NCOR1; loss of interaction with NCOA1; no effect on sequence-specific DNA-binding; dbSNP:rs121909796.
type:sequence variant  description:In VDDR2A; loss of calcitriol receptor activity; no effect on interaction with RXRA; changed interaction with NCOR1; loss of interaction with NCOA1; no effect on sequence-specific DNA-binding; dbSNP:rs121909798.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909799.
type:sequence variant  description:In VDDR2A; decreased calcitriol receptor activity; decreased affinity for calcitriol; decreased ligand-independent localization to the nucleus; loss of interaction with RXRA; decreased interaction with NCOR1; decreased interaction with NCOA1; decreased sequence-specific DNA-binding; dbSNP:rs267607169.
type:sequence variant  description:In VDDR2A; loss of calcitriol receptor activity; loss of affinity for calcitriol; decreased ligand-independent localization to the nucleus; loss of interaction with RXRA; loss of interaction with NCOR1; loss of interaction with NCOA1; loss of sequence-specific DNA-binding.
type:sequence variant  description:In dbSNP:rs11574115.
type:sequence variant  description:In VDDR2A; dbSNP:rs121909800.
type:mutagenesis site  description:Abolishes nuclear export.
type:mutagenesis site  description:Promotes heterodimerization with RXRA; when associated with A-75.
type:mutagenesis site  description:Promotes heterodimerization with RXRA; when associated with A-61 and A-62.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.11protein ======
type:signal peptide  description:None
type:chain  description:Vitamin D 25-hydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate; via carbonyl oxygen
type:sequence variant  description:In VDDR1B; complete loss of activity; dbSNP:rs61495246.
type:sequence variant  description:Reduces 25-hydroxylase activity.
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.12protein ======
type:chain  description:Vitamin D3 receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Interaction with coactivator LXXLL motif
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:sequence conflict  description:In Ref. 1; BAA06737.
====== NO.13protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.12.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.19.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.08.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.16.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.15.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.16.
type:mutagenesis site  description:Increases the C23:C24 hydroxylation ratio from 0.01 to 0.13.
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.14protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In HCINF1; complete loss of function.
type:sequence variant  description:In dbSNP:rs35051736.
type:sequence variant  description:In HCINF1; complete loss of function; dbSNP:rs387907322.
type:sequence variant  description:In HCINF1; complete loss of function; dbSNP:rs387907324.
type:sequence variant  description:In dbSNP:rs6022990.
type:sequence variant  description:In HCINF1; complete loss of function; dbSNP:rs114368325.
type:sequence variant  description:In HCINF1; retains small but measurable levels of activity; dbSNP:rs6068812.
type:sequence conflict  description:In Ref. 1; AAA62379/AAB03776.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 1; AAA62379.
type:sequence conflict  description:In Ref. 6; AAB29308.
====== NO.15protein ======
type:chain  description:Vitamin D3 receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Interaction with coactivator LXXLL motif
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.16protein ======
type:chain  description:Vitamin D 25-hydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate; via carbonyl oxygen
====== NO.17protein ======
type:chain  description:Vitamin D3 receptor A
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Interaction with coactivator LXXLL motif
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:sequence conflict  description:In Ref. 1; AAF21427.
type:sequence conflict  description:In Ref. 1; AAF21427.
type:sequence conflict  description:In Ref. 1; AAF21427.
type:sequence conflict  description:In Ref. 1; AAF21427.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.18protein ======
type:chain  description:Phosphate-regulating neutral endopeptidase PHEX
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:domain  description:Peptidase M13
type:active site  description:None
type:active site  description:Proton donor
type:metal ion-binding site  description:Zinc; catalytic
type:metal ion-binding site  description:Zinc; catalytic
type:metal ion-binding site  description:Zinc; catalytic
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; dbSNP:rs1556014287.
type:sequence variant  description:In XLHR; dbSNP:rs137853269.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; dbSNP:rs751230094.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; dbSNP:rs267606945.
type:sequence variant  description:In XLHR; dbSNP:rs267606946.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; dbSNP:rs1556091855.
type:sequence variant  description:In XLHR; dbSNP:rs886041363.
type:sequence variant  description:In XLHR; dbSNP:rs137853270.
type:sequence variant  description:In XLHR; sporadic; dbSNP:rs760870713.
type:sequence variant  description:In XLHR; sporadic; dbSNP:rs1556135308.
type:sequence variant  description:In XLHR; dbSNP:rs875989883.
type:sequence variant  description:In XLHR; dbSNP:rs1057517980.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic; dbSNP:rs1556151526.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic; dbSNP:rs1556200989.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; sporadic.
type:sequence variant  description:In XLHR; dbSNP:rs1556206403.
type:sequence conflict  description:In Ref. 9; AAC50552.
type:sequence conflict  description:In Ref. 9; AAC50552.
type:sequence conflict  description:In Ref. 9; AAC50552.
====== NO.19protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.20protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:Sterol 26-hydroxylase, mitochondrial
type:region of interest  description:Sterol-binding
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:sequence conflict  description:In Ref. 4; AAA86314.
type:sequence conflict  description:In Ref. 3; AAA41786 and 4; AAA86314.
type:sequence conflict  description:In Ref. 3; AAA41786 and 4; AAA86314.
type:sequence conflict  description:In Ref. 4; AAA86314.
type:sequence conflict  description:In Ref. 4; AAA86314.
type:sequence conflict  description:In Ref. 4; AAA86314.
type:sequence conflict  description:In Ref. 2; AAB02287.
====== NO.21protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:Sterol 26-hydroxylase, mitochondrial
type:region of interest  description:Sterol-binding
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:sequence variant  description:In CTX; dbSNP:rs72551313.
type:sequence variant  description:In dbSNP:rs59443548.
type:sequence variant  description:In dbSNP:rs2229381.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908096.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908096.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908099.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908097.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs121908098.
type:sequence variant  description:In CTX; impairs sterol 26-hydroxylase activity; dbSNP:rs72551322.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity; when associated with A-244 and A-248.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity; when associated with A-240 and A-248.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity; when associated with A-240 and A-244.
type:mutagenesis site  description:Impairs sterol 26-hydroxylase activity; confers demethylase activity.
type:mutagenesis site  description:Reduces sterol 26-hydroxylase activity.
type:mutagenesis site  description:Reduces sterol 26-hydroxylase activity.
type:sequence conflict  description:In Ref. 2; CAA42481.
type:sequence conflict  description:In Ref. 2; CAA42481.
type:sequence conflict  description:In Ref. 3; AAO21126.
====== NO.22protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 24
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:short sequence motif  description:LXXLL motif 4
type:short sequence motif  description:LXXLL motif 5
type:short sequence motif  description:LXXLL motif 6
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs34585432.
type:sequence conflict  description:In Ref. 3; BAA09479.
type:sequence conflict  description:In Ref. 8; AA sequence.
type:sequence conflict  description:In Ref. 2; AAF78764.
type:sequence conflict  description:In Ref. 4; BAG51081.
type:sequence conflict  description:In Ref. 4; BAG51081.
type:sequence conflict  description:In Ref. 4; BAG51081.
====== NO.23protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:Sterol 26-hydroxylase, mitochondrial
type:region of interest  description:Sterol-binding
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
====== NO.24protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:Sterol 26-hydroxylase, mitochondrial
type:region of interest  description:Sterol-binding
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
====== NO.25protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 13
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Ser-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In MRD61; unknown pathological significance.
type:sequence variant  description:In MRD61.
type:sequence variant  description:In dbSNP:rs34805963.
type:sequence variant  description:In dbSNP:rs35996128.
type:sequence variant  description:In MRD61; no effect on protein levels.
type:sequence variant  description:In MRD61; unknown pathological significance.
type:sequence variant  description:In MRD61; unknown pathological significance.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
type:sequence conflict  description:In Ref. 1; AAD22032.
====== NO.26protein ======
type:chain  description:Phosphate-regulating neutral endopeptidase PHEX
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:domain  description:Peptidase M13
type:active site  description:None
type:active site  description:Proton donor
type:metal ion-binding site  description:Zinc; catalytic
type:metal ion-binding site  description:Zinc; catalytic
type:metal ion-binding site  description:Zinc; catalytic
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 3; AAB47750.
====== NO.27protein ======
type:domain  description:Peptidase_M3
type:domain  description:Peptidase_M3
type:coiled-coil region  description:None
====== NO.28protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.29protein ======
type:transmembrane region  description:Helical
====== NO.30protein ======
type:domain  description:Pyr_redox_2
====== NO.31protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:region of interest  description:Disordered
====== NO.32protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.33protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:PAS
type:domain  description:PAC
type:domain  description:Cyclic nucleotide-binding
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Pro-rich
====== NO.34protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.35protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.36protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.37protein ======
====== NO.38protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.39protein ======
type:domain  description:Pyr_redox_2
====== NO.40protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.41protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.42protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.43protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.44protein ======
type:domain  description:Pyr_redox_2
====== NO.45protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:region of interest  description:Disordered
type:non-terminal residue  description:None
====== NO.46protein ======
====== NO.47protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.48protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.49protein ======
type:domain  description:Pyr_redox_2
====== NO.50protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.51protein ======
type:domain  description:Pyr_redox_2
====== NO.52protein ======
type:domain  description:Albumin
====== NO.53protein ======
type:domain  description:Pyr_redox_2
====== NO.54protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.55protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.56protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.57protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.58protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.59protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:coiled-coil region  description:None
====== NO.60protein ======
type:domain  description:Pyr_redox_2
====== NO.61protein ======
type:domain  description:Med1
====== NO.62protein ======
type:domain  description:Pyr_redox_2
====== NO.63protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.64protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.65protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.66protein ======
type:transmembrane region  description:Helical
====== NO.67protein ======
type:domain  description:Pyr_redox_2
====== NO.68protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.69protein ======
type:transmembrane region  description:Helical
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.70protein ======
type:domain  description:Pyr_redox_2
====== NO.71protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.72protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.73protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.74protein ======
type:domain  description:Pyr_redox_2
====== NO.75protein ======
====== NO.76protein ======
type:domain  description:Albumin
====== NO.77protein ======
type:domain  description:Pyr_redox_2
====== NO.78protein ======
====== NO.79protein ======
====== NO.80protein ======
type:transmembrane region  description:Helical
====== NO.81protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.82protein ======
type:transmembrane region  description:Helical
====== NO.83protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.84protein ======
type:transmembrane region  description:Helical
====== NO.85protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.86protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.87protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.88protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.89protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.90protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.91protein ======
type:domain  description:Pyr_redox_2
====== NO.92protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.93protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.94protein ======
type:domain  description:Pyr_redox_2
====== NO.95protein ======
type:domain  description:Pyr_redox_2
====== NO.96protein ======
type:domain  description:Pyr_redox_2
====== NO.97protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.98protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.99protein ======
type:domain  description:Pyr_redox_2
====== NO.100protein ======
type:domain  description:Pyr_redox_2
====== NO.101protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.102protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.103protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.104protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.105protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.106protein ======
type:transmembrane region  description:Helical
type:domain  description:Peptidase_M13_N
type:domain  description:Peptidase_M13
====== NO.107protein ======
type:domain  description:Protein kinase
type:non-terminal residue  description:None
====== NO.108protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.109protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.110protein ======
====== NO.111protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.112protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.113protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:Ion_trans
type:domain  description:Ion_trans
====== NO.114protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.115protein ======
type:signal peptide  description:None
type:chain  description:None
type:transmembrane region  description:Helical
type:domain  description:Tyrosinase_Cu-bd
type:domain  description:Tyrosinase_Cu-bd
====== NO.116protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.117protein ======
====== NO.118protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.119protein ======
type:signal peptide  description:None
type:chain  description:None
====== NO.120protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.121protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.122protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.123protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
====== NO.124protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.125protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.126protein ======
====== NO.127protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.128protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.129protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.130protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.131protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.132protein ======
====== NO.133protein ======
====== NO.134protein ======
====== NO.135protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.136protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.137protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.138protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.139protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.140protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.141protein ======
====== NO.142protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.143protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.144protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.145protein ======
type:domain  description:SKIP_SNW
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.146protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.147protein ======
type:transmembrane region  description:Helical
====== NO.148protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.149protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.150protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.151protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.152protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.153protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.154protein ======
====== NO.155protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Fibrinogen C-terminal
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.156protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.157protein ======
type:domain  description:Sulfotransfer_1
====== NO.158protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.159protein ======
====== NO.160protein ======
type:domain  description:Nuclear receptor
type:non-terminal residue  description:None
====== NO.161protein ======
type:signal peptide  description:None
type:chain  description:Transforming growth factor beta
====== NO.162protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.163protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.164protein ======
type:domain  description:VitD-bind_III
type:region of interest  description:Disordered
type:compositionally biased region  description:Basic
type:non-terminal residue  description:None
====== NO.165protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.166protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.167protein ======
type:domain  description:Sulfotransfer_1
====== NO.168protein ======
type:domain  description:RING-type
type:domain  description:B30.2/SPRY
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.169protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.170protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
====== NO.171protein ======
type:transmembrane region  description:Helical
type:domain  description:Peptidase_M13_N
type:domain  description:Peptidase_M13
====== NO.172protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.173protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.174protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.175protein ======
====== NO.176protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:domain  description:ABC transmembrane type-1
type:domain  description:ABC transporter
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.177protein ======
type:domain  description:RING-type
type:domain  description:B30.2/SPRY
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.178protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.179protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.180protein ======
====== NO.181protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.182protein ======
type:signal peptide  description:None
type:chain  description:Parathyroid hormone
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.183protein ======
type:transmembrane region  description:Helical
type:domain  description:Peptidase_M13_N
type:domain  description:Peptidase_M13
====== NO.184protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:Ion_trans
type:domain  description:Ion_trans
====== NO.185protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.186protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.187protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.188protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.189protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.190protein ======
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.191protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.192protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.193protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.194protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.195protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.196protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.197protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.198protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.199protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.200protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.201protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.202protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.203protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.204protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.205protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.206protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.207protein ======
====== NO.208protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:TGF_BETA_2
type:region of interest  description:Disordered
====== NO.209protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.210protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.211protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.212protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.213protein ======
type:signal peptide  description:None
type:chain  description:None
type:transmembrane region  description:Helical
type:domain  description:Tyrosinase_Cu-bd
type:domain  description:Tyrosinase_Cu-bd
====== NO.214protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.215protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.216protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.217protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.218protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.219protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
====== NO.220protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
====== NO.221protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.222protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.223protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.224protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.225protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.226protein ======
type:transmembrane region  description:Helical
====== NO.227protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.228protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.229protein ======
====== NO.230protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.231protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.232protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.233protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.234protein ======
type:transmembrane region  description:Helical
====== NO.235protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.236protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.237protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.238protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.239protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.240protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.241protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:ZnMc
type:repeat  description:Hemopexin
type:repeat  description:Hemopexin
type:repeat  description:Hemopexin
type:repeat  description:Hemopexin
type:active site  description:None
====== NO.242protein ======
type:domain  description:SAP
type:domain  description:PINIT
type:domain  description:SP-RING-type
type:zinc finger region  description:SP-RING-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.243protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.244protein ======
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.245protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.246protein ======
====== NO.247protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.248protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.249protein ======
type:domain  description:Sulfotransfer_1
====== NO.250protein ======
====== NO.251protein ======
====== NO.252protein ======
type:transmembrane region  description:Helical
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.253protein ======
type:transmembrane region  description:Helical
====== NO.254protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.255protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.256protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.257protein ======
type:transmembrane region  description:Helical
====== NO.258protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.259protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.260protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.261protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.262protein ======
type:domain  description:Pyr_redox_2
====== NO.263protein ======
type:domain  description:Pyr_redox_2
====== NO.264protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.265protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.266protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.267protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.268protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.269protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:repeat  description:ANK
====== NO.270protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.271protein ======
====== NO.272protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.273protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.274protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.275protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.276protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.277protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.278protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.279protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.280protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.281protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.282protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.283protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.284protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.285protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.286protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.287protein ======
type:signal peptide  description:None
type:chain  description:None
====== NO.288protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.289protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.290protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.291protein ======
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.292protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.293protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.294protein ======
type:transmembrane region  description:Helical
====== NO.295protein ======
type:domain  description:Albumin
====== NO.296protein ======
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.297protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.298protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.299protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.300protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.301protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.302protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.303protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.304protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.305protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.306protein ======
type:domain  description:Pyr_redox_2
====== NO.307protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.308protein ======
type:domain  description:Pyr_redox_2
====== NO.309protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.310protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.311protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
====== NO.312protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.313protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.314protein ======
====== NO.315protein ======
type:domain  description:Pyr_redox_2
====== NO.316protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.317protein ======
type:transmembrane region  description:Helical
====== NO.318protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.319protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.320protein ======
====== NO.321protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.322protein ======
type:domain  description:Pyr_redox_2
====== NO.323protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.324protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.325protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.326protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.327protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.328protein ======
type:domain  description:Gla
====== NO.329protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.330protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:repeat  description:ANK
====== NO.331protein ======
type:transmembrane region  description:Helical
type:region of interest  description:Disordered
====== NO.332protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.333protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.334protein ======
type:domain  description:Pyr_redox_2
====== NO.335protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.336protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.337protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.338protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
====== NO.339protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.340protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.341protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.342protein ======
type:domain  description:Pyr_redox_2
====== NO.343protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.344protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.345protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.346protein ======
type:domain  description:Pyr_redox_2
====== NO.347protein ======
type:transmembrane region  description:Helical
====== NO.348protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.349protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.350protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.351protein ======
type:domain  description:Pyr_redox_2
====== NO.352protein ======
type:domain  description:Pyr_redox_2
====== NO.353protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.354protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:coiled-coil region  description:None
type:non-terminal residue  description:None
====== NO.355protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.356protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.357protein ======
====== NO.358protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.359protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.360protein ======
type:transmembrane region  description:Helical
====== NO.361protein ======
type:domain  description:Pyr_redox_2
====== NO.362protein ======
type:transmembrane region  description:Helical
====== NO.363protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.364protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.365protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.366protein ======
type:domain  description:Pyr_redox_2
====== NO.367protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.368protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.369protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.370protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.371protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.372protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:coiled-coil region  description:None
====== NO.373protein ======
type:domain  description:Pyr_redox_2
====== NO.374protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.375protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.376protein ======
type:domain  description:Pyr_redox_2
====== NO.377protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.378protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.379protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.380protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.381protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.382protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.383protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.384protein ======
type:signal peptide  description:None
type:chain  description:None
====== NO.385protein ======
type:domain  description:Pyr_redox_2
====== NO.386protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.387protein ======
type:domain  description:Pyr_redox_2
====== NO.388protein ======
type:domain  description:Pyr_redox_2
====== NO.389protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.390protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.391protein ======
type:domain  description:Albumin
====== NO.392protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:coiled-coil region  description:None
====== NO.393protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.394protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.395protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.396protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.397protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.398protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.399protein ======
type:domain  description:Pyr_redox_2
====== NO.400protein ======
====== NO.401protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.402protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.403protein ======
type:domain  description:Pyr_redox_2
====== NO.404protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.405protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.406protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.407protein ======
type:domain  description:Pyr_redox_2
====== NO.408protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.409protein ======
type:domain  description:Albumin
====== NO.410protein ======
type:transmembrane region  description:Helical
====== NO.411protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.412protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.413protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.414protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.415protein ======
type:transmembrane region  description:Helical
====== NO.416protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.417protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.418protein ======
====== NO.419protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.420protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.421protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.422protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
====== NO.423protein ======
type:domain  description:Pyr_redox_2
====== NO.424protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:coiled-coil region  description:None
====== NO.425protein ======
type:transmembrane region  description:Helical
====== NO.426protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.427protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.428protein ======
type:transmembrane region  description:Helical
====== NO.429protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.430protein ======
type:transmembrane region  description:Helical
====== NO.431protein ======
type:domain  description:Pyr_redox_2
====== NO.432protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.433protein ======
type:domain  description:Pyr_redox_2
====== NO.434protein ======
type:transmembrane region  description:Helical
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.435protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.436protein ======
type:domain  description:Pyr_redox_2
====== NO.437protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.438protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.439protein ======
type:domain  description:Pyr_redox_2
====== NO.440protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.441protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.442protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.443protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.444protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.445protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.446protein ======
type:domain  description:Pyr_redox_2
====== NO.447protein ======
type:domain  description:Pyr_redox_2
====== NO.448protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.449protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.450protein ======
====== NO.451protein ======
====== NO.452protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.453protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.454protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.455protein ======
====== NO.456protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.457protein ======
type:domain  description:Pyr_redox_2
====== NO.458protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.459protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.460protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.461protein ======
====== NO.462protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.463protein ======
type:transmembrane region  description:Helical
====== NO.464protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.465protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:NADP; via amide nitrogen
====== NO.466protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:coiled-coil region  description:None
====== NO.467protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.468protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.469protein ======
type:transmembrane region  description:Helical
====== NO.470protein ======
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.471protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:NADP; via amide nitrogen
====== NO.472protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:IRK
type:domain  description:IRK_C
type:region of interest  description:Disordered
type:site  description:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium
====== NO.473protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.474protein ======
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.475protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.476protein ======
====== NO.477protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.478protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.479protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.480protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.481protein ======
====== NO.482protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.483protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.484protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.485protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.486protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.487protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.488protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.489protein ======
type:transmembrane region  description:Helical
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.490protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.491protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.492protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.493protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.494protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.495protein ======
type:signal peptide  description:None
type:chain  description:None
type:transmembrane region  description:Helical
type:domain  description:Tyrosinase_Cu-bd
type:domain  description:Tyrosinase_Cu-bd
type:region of interest  description:Disordered
====== NO.496protein ======
type:domain  description:UBC core
type:active site  description:Glycyl thioester intermediate
====== NO.497protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.498protein ======
type:transmembrane region  description:Helical
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.499protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.500protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.501protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.502protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.503protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
====== NO.504protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.505protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.506protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.507protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.508protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
====== NO.509protein ======
type:signal peptide  description:None
type:chain  description:C-X-C motif chemokine 10
type:modified residue  description:Citrulline
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAB60485.
====== NO.510protein ======
type:signal peptide  description:None
type:chain  description:Extracellular calcium-sensing receptor
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:region of interest  description:Ligand-binding 1 (LB1)
type:region of interest  description:Anion binding
type:region of interest  description:Ligand-binding 2 (LB2)
type:region of interest  description:Anion binding
type:region of interest  description:Cysteine-rich (CR)
type:region of interest  description:Interaction with RNF19A
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:disulfide bond  description:Interchain
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.511protein ======
type:signal peptide  description:None
type:chain  description:Extracellular calcium-sensing receptor
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:region of interest  description:Ligand-binding 1 (LB1)
type:region of interest  description:Anion binding
type:region of interest  description:Ligand-binding 2 (LB2)
type:region of interest  description:Anion binding
type:region of interest  description:Cysteine-rich (CR)
type:region of interest  description:Interaction with RNF19A
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid
type:site  description:Important for ability of agonist AMG 416 to activate G-protein-coupled receptor activity
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:disulfide bond  description:Interchain
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:sequence variant  description:In HHC1; demonstrates reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; fails to be inserted in the microsomes and does not undergo proper glycosylation; dbSNP:rs200673016.
type:sequence variant  description:In HHC1; has a dose-response curve shifted to the right relative to that of wild-type; demonstrates reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; fails to be inserted in the microsomes and does not undergo proper glycosylation; dbSNP:rs104893717.
type:sequence variant  description:Does not demonstrate reduced intracellular and plasma membrane expression and signaling to the MAPK pathway in response to extracellular calcium relative to wild-type; does not fail to be inserted in the microsomes and does undergo proper glycosylation; dbSNP:rs199515839.
type:sequence variant  description:In HHC1; dbSNP:rs1064794290.
type:sequence variant  description:Found in a patient with primary hyperparathyroidism detected at adulthood; mutant CASR is activated by a higher calcium concentrations than the wild-type.
type:sequence variant  description:In HHC1; dbSNP:rs121909262.
type:sequence variant  description:In HHC1; dbSNP:rs1553765909.
type:sequence variant  description:In HYPOC1; the EC(50) of the mutant is significantly lower than that of wild-type; dbSNP:rs104893702.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs886041154.
type:sequence variant  description:In HHC1; mild; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909265.
type:sequence variant  description:In HHC1; does not affect homodimerization; impaired N-glycosylation; impaired cell membrane localization; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909266.
type:sequence variant  description:In HHC1; does not affect homodimerization; impaired N-glycosylation; impaired cell membrane localization; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1276839362.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In NSHPT; Abolished G-protein coupled receptor activity.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HYPOC1; dbSNP:rs104893691.
type:sequence variant  description:In HYPOC1; the mutation shifts the concentration-response curve to the left and increases maximal activity; dbSNP:rs104893695.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1; shifts the concentration-response curve of calcium ions to the left; dbSNP:rs104893708.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs121909260.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893696.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1; associated with clinical features of Bartter syndrome; dbSNP:rs121909267.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909263.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909264.
type:sequence variant  description:In HHC1; dbSNP:rs769256610.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893694.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; dbSNP:rs193922441.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs201851934.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1060502855.
type:sequence variant  description:In HHC1; although the mutant receptor is expressed normally at the cell surface it is unresponsive with respect to intracellular signaling (MAPK activation) to increases in extracellular calcium concentrations; dbSNP:rs121909268.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs104893689.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; dbSNP:rs104893697.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; dbSNP:rs1482119762.
type:sequence variant  description:In HYPOC1; dbSNP:rs397514728.
type:sequence variant  description:In HHC1; dbSNP:rs397514728.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In NSHPT; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs28936684.
type:sequence variant  description:In HHC1; G-protein coupled receptor signaling pathway; less markedly impaired relative to wild-type than L-227; does not affect cell membrane localization; dbSNP:rs28936684.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In dbSNP:rs62269092.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909259.
type:sequence variant  description:In NSHPT.
type:sequence variant  description:Mutation found in a patient with primary hyperparathyroidism detected at adulthood; inactivating mutation; mutant CASR is activated by a higher calcium concentrations than the wild-type.
type:sequence variant  description:In EIG8; patients present juvenile myoclonus epilepsy.
type:sequence variant  description:In HHC1; dbSNP:rs1064794291.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In HHC1; loss-of-function mutation; the quantity of the mutant receptor is higher than that of the wild-type receptor; dose-response curves show that the mutation significantly reduces the sensitivity of the receptor to extracellular calcium concentrations; dbSNP:rs104893716.
type:sequence variant  description:In HHC1; dbSNP:rs193922423.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In NSHPT; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs1060502861.
type:sequence variant  description:In HHC1; dbSNP:rs104893719.
type:sequence variant  description:In HHC1; dbSNP:rs777646067.
type:sequence variant  description:In HHC1; Abolished G-protein coupled receptor activity.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In HHC1; dbSNP:rs104893690.
type:sequence variant  description:In NSHPT and HHC1; dbSNP:rs104893690.
type:sequence variant  description:In HHC1; impaired homodimerization; impaired cell membrane localization.
type:sequence variant  description:In HYPOC1; there is a significant leftward shift in the concentration response curves for the effects of extracellular calcium on both intracellular calcium mobilization and MAPK activity; dbSNP:rs104893712.
type:sequence variant  description:In HYPOC1; dbSNP:rs104893698.
type:sequence variant  description:In HYPOC1; does not affect the total accumulation of inositol phosphates as a function of extracellular calcium concentrations in transfected cells; dbSNP:rs104893703.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In NSHPT.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In NSHPT; dbSNP:rs104893700.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; dbSNP:rs773146939.
type:sequence variant  description:In HYPOC1; dbSNP:rs121909261.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In EIG8; patients present juvenile myoclonus epilepsy; dbSNP:rs753013993.
type:sequence variant  description:In NSHPT.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1; decreased protein level.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway; does not affect cell membrane localization; dbSNP:rs104893718.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1; the mutation shifts the concentration-response curve to the left and increases maximal activity; dbSNP:rs104893699.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; does not affect cell membrane localization.
type:sequence variant  description:In HYPOC1; leftward shift in the concentration-response curve for the mutant receptor; cells cotransfected with both the wild-type and the mutant receptor show an EC(50) similar to the mutant; a gain-of-function mutation rendering the receptor more sensitive than normal to activation; dbSNP:rs104893701.
type:sequence variant  description:In HYPOC1; induces a significant shift to the left relative to the wild-type protein in the MAPK response to increasing extracellular calcium concentrations; dbSNP:rs886041537 and dbSNP:rs104893711.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs121909258.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs140022350.
type:sequence variant  description:In HYPOC1; does not produce a significant activating effect; decreased cell surface receptor expression; dbSNP:rs104893693.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs1057518933.
type:sequence variant  description:In HYPOC1; the concentration-response curve of the mutant receptor is left-shifted and its EC(50) is significantly lower than that of the wild-type; dbSNP:rs104893710.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1.
type:sequence variant  description:In HYPOC1; increased G-protein coupled receptor signaling pathway.
type:sequence variant  description:In HYPOC1; also in HYPOC1 associated with clinical features of Bartter syndrome; shifts the concentration-response curve of calcium ions to the left; dbSNP:rs104893706.
type:sequence variant  description:In dbSNP:rs200777304.
type:sequence variant  description:Probable disease-associated variant found in a patient with hypercalciuric hypercalcemia; mutant CASR has a right-shifted dose-response to extracellular calcium concentrations; activated by a higher calcium concentrations than the wild-type; dbSNP:rs104893704.
type:sequence variant  description:In HHC1.
type:sequence variant  description:In EIG8; dbSNP:rs121909269.
type:sequence variant  description:In dbSNP:rs4987051.
type:sequence variant  description:In HHC1; decreased G-protein coupled receptor signaling pathway; dbSNP:rs200620134.
type:sequence variant  description:Common polymorphism associated with high serum level of calcium; is also a potential predisposing factor in disorders of bone and mineral metabolism; dbSNP:rs1801725.
type:sequence variant  description:In EIG8; patients present juvenile myoclonus epilepsy.
type:sequence variant  description:In EIG8; patients present juvenile myoclonus epilepsy; dbSNP:rs759027000.
type:sequence variant  description:Common polymorphism associated with low serum level of calcium; dbSNP:rs1042636.
type:sequence variant  description:Common polymorphism; dbSNP:rs1801726.
type:mutagenesis site  description:Abolishes G-protein coupled receptor signaling pathway.
type:mutagenesis site  description:Abolishes G-protein coupled receptor activity.
type:mutagenesis site  description:Abolishes G-protein coupled receptor activity.
type:mutagenesis site  description:Nearly abolished G-protein coupled receptor activity.
type:mutagenesis site  description:Abolishes G-protein coupled receptor activity.
type:mutagenesis site  description:Abolishes G-protein coupled receptor activity.
type:mutagenesis site  description:Abolishes ability to sense calcium or magnesium levels.
type:mutagenesis site  description:Abolishes G-protein coupled receptor signaling pathway.
type:mutagenesis site  description:Decreased G-protein coupled receptor signaling pathway.
type:mutagenesis site  description:Abolishes ability of agonist AMG 416 to activate G-protein-coupled receptor activity.
type:sequence conflict  description:In Ref. 3; BAA09453.
type:sequence conflict  description:In Ref. 3; BAA09453.
type:sequence conflict  description:In Ref. 2; AAA86503.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.512protein ======
type:chain  description:Coiled-coil domain-containing protein 62
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs58131754.
type:sequence variant  description:In dbSNP:rs17855031.
type:mutagenesis site  description:Abrogates interaction with ESR1 and ESR2.
type:mutagenesis site  description:No effect on interaction with ESR1 or ESR2.
type:sequence conflict  description:In Ref. 2; BAF85155.
type:sequence conflict  description:In Ref. 4; AAG49396.
====== NO.513protein ======
type:chain  description:Cytochrome P450 monooxygenase 521A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.514protein ======
type:signal peptide  description:None
type:chain  description:CCN family member 1
type:domain  description:IGFBP N-terminal
type:domain  description:VWFC
type:domain  description:TSP type-1
type:domain  description:CTCK
type:region of interest  description:Heparin-binding
type:modified residue  description:Phosphoserine; by FAM20C
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs9658587.
type:sequence conflict  description:In Ref. 2; CAA72167.
type:sequence conflict  description:In Ref. 5; AAB84227.
type:sequence conflict  description:In Ref. 5; AAB84227.
type:sequence conflict  description:In Ref. 7; AAG59863.
====== NO.515protein ======
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
====== NO.516protein ======
type:chain  description:Probable cytochrome P450 515A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.517protein ======
type:chain  description:Probable cytochrome P450 519D1
type:transmembrane region  description:Helical
type:compositionally biased region  description:Asn-rich
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Asn-rich
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.518protein ======
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs3087335.
type:sequence variant  description:In dbSNP:rs11554376.
type:sequence variant  description:In a glioblastoma multiforme sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs2069413.
type:mutagenesis site  description:Reduced phosphorylation by CAK.
type:mutagenesis site  description:2-fold increase in activity.
type:mutagenesis site  description:2-fold increase in activity.
type:mutagenesis site  description:Reduced phosphorylation by CAK.
type:mutagenesis site  description:Abolishes activity.
type:mutagenesis site  description:Reduced phosphorylation by CAK and reduced kinase activity.
type:sequence conflict  description:In Ref. 5; BAA32794.
type:sequence conflict  description:In Ref. 5; BAA32794.
type:sequence conflict  description:In Ref. 5; BAA32794.
type:sequence conflict  description:In Ref. 5; BAA32794.
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
====== NO.519protein ======
type:chain  description:Probable cytochrome P450 508A3
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.520protein ======
type:chain  description:Cyclin-dependent kinase 4 inhibitor D
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:modified residue  description:N-acetylmethionine
type:sequence conflict  description:In Ref. 2; AAA85436.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.521protein ======
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
type:sequence conflict  description:In Ref. 2; BAA09638.
type:sequence conflict  description:In Ref. 2; BAA09638.
type:sequence conflict  description:In Ref. 2; BAA09638.
====== NO.522protein ======
type:chain  description:Probable cytochrome P450 508C1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.523protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.524protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.525protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.526protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.527protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.528protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.529protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.530protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.531protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.532protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.533protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.534protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.535protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.536protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.537protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.538protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.539protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.540protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.541protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:coiled-coil region  description:None
====== NO.542protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.543protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.544protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
====== NO.545protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.546protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.547protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.548protein ======
type:chain  description:Transcription initiation factor TFIID subunit 11
type:modified residue  description:N-acetylmethionine
====== NO.549protein ======
type:chain  description:E3 ubiquitin/ISG15 ligase TRIM25
type:domain  description:B30.2/SPRY
type:zinc finger region  description:RING-type
type:coiled-coil region  description:None
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)
type:sequence conflict  description:In Ref. 1; BAA09941.
type:sequence conflict  description:In Ref. 1; BAA09941.
type:sequence conflict  description:In Ref. 1; BAA09941.
type:sequence conflict  description:In Ref. 1; BAA09941.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.550protein ======
type:chain  description:Vitamin D3 receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:region of interest  description:Vitamin D3 binding
type:region of interest  description:Interaction with coactivator LXXLL motif
type:region of interest  description:Vitamin D3 binding
type:short sequence motif  description:9aaTAD
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
type:binding site  description:Vitamin D3
====== NO.551protein ======
type:chain  description:Transcription initiation factor TFIID subunit 4
type:domain  description:TAFH
type:compositionally biased region  description:Poly-His
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Gly
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Asp
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:sequence variant  description:In dbSNP:rs6089604.
type:sequence conflict  description:In Ref. 5; AAC50901.
type:sequence conflict  description:In Ref. 1; CAA72189 and 5; AAC50901.
type:sequence conflict  description:In Ref. 1; CAA72189 and 5; AAC50901.
type:sequence conflict  description:In Ref. 5; AAC50901.
type:sequence conflict  description:In Ref. 5; AAC50901.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
====== NO.552protein ======
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; BAB27297.
====== NO.553protein ======
type:signal peptide  description:None
type:chain  description:Stanniocalcin-2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.554protein ======
type:initiator methionine  description:Removed
type:chain  description:SUMO-conjugating enzyme UBC9
type:domain  description:UBC core
type:region of interest  description:Interaction with SUMO1
type:active site  description:Glycyl thioester intermediate
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Substrate binding
type:modified residue  description:N-acetylserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine; by CDK1
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.555protein ======
type:chain  description:Transient receptor potential cation channel subfamily V member 5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:intramembrane region  description:Pore-forming
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:repeat  description:ANK 5
type:repeat  description:ANK 6
type:region of interest  description:Interaction with S100A10
type:region of interest  description:Involved in Ca(2+)-dependent inactivation
type:region of interest  description:Involved in Ca(2+)-dependent inactivation
type:metal ion-binding site  description:Calcium; shared with neighboring subunits
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:mutagenesis site  description:Induces faster Ca(2+)-dependent channel inactivation.
type:mutagenesis site  description:Abolishes interaction with S100A10, plasma membrane localization and channel activity.
type:sequence conflict  description:In Ref. 2; AK085479.
====== NO.556protein ======
type:chain  description:Heterogeneous nuclear ribonucleoproteins A2/B1
type:domain  description:RRM 1
type:domain  description:RRM 2
type:region of interest  description:Low complexity (LC) region
type:region of interest  description:Nuclear targeting sequence
type:compositionally biased region  description:Gly-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6,N6-dimethyllysine; alternate
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine; alternate
type:modified residue  description:Dimethylated arginine; alternate
type:modified residue  description:Omega-N-methylarginine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine; alternate
type:modified residue  description:Dimethylated arginine; alternate
type:modified residue  description:Omega-N-methylarginine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine; alternate
type:modified residue  description:Omega-N-methylarginine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Omega-N-methylarginine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.557protein ======
type:chain  description:Transcription intermediary factor 1-alpha
type:domain  description:Bromo
type:zinc finger region  description:RING-type
type:zinc finger region  description:B box-type 1
type:zinc finger region  description:B box-type 2
type:zinc finger region  description:PHD-type
type:region of interest  description:Nuclear receptor binding site (NRBS)
type:region of interest  description:Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)
type:coiled-coil region  description:None
type:short sequence motif  description:Nuclear localization signal
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Poly-Ser
type:site  description:Breakpoint for translocation to form TRIM24-BRAF oncogene
type:site  description:Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform Short.
type:mutagenesis site  description:Loss of sumoylation; when associated with R-742.
type:mutagenesis site  description:Loss of sumoylation; when associated with R-724.
====== NO.558protein ======
type:chain  description:Small ubiquitin-related modifier 3
type:propeptide  description:None
type:domain  description:Ubiquitin-like
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
====== NO.559protein ======
type:signal peptide  description:None
type:chain  description:Tyrosinase
type:topological domain  description:Lumenal, melanosome
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper B
type:metal ion-binding site  description:Copper B
type:metal ion-binding site  description:Copper B
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In OCA1A; dbSNP:rs61753177.
type:sequence variant  description:In OCA1A; dbSNP:rs61753178.
type:sequence variant  description:In OCA1A; dbSNP:rs61753179.
type:sequence variant  description:In OCA1A; dbSNP:rs28940878.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs755700581.
type:sequence variant  description:In OCA1A; dbSNP:rs61753180.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61753181.
type:sequence variant  description:In OCA1; dbSNP:rs61753182.
type:sequence variant  description:In OCA1A; dbSNP:rs28940879.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61753185.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61753184.
type:sequence variant  description:In OCA1A; dbSNP:rs544053015.
type:sequence variant  description:In OCA1A; dbSNP:rs61753188.
type:sequence variant  description:In OCA1A; dbSNP:rs28940876.
type:sequence variant  description:In OCA1A; dbSNP:rs28940877.
type:sequence variant  description:In OCA1A; dbSNP:rs137854890.
type:sequence variant  description:In OCA1A; dbSNP:rs61753252.
type:sequence variant  description:In OCA1A; dbSNP:rs61753253.
type:sequence variant  description:In dbSNP:rs33955261.
type:sequence variant  description:In dbSNP:rs11545463.
type:sequence variant  description:In OCA1B; dbSNP:rs145513733.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61753259.
type:sequence variant  description:In OCA1A; dbSNP:rs138487695.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs779878377.
type:sequence variant  description:Associated with SHEP3; light/dark skin; dbSNP:rs1042602.
type:sequence variant  description:In OCA1A; dbSNP:rs750553908.
type:sequence variant  description:In OCA1A; dbSNP:rs1338186937.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61754362.
type:sequence variant  description:In OCA1A; dbSNP:rs28940880.
type:sequence variant  description:In OCA1A; dbSNP:rs61754363.
type:sequence variant  description:In OCA1A; dbSNP:rs63159160.
type:sequence variant  description:In OCA1A; dbSNP:rs61754365.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs63159160.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61754367.
type:sequence variant  description:In OCA1A; dbSNP:rs774670098.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61754369.
type:sequence variant  description:In OCA1A; dbSNP:rs61754370.
type:sequence variant  description:In OCA1A; dbSNP:rs62645902.
type:sequence variant  description:In OCA1B and OCA1A; dbSNP:rs104894314.
type:sequence variant  description:In OCA1A; dbSNP:rs1463109821.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs1468041471.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A and OCA1B; dbSNP:rs757754120.
type:sequence variant  description:In OCA1A; dbSNP:rs200854796.
type:sequence variant  description:In OCA1A; dbSNP:rs61754375.
type:sequence variant  description:In OCA1A; dbSNP:rs61754374.
type:sequence variant  description:In dbSNP:rs1042608.
type:sequence variant  description:In OCA1; dbSNP:rs61754377.
type:sequence variant  description:In OCA1; dbSNP:rs61754378.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1B; dbSNP:rs61754379.
type:sequence variant  description:In OCA1A; dbSNP:rs61754380.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs372534292.
type:sequence variant  description:In OCA1A; dbSNP:rs62645906.
type:sequence variant  description:In OCA1; dbSNP:rs62645907.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs773970123.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs62645908.
type:sequence variant  description:In OCA1A; dbSNP:rs151206295.
type:sequence variant  description:In OCA1A; dbSNP:rs61754383.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs776054795.
type:sequence variant  description:In OCA1A; dbSNP:rs61754385.
type:sequence variant  description:In OCA1A; dbSNP:rs61754387.
type:sequence variant  description:In OCA1A; dbSNP:rs61754386.
type:sequence variant  description:In OCA1A; dbSNP:rs61754388.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1B; dbSNP:rs61754391.
type:sequence variant  description:In OCA1A; dbSNP:rs104894315.
type:sequence variant  description:In OCA1A; dbSNP:rs121908011.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1B; dbSNP:rs62645914.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs752344007.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs62645916.
type:sequence variant  description:In OCA1B.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In dbSNP:rs1126809.
type:sequence variant  description:In OCA1A and OCA1B; dbSNP:rs104894316.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA-I; dbSNP:rs62645920.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A and OCA1B; dbSNP:rs104894313.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs61754392.
type:sequence variant  description:In OCA1A and OCA1B; temperature sensitive variant; dbSNP:rs61754393.
type:sequence variant  description:In OCA1A; dbSNP:rs758747581.
type:sequence variant  description:In OCA1A; dbSNP:rs1362285246.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs281865325.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs281865327.
type:sequence variant  description:In OCA1A.
type:sequence variant  description:In OCA1A; dbSNP:rs104894317.
type:sequence variant  description:In OCA1A; dbSNP:rs104894318.
type:sequence variant  description:In OCA1A; dbSNP:rs1050708792.
type:sequence conflict  description:In Ref. 2; AAA61241.
type:sequence conflict  description:In Ref. 4; CAA68756.
type:sequence conflict  description:In Ref. 2; AAA61241.
type:sequence conflict  description:In Ref. 2; AAA61241/AAA61244.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 2.
====== NO.560protein ======
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.561protein ======
type:chain  description:Retinoic acid receptor RXR-alpha
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating domain
type:region of interest  description:Nuclear localization signal
type:region of interest  description:Hinge
type:region of interest  description:Required for nuclear export
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:binding site  description:9-cis retinoic acid
type:binding site  description:9-cis retinoic acid; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphothreonine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:mutagenesis site  description:Loss of constituitive phosphorylation. No effect on RXRA transcriptional activity.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-75 and A-87. No effect on RXRA transcriptional activity.
type:mutagenesis site  description:No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-61 and A-87.
type:mutagenesis site  description:No effect on constituitive phosphorylation, decreased stress-induced phosphorylation but no effect on RXRA transcriptional activity. Abolishes stress-induced phosphorylation but no effect on RXRA transcriptional activity; when associated with A-61 and A-75. phosphorylation. No effect on RXRA transcriptional activity.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constituitive phosphorylation.
type:mutagenesis site  description:No effect on constiuitive phosphorylation but loss of stress-induced phosphorylation. No effect on RXRA transcriptional activity.
type:mutagenesis site  description:Abolishes interaction with ASXL1 and NCOA1.
type:mutagenesis site  description:Abolishes interaction with ASXL1 and NCOA1.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
====== NO.562protein ======
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
====== NO.563protein ======
type:chain  description:SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1
type:domain  description:SWIB/MDM2
type:region of interest  description:Interaction with ESR1, NR1H4, NR3C1, PGR and SMARCA4
type:region of interest  description:Interaction with SMARCC1 and SMARCC2
type:region of interest  description:Necessary for GR/NR3C1-mediated remodeling and transcription from chromatin; required for GR/NR3C1 interaction with the BRG1/SMARCA4 complex in vivo
type:coiled-coil region  description:None
type:compositionally biased region  description:Poly-Lys
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:sequence conflict  description:In Ref. 2; AAA53377 and 3; AAC52794.
type:sequence conflict  description:In Ref. 4; BAC35856.
type:sequence conflict  description:In Ref. 4; BAC35856.
type:sequence conflict  description:In Ref. 2; AAA53377 and 3; AAC52794.
type:sequence conflict  description:In Ref. 2; AAA53377 and 3; AAC52794.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.564protein ======
type:chain  description:Transcription initiation factor TFIID subunit 11
type:modified residue  description:N-acetylmethionine
====== NO.565protein ======
type:signal peptide  description:None
type:chain  description:Pleiotrophin
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate A binding
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 14; AA sequence.
type:sequence conflict  description:In Ref. 14; AA sequence.
type:sequence conflict  description:In Ref. 9; AAV38498.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
====== NO.566protein ======
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 3; AAA35637.
====== NO.567protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:Reduced molecular weight.
type:mutagenesis site  description:No effect on molecular weight.
type:sequence conflict  description:In Ref. 1 and 3.
type:sequence conflict  description:In Ref. 2; AAB70793.
====== NO.568protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 2; AAH24495.
type:sequence conflict  description:In Ref. 1; AAC53145.
====== NO.569protein ======
type:initiator methionine  description:Removed
type:chain  description:SNW domain-containing protein 1
type:region of interest  description:Interaction with PPIL1
type:region of interest  description:SNW
type:compositionally biased region  description:Pro-rich
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:mutagenesis site  description:Abolishes interaction with PPIL1.
type:mutagenesis site  description:Abolishes interaction with PPIL1.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
====== NO.570protein ======
type:initiator methionine  description:Removed
type:chain  description:Vimentin
type:domain  description:IF rod
type:region of interest  description:Head
type:region of interest  description:Coil 1A
type:region of interest  description:Linker 1
type:region of interest  description:Coil 1B
type:region of interest  description:Linker 12
type:region of interest  description:Coil 2
type:region of interest  description:Tail
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:short sequence motif  description:[IL]-x-C-x-x-[DE] motif
type:site  description:Stutter
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by PKA and PKC; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by PKC
type:modified residue  description:Phosphoserine; by PKC
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by PKC; alternate
type:modified residue  description:Phosphoserine; by CaMK2, PKA, PKC and ROCK2
type:modified residue  description:Phosphoserine; by PKC
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine; by PKA and PKC
type:modified residue  description:Phosphoserine; by AURKB and ROCK2
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GlcNAc) serine; alternate
type:glycosylation site  description:O-linked (GlcNAc) threonine
type:glycosylation site  description:O-linked (GlcNAc) serine; alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:mutagenesis site  description:Retains filamentous network during mitosis when transfected alone and when coexpressed with nestin.
type:mutagenesis site  description:Induces loss of filamentous network when coexpressed with nestin.
====== NO.571protein ======
type:initiator methionine  description:Removed
type:chain  description:Vitamin K-dependent gamma-carboxylase
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Lumenal
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Lumenal
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Lumenal
type:modified residue  description:N-acetylalanine
type:disulfide bond  description:None
====== NO.572protein ======
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.573protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Bone morphogenetic protein 7
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:sequence variant  description:Found in a patient with unilateral microphthalmia, optic disk and chorioretinal coloboma, mild learning difficulties; dbSNP:rs376798352.
type:sequence variant  description:In dbSNP:rs61733438.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
====== NO.574protein ======
type:chain  description:Probable cytochrome P450 518A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.575protein ======
type:signal peptide  description:None
type:chain  description:Tyrosinase
type:topological domain  description:Lumenal, melanosome
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:compositionally biased region  description:Poly-Lys
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper A
type:metal ion-binding site  description:Copper B
type:metal ion-binding site  description:Copper B
type:metal ion-binding site  description:Copper B
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:sequence variant  description:In albino mice.
type:sequence variant  description:In strain: Himalayan.
type:sequence variant  description:In chinchilla mice.
type:sequence conflict  description:In Ref. 4; AAA37806.
type:sequence conflict  description:In Ref. 4; AAA37806.
type:sequence conflict  description:In Ref. 3; CAA31273.
type:sequence conflict  description:In Ref. 2; AAA40516.
====== NO.576protein ======
type:chain  description:Thioredoxin-interacting protein
type:modified residue  description:Phosphoserine
type:disulfide bond  description:Interchain
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs6674773.
type:sequence conflict  description:In Ref. 1; AAB31977 and 2; AAT01927.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.577protein ======
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.578protein ======
type:chain  description:Tumor necrosis factor, membrane form
type:chain  description:Intracellular domain 1
type:chain  description:Intracellular domain 2
type:chain  description:C-domain 1
type:chain  description:C-domain 2
type:chain  description:Tumor necrosis factor, soluble form
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by ADAM17
type:modified residue  description:Phosphoserine; by CK1
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:glycosylation site  description:O-linked (GalNAc...) serine; in soluble form
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:sequence variant  description:In strain: BALB/c and C57BL/6.
type:sequence variant  description:In strain: BALB/c and C57BL/6.
type:sequence conflict  description:In Ref. 8; AAB65593.
type:sequence conflict  description:In Ref. 3 and 4.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
====== NO.579protein ======
type:chain  description:Small ubiquitin-related modifier 2
type:propeptide  description:None
type:domain  description:Ubiquitin-like
type:modified residue  description:N6-acetyllysine; alternate
type:cross-link  description:Peptide (Met-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
====== NO.580protein ======
type:chain  description:Two pore calcium channel protein 2
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S1 of repeat I
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S2 of repeat I
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S3 of repeat I
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S4 of repeat I
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S5 of repeat I
type:topological domain  description:Extracellular
type:intramembrane region  description:Helical; Pore-forming
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S6 of repeat I
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S1 of repeat II
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S2 of repeat II
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S3 of repeat II
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S4 of repeat II
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=S5 of repeat II
type:topological domain  description:Extracellular
type:intramembrane region  description:Helical; Pore-forming
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=S6 of repeat II
type:topological domain  description:Cytoplasmic
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Complete loss of selectivity for calcium over monocovalent cations.
type:mutagenesis site  description:Loss of N-glycosylation; when associated with N-601.
type:mutagenesis site  description:Loss of N-glycosylation; when associated with N-594.
type:mutagenesis site  description:Partial loss of selectivity for calcium over monocovalent cations.
type:sequence conflict  description:In Ref. 1; BAC41072.
type:sequence conflict  description:In Ref. 1; BAC41072.
type:sequence conflict  description:In Ref. 1; BAC41072.
====== NO.581protein ======
type:chain  description:E3 ubiquitin/ISG15 ligase TRIM25
type:domain  description:B30.2/SPRY
type:zinc finger region  description:RING-type
type:region of interest  description:Interaction with influenza A virus NS1
type:coiled-coil region  description:None
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)
type:sequence variant  description:In dbSNP:rs7212260.
type:sequence variant  description:In dbSNP:rs205498.
type:mutagenesis site  description:No effect on ISGylation.
type:mutagenesis site  description:No effect on ISGylation.
type:mutagenesis site  description:No effect on ISGylation.
type:mutagenesis site  description:No ISGylation.
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.582protein ======
type:chain  description:SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1
type:domain  description:SWIB/MDM2
type:region of interest  description:Interaction with ESR1, NR1H4, NR3C1, PGR and SMARCA4
type:region of interest  description:Interaction with SMARCC1 and SMARCC2
type:region of interest  description:Necessary for GR/NR3C1-mediated remodeling and transcription from chromatin; required for GR/NR3C1 interaction with the BRG1/SMARCA4 complex in vivo
type:coiled-coil region  description:None
type:compositionally biased region  description:Poly-Lys
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 1; AAC50695.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
====== NO.583protein ======
type:chain  description:Zinc finger protein SNAI2
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5; atypical
type:region of interest  description:SNAG domain
type:sequence variant  description:In dbSNP:rs11544360.
type:sequence variant  description:In a patient with neural tube defects; dbSNP:rs748917911.
type:sequence variant  description:In dbSNP:rs13280993.
type:mutagenesis site  description:Increases protein stability. Does not affect repressor activity on E-cadherin/CDH1 promoter.
type:mutagenesis site  description:Increases protein stability, nuclear accumulation and repressor activity on E-cadherin/CDH1 promoter; when associated with A-96.
type:mutagenesis site  description:Increases protein stability, nuclear accumulation and repressor activity on E-cadherin/CDH1 promoter; when associated with A-92.
type:mutagenesis site  description:Increases protein stability and half-life, nuclear accumulation and repressor activity on E-cadherin/CDH1 promoter; when associated with A-104.
type:mutagenesis site  description:Increases protein stability and half-life, nuclear accumulation and repressor activity on E-cadherin/CDH1 promoter; when associated with A-100.
type:mutagenesis site  description:Abolishes binding to KPNA2, KPNB1 and IPO7 and impairs binding to TMPO1; when associated with E-175.
type:mutagenesis site  description:Abolishes binding to KPNA2, KPNB1 and IPO7 and impairs binding to TMPO1; when associated with E-166.
type:mutagenesis site  description:Abolishes binding to KPNA2 and impairs binding to KPNB1, IPO7 and TMPO1; when associated with E-196.
type:mutagenesis site  description:Abolishes binding to KPNA2 and impairs binding to KPNB1, IPO7 and TMPO1; when associated with E-192.
type:mutagenesis site  description:Abolishes binding to KPNA2, KPNB1 and IPO7 and impairs binding to TMPO1; when associated with E-229.
type:mutagenesis site  description:Abolishes binding to KPNA2, KPNB1 and IPO7 and impairs binding to TMPO1; when associated with E-225.
type:sequence conflict  description:In Ref. 5; BAD97088.
====== NO.584protein ======
type:chain  description:Tumor necrosis factor, membrane form
type:chain  description:Intracellular domain 1
type:chain  description:Intracellular domain 2
type:chain  description:C-domain 1
type:chain  description:C-domain 2
type:chain  description:Tumor necrosis factor, soluble form
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by ADAM17
type:modified residue  description:Phosphoserine; by CK1
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:glycosylation site  description:O-linked (GalNAc...) serine; in soluble form
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:sequence variant  description:None
type:sequence variant  description:None
type:sequence conflict  description:In Ref. 2; CAA05290/CAA47146.
type:sequence conflict  description:In Ref. 2; CAA05290/CAA47146.
type:sequence conflict  description:In Ref. 2; CAA05290/CAA47146.
====== NO.585protein ======
type:signal peptide  description:None
type:chain  description:UDP-glucuronosyltransferase 1A3
type:transmembrane region  description:Helical
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs28898617.
type:sequence variant  description:In dbSNP:rs3821242.
type:sequence variant  description:In dbSNP:rs45625338.
type:sequence variant  description:In dbSNP:rs6431625.
type:sequence variant  description:In dbSNP:rs45595237.
type:sequence variant  description:In dbSNP:rs28898618.
type:sequence variant  description:In dbSNP:rs28898619.
type:sequence variant  description:In dbSNP:rs13406898.
type:sequence variant  description:In dbSNP:rs61764030.
type:sequence variant  description:In dbSNP:rs45449995.
====== NO.586protein ======
type:chain  description:Thioredoxin-interacting protein
type:modified residue  description:Phosphoserine
type:disulfide bond  description:Interchain
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
====== NO.587protein ======
type:chain  description:Transcription initiation factor TFIID subunit 7
type:coiled-coil region  description:None
type:short sequence motif  description:[KR]-[STA]-K motif
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.588protein ======
type:chain  description:Transcription intermediary factor 1-alpha
type:domain  description:Bromo
type:zinc finger region  description:RING-type
type:zinc finger region  description:B box-type 1
type:zinc finger region  description:B box-type 2
type:zinc finger region  description:PHD-type
type:region of interest  description:Nuclear receptor binding site (NRBS)
type:region of interest  description:Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)
type:region of interest  description:Interaction with histone H3 that is acetylated at 'Lys-23' (H3K23ac)
type:coiled-coil region  description:None
type:short sequence motif  description:Nuclear localization signal
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Gln
type:site  description:Breakpoint for translocation to form TRIM24-RET oncogene
type:site  description:Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform Short.
type:sequence variant  description:In an ovarian serous carcinoma sample; somatic mutation.
type:sequence variant  description:In a lung squamous cell carcinoma sample; somatic mutation.
type:sequence variant  description:None
type:sequence variant  description:In dbSNP:rs35356723.
type:sequence variant  description:In dbSNP:rs34585297.
type:mutagenesis site  description:Strongly reduced affinity for histone H3 that is not methylated at 'Lys-4' (H3K4me0).
type:mutagenesis site  description:Abolishes interaction with histone H3.
type:mutagenesis site  description:Strongly reduced affinity for histone H3 that is acetylated at 'Lys-23' (H3K23ac).
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:sequence conflict  description:In Ref. 1; AAB63585.
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
====== NO.589protein ======
type:chain  description:Thioredoxin-interacting protein
type:modified residue  description:Phosphoserine
type:disulfide bond  description:Interchain
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 3; BAB23444.
type:sequence conflict  description:In Ref. 1; AAD48499.
type:sequence conflict  description:In Ref. 1; AAD48499.
type:sequence conflict  description:In Ref. 2; AAG32665/AAG32666.
type:sequence conflict  description:In Ref. 4; AAH31850.
type:sequence conflict  description:In Ref. 1; AAD48499.
====== NO.590protein ======
type:signal peptide  description:None
type:chain  description:UDP-glucuronosyltransferase 1A4
type:transmembrane region  description:Helical
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs3892221.
type:sequence variant  description:In dbSNP:rs6755571.
type:sequence variant  description:Increased glucuronosyltransferase activity towards calcidiol; dbSNP:rs2011425.
type:sequence variant  description:In dbSNP:rs45621441.
type:sequence variant  description:In dbSNP:rs45540231.
====== NO.591protein ======
type:initiator methionine  description:Removed
type:chain  description:SUMO-conjugating enzyme UBC9
type:domain  description:UBC core
type:region of interest  description:Interaction with SUMO1
type:active site  description:Glycyl thioester intermediate
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Substrate binding
type:modified residue  description:N-acetylserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine; by CDK1
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:mutagenesis site  description:Impairs binding to SUMO1 and catalytic activity.
type:mutagenesis site  description:Impairs binding to SUMO1 and catalytic activity.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Slightly impairs binding to RANBP2.
type:mutagenesis site  description:Slightly impairs binding to RANBP2.
type:mutagenesis site  description:Slightly impairs binding to RANBP2.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Impairs binding to RANBP2.
type:mutagenesis site  description:Slightly impairs binding to RANBP2.
type:mutagenesis site  description:Impairs catalytic activity.
type:mutagenesis site  description:Impairs catalytic activity.
type:mutagenesis site  description:Loss of enhancement of sumoylation by RWDD3. No effect on RWDD3 protein levels.
type:mutagenesis site  description:Impairs catalytic activity.
type:mutagenesis site  description:Impairs catalytic activity.
type:mutagenesis site  description:No effect on catalytic activity.
type:sequence conflict  description:In Ref. 6; AAC50603.
type:sequence conflict  description:In Ref. 6; AAC50603.
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.592protein ======
type:signal peptide  description:None
type:chain  description:Vitamin D-binding protein
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.593protein ======
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 5; AA sequence.
type:sequence conflict  description:In Ref. 6; AAA40843.
type:sequence conflict  description:In Ref. 3; AAA40853.
type:sequence conflict  description:In Ref. 6; AAA40843.
type:sequence conflict  description:In Ref. 5; AA sequence.
type:sequence conflict  description:In Ref. 6; AAA40843.
====== NO.594protein ======
type:chain  description:Zinc finger protein SNAI1
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4; atypical
type:region of interest  description:SNAG domain
type:region of interest  description:Required and sufficient for interaction with KDM1A
type:region of interest  description:LATS2 binding
type:region of interest  description:Required for FBXL14-triggered degradation
type:region of interest  description:Required for nuclear localization and interaction with KPNB1, NOTCH1 and PARP1
type:short sequence motif  description:Destruction motif
type:compositionally biased region  description:Ser-rich
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by CK2
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by LATS2
type:modified residue  description:Phosphoserine; by PAK1
type:glycosylation site  description:O-linked (GlcNAc) serine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:sequence variant  description:In dbSNP:rs34261470.
type:sequence variant  description:In dbSNP:rs4647958.
type:mutagenesis site  description:Abolishes repressor activity on E-cadherin/CDH1 promoter and binding to KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Loss of interaction with KDM1A.
type:mutagenesis site  description:Does not affect E-cadherin/CDH1 repression; when associated with R-16.
type:mutagenesis site  description:Abolishes PKA phosphorylation. Strongly decreases repressor activity on E-cadherin/CDH1 and CLDN1 promoters. Increases protein stability. Affects function in EMT.
type:mutagenesis site  description:Does not affect E-cadherin repression; when associated with R-9.
type:mutagenesis site  description:Abolishes CK2 phosphorylation. Strongly decreases repressor activity on E-cadherin/CDH1 and CLDN1 promoters. Increases protein stability. Affects function in cell survival. Abolishes phosphorylation in the serine-rich region; when associated with A-104 and A-107.
type:mutagenesis site  description:Does not affect repressor activity on E-cadherin/CDH1 promoter.
type:mutagenesis site  description:Abolishes recognition and ubiquitination by BTRC which increases steady state level and half-life. Preferentially localizes to the nucleus. Induces a more aggressive tissue invasion program. Lower sensitivity to BTRC-triggered degradation, impairs phosphorylation by GSK3B and does not affect NOTCH1-induced degradation; when associated with A-100. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-100; A-107; A-111; A-115 and A-119.
type:mutagenesis site  description:No change. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation and loss of ability to repress E-cadherin/CDH1; when associated with R-137 and R-146.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation and impaired phosphorylation by GSK3B; when associated with A-96. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-107; A-111; A-115 and A-119. Does not affect NOTCH1-induced degradation; when associated with A-96. Abolishes phosphorylation at S-96.
type:mutagenesis site  description:Increases protein stability, does not affect repressor activity on E-cadherin/CDH1 promoter, preferentially localizes to the nucleus, induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B, binding to BTRC and ubiquitination; when associated with A-107. Impairs phosphorylation in the serine-rich domain/region; when associated with A-92 and A-107. Abolishes phosphorylation at S-96.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-111; A-115 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-111; A-115 and A-119. Increases protein stability, does not affect repressor activity on E-cadherin promoter, preferentially localizes to the nucleus, induces a more aggressive tissue invasion program and impairs phosphorylation by GSK3B, binding to BTRC and ubiquitination; when associated with A-104. Impairs phosphorylation in the serine-rich region; when associated with A-92 and A-104. Abolishes phosphorylation at S-96.
type:mutagenesis site  description:Predominantly localized to the cytoplasm; when associated with E-111; E-115 and E-119.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-115 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-115 and A-119.
type:mutagenesis site  description:Predominantly localized to the cytoplasm; when associated with E-107; E-115 and E-119.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-111 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-111 and A-119.
type:mutagenesis site  description:Predominantly localized to the cytoplasm; when associated with E-107; E-111 and E-119.
type:mutagenesis site  description:Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-107; A-111 and A-119. Lower sensitivity to BTRC-triggered degradation, impaired phosphorylation by GSK3B and loss of cytoplasmic localization; when associated with A-96; A-100; A-107; A-111 and A-115.
type:mutagenesis site  description:Predominantly localized to the cytoplasm; when associated with E-107; E-111 and E-115.
type:mutagenesis site  description:Lower sensitivity to FBXL14-triggered degradation. Lower sensitivity to FBXL14-triggered degradation; when associated with R-146. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation and loss of ability to repress E-cadherin; when associated with R-98 and R-146.
type:mutagenesis site  description:Lower sensitivity to FBXL14-triggered degradation. Lower sensitivity to FBXL14-triggered degradation; when associated with R-137. Complete loss of sensitivity to FBXL14- and BTRC-triggered degradation; when associated with R-98 and R-137.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1.
type:mutagenesis site  description:Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-170. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-187 and/or E-220.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-161.
type:mutagenesis site  description:Impairs binding to KPNB1, IPO7 and TNPO1 and abolishes binding to KPNA2. Localizes to cytoplasm and nucleus.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-191. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-161 and/or E-220.
type:mutagenesis site  description:Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with A-193. Loss of binding to KPNB1 and nuclear import; when associated with A-193 and A-196.
type:mutagenesis site  description:Mildly reduces binding to KPNB1. Does not affect binding to KPNA2, IPO7 or TNPO1.
type:mutagenesis site  description:Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with E-191. Loss of binding to KPNB1 and nuclear import; when associated with E-191 and A-196.
type:mutagenesis site  description:Loss of binding to KPNB1 and nuclear import; when associated with E-191 and A-193.
type:mutagenesis site  description:Abolishes LATS2 phosphorylation. Does not affect binding to LATS2. Reduces protein stability. Equally distributed between nucleus and cytoplasm. Increases capacity to associate with nuclear pore importins. Unable to accumulate in the nucleus. Does not abrogate function.
type:mutagenesis site  description:Exclusively localizes to the cytoplasm. Reduces capacity to associate with nuclear pore importins. Unable to enter the nucleus. Does not abrogate function.
type:mutagenesis site  description:Impairs binding to KPNB1, IPO7 and TNPO1 and abolishes binding to KPNA2. Localizes to cytoplasm and nucleus.
type:mutagenesis site  description:Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1. No change in subcellular localization.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-222 and E-224. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-224. Abolishes binding to KPNB1, KPNA2, IPO7 and TNPO1 and nuclear localization; when associated with E-161 and/or E-187.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-220 and E-224.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1. No change in subcellular localization. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1; when associated with E-220 and E-222. Impairs binding to KPNB1, KPNA2, IPO7 and TNPO1 and abolishes nuclear localization, DNA binding and repressor activity on E-cadherin/CDH1 promoter; when associated with E-220.
type:mutagenesis site  description:Mildly reduces binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with A-228.
type:mutagenesis site  description:Very minor effect on binding to KPNB1 and nuclear import. Strongly reduces binding to KPNB1 and nuclear import; when associated with E-224.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7 or TNPO1.
type:mutagenesis site  description:Impairs binding to KPNB1 and IPO7 and abolishes binding to KPNA2 and TNPO1 and nuclear localization.
type:mutagenesis site  description:Does not affect binding to KPNB1, KPNA2, IPO7, TNPO1 or DNA.
type:mutagenesis site  description:Decreases repression activity on E-cadherin/CDH1, occludin and aromatase promoters. Preferentially localizes to the cytoplasm. Abolishes phosphorylation by PAK1.
type:mutagenesis site  description:Mildly reduces binding to KPNB1 and nuclear import.
type:sequence conflict  description:In Ref. 4; BAG36039.
type:sequence conflict  description:In Ref. 7; AAF32527.
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
====== NO.595protein ======
type:initiator methionine  description:Removed
type:chain  description:SNW domain-containing protein 1
type:region of interest  description:Interaction with PPIL1
type:region of interest  description:SNW
type:compositionally biased region  description:Pro-rich
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.596protein ======
type:chain  description:Coiled-coil domain-containing protein 62
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
====== NO.597protein ======
type:signal peptide  description:None
type:chain  description:Extracellular calcium-sensing receptor
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:region of interest  description:Ligand-binding 1 (LB1)
type:region of interest  description:Anion binding
type:region of interest  description:Ligand-binding 2 (LB2)
type:region of interest  description:Anion binding
type:region of interest  description:Cysteine-rich (CR)
type:region of interest  description:Interaction with RNF19A
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid; via carbonyl oxygen
type:binding site  description:Aromatic amino acid
type:binding site  description:Aromatic amino acid
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:disulfide bond  description:Interchain
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform B.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 5; AAF00193.
type:sequence conflict  description:In Ref. 1; AAD28371/AAD28372.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 1; AAD28371/AAD28372.
type:sequence conflict  description:In Ref. 7; BAA77688.
type:sequence conflict  description:In Ref. 7; BAA77688.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 1; AAD28371/AAD28372.
type:sequence conflict  description:In Ref. 1; AAD28371/AAD28372.
type:sequence conflict  description:In Ref. 2; AAD40638.
type:sequence conflict  description:In Ref. 2; AAD40638.
====== NO.598protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor 23
type:glycosylation site  description:O-linked (GalNAc) threonine
type:disulfide bond  description:None
====== NO.599protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:mutagenesis site  description:Impaired 1-alpha hydroxylase activity toward 25-hydroxyvitamin D3. Impaired heme binding.
type:mutagenesis site  description:Impaired 1-alpha hydroxylase activity toward 25-hydroxyvitamin D3.
====== NO.600protein ======
type:chain  description:Ecdysone-induced protein 78C
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:compositionally biased region  description:Glu-rich
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Asn-rich
type:splice variant  description:In isoform B.
type:sequence conflict  description:In Ref. 2; CAA67384.
type:sequence conflict  description:In Ref. 1; AAA19975, 2; CAA67384 and 3; AAF69494.
type:sequence conflict  description:In Ref. 2; CAA67384.
type:sequence conflict  description:In Ref. 6; CAA51523.
type:sequence conflict  description:In Ref. 6; CAA51523.
type:sequence conflict  description:In Ref. 3; AAF69495.
type:sequence conflict  description:In Ref. 1; AAA19975, 2; CAA67384 and 3; AAF69494.
type:sequence conflict  description:In Ref. 2; CAA67384/CAA67385.
type:sequence conflict  description:In Ref. 1; AAA19975/AAA19976.
====== NO.601protein ======
type:initiator methionine  description:Removed
type:chain  description:Plasma membrane calcium-transporting ATPase 1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Calmodulin-binding subdomain A
type:region of interest  description:Required for basolateral membrane targeting
type:compositionally biased region  description:Poly-Glu
type:active site  description:4-aspartylphosphate intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium; via carbonyl oxygen
type:metal ion-binding site  description:Magnesium
type:modified residue  description:N-acetylglycine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by PKC
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform K.
type:splice variant  description:In isoform C.
type:splice variant  description:In isoform D.
type:splice variant  description:In isoform A and isoform E.
type:splice variant  description:In isoform A.
type:splice variant  description:In isoform E.
type:sequence variant  description:Rare polymorphism.
type:sequence conflict  description:In Ref. 2; AAA36000.
====== NO.602protein ======
type:chain  description:Probable cytochrome P450 518B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.603protein ======
type:chain  description:Probable cytochrome P450 508A2
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.604protein ======
type:signal peptide  description:None
type:chain  description:T-cell surface glycoprotein CD4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like V-type
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:region of interest  description:HIV-1 Vpu-susceptibility domain
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:S-palmitoyl cysteine
type:lipid moiety-binding region  description:S-palmitoyl cysteine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs28917504.
type:sequence variant  description:In dbSNP:rs11064419.
type:sequence variant  description:In OKT4-negative populations; dbSNP:rs28919570.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:About 75% loss of internalization.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:Loss of Nef-induced CD4 down-modulation.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:Loss of homodimerization; when associated with A-447.
type:mutagenesis site  description:Loss of homodimerization; when associated with A-445.
type:mutagenesis site  description:Abolished interaction with SPG21 and induced T-cell activation.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
====== NO.605protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Bone morphogenetic protein 7
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:sequence conflict  description:In Ref. 1; CAA40222.
====== NO.606protein ======
type:initiator methionine  description:Removed
type:chain  description:Vitamin D(3) 25-hydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
type:mutagenesis site  description:Increases 25-hydroxylase activity 2.0-fold. Increases 25-hydroxylase activity 21.6-fold; when associated with V156L, E216M and E348R.
type:mutagenesis site  description:Increases 25-hydroxylase activity 21.6-fold; when associated with T70R; E216M and E348R.
type:mutagenesis site  description:Increases 25-hydroxylase activity 2.5-fold.
type:mutagenesis site  description:Increases 25-hydroxylase activity 1.9-fold.
type:mutagenesis site  description:Increases 25-hydroxylase activity 21.6-fold; when associated with T70R; V156L and E348R.
type:mutagenesis site  description:Increases 25-hydroxylase activity 2.8-fold. Increases 25-hydroxylase activity 21.6-fold; when associated with T70R; V156L and E216M.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.607protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:Cholesterol side-chain cleavage enzyme, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:mutagenesis site  description:Impairs the hydroxylase activity toward cholesterol; increases the electron leakage from the electron transfer chain.
type:mutagenesis site  description:Markedly reduces the hydroxylase activity toward cholesterol.
type:sequence conflict  description:In Ref. 4; AAA30681.
type:sequence conflict  description:In Ref. 2; AA sequence.
type:sequence conflict  description:In Ref. 2; AA sequence.
type:sequence conflict  description:In Ref. 2; AA sequence.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.608protein ======
type:chain  description:Probable cytochrome P450 508D1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.609protein ======
type:signal peptide  description:None
type:propeptide  description:Removed in mature form
type:chain  description:Cubilin
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:EGF-like 4; calcium-binding
type:domain  description:EGF-like 5
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7; calcium-binding
type:domain  description:CUB 1
type:domain  description:CUB 2
type:domain  description:CUB 3
type:domain  description:CUB 4
type:domain  description:CUB 5
type:domain  description:CUB 6
type:domain  description:CUB 7
type:domain  description:CUB 8
type:domain  description:CUB 9
type:domain  description:CUB 10
type:domain  description:CUB 11
type:domain  description:CUB 12
type:domain  description:CUB 13
type:domain  description:CUB 14
type:domain  description:CUB 15
type:domain  description:CUB 16
type:domain  description:CUB 17
type:domain  description:CUB 18
type:domain  description:CUB 19
type:domain  description:CUB 20
type:domain  description:CUB 21
type:domain  description:CUB 22
type:domain  description:CUB 23
type:domain  description:CUB 24
type:domain  description:CUB 25
type:domain  description:CUB 26
type:domain  description:CUB 27
type:region of interest  description:Interaction with AMN
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4; via carbonyl oxygen
type:site  description:Cleavage; by furin
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:No effect on trafficking to the cell surface.
type:mutagenesis site  description:Decreased AMN-dependent trafficking to the cell surface.
type:mutagenesis site  description:No effect on trafficking to the cell surface.
type:mutagenesis site  description:No effect on trafficking to the cell surface.
type:mutagenesis site  description:No effect on trafficking to the cell surface.
type:mutagenesis site  description:Decreased AMN-dependent trafficking to the cell surface.
type:mutagenesis site  description:Impaired glycosylation and loss of export to the cell surface; when associated with D-749; D-781 and D-857.
type:mutagenesis site  description:Impaired glycosylation and loss of export to the cell surface; when associated with D-711; D-781 and D-857.
type:mutagenesis site  description:Impaired glycosylation and loss of export to the cell surface; when associated with D-711; D-749 and D-857.
type:mutagenesis site  description:Decreased AMN-dependent trafficking to the cell surface.
type:mutagenesis site  description:Impaired glycosylation and loss of export to the cell surface; when associated with D-711; D-749 and D-781.
type:mutagenesis site  description:No effect on trafficking to the cell surface.
====== NO.610protein ======
type:chain  description:Cytochrome P450 3A8
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.611protein ======
type:signal peptide  description:None
type:propeptide  description:Removed in mature form
type:chain  description:Cubilin
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:EGF-like 4; calcium-binding
type:domain  description:EGF-like 5
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7; calcium-binding
type:domain  description:CUB 1
type:domain  description:CUB 2
type:domain  description:CUB 3
type:domain  description:CUB 4
type:domain  description:CUB 5
type:domain  description:CUB 6
type:domain  description:CUB 7
type:domain  description:CUB 8
type:domain  description:CUB 9
type:domain  description:CUB 10
type:domain  description:CUB 11
type:domain  description:CUB 12
type:domain  description:CUB 13
type:domain  description:CUB 14
type:domain  description:CUB 15
type:domain  description:CUB 16
type:domain  description:CUB 17
type:domain  description:CUB 18
type:domain  description:CUB 19
type:domain  description:CUB 20
type:domain  description:CUB 21
type:domain  description:CUB 22
type:domain  description:CUB 23
type:domain  description:CUB 24
type:domain  description:CUB 25
type:domain  description:CUB 26
type:domain  description:CUB 27
type:region of interest  description:Interaction with AMN
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4; via carbonyl oxygen
type:site  description:Cleavage; by furin
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs12259370.
type:sequence variant  description:In dbSNP:rs1801220.
type:sequence variant  description:In dbSNP:rs1801222.
type:sequence variant  description:In dbSNP:rs57335729.
type:sequence variant  description:In dbSNP:rs1801224.
type:sequence variant  description:In dbSNP:rs2228053.
type:sequence variant  description:In dbSNP:rs7905349.
type:sequence variant  description:In a breast cancer sample; somatic mutation; dbSNP:rs1228797857.
type:sequence variant  description:In dbSNP:rs11254354.
type:sequence variant  description:In dbSNP:rs1801227.
type:sequence variant  description:In RH-MGA1; decreases strongly the CBLIF binding affinity; dbSNP:rs121434430.
type:sequence variant  description:None
type:sequence variant  description:In dbSNP:rs1801231.
type:sequence variant  description:In dbSNP:rs74116778.
type:sequence variant  description:In dbSNP:rs1276708.
type:sequence variant  description:In dbSNP:rs2271462.
type:sequence variant  description:In dbSNP:rs41289305.
type:sequence variant  description:In dbSNP:rs2356590.
type:sequence variant  description:Higher frequency in West Africans than in individuals of European ancestry; occurs with variants V-2984 and G-3002 only in individuals of European ancestry; dbSNP:rs62619939.
type:sequence variant  description:In dbSNP:rs1276712.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation; dbSNP:rs529856485.
type:sequence variant  description:In dbSNP:rs2271460.
type:sequence variant  description:In dbSNP:rs11254274.
type:sequence variant  description:In dbSNP:rs3740168.
type:sequence variant  description:In dbSNP:rs1801237.
type:sequence variant  description:In dbSNP:rs2796835.
type:sequence variant  description:In dbSNP:rs1801238.
type:sequence variant  description:In a breast cancer sample; somatic mutation; dbSNP:rs45551835.
type:sequence variant  description:In dbSNP:rs45569534.
type:sequence variant  description:Not found in West Africans; occurs with variants F-2153 and G-3002 only in individuals of European ancestry; associated with albuminuria in individuals of European ancestry and African Americans, both with and without diabetes; associated with 42% increased risk of developing persistent microalbuminuria in individuals with type I diabetes; dbSNP:rs1801239.
type:sequence variant  description:Higher frequency in West Africans than in individuals of European ancestry; occurs with variants F-2153 and V-2984 only in individuals of European ancestry; dbSNP:rs1801240.
type:sequence variant  description:In a breast cancer sample; somatic mutation; dbSNP:rs111265129.
type:sequence variant  description:Found in a renal cell carcinoma case; somatic mutation.
type:sequence variant  description:In dbSNP:rs1801230.
type:sequence variant  description:In dbSNP:rs7898873.
type:sequence variant  description:In dbSNP:rs1801232.
type:sequence conflict  description:In Ref. 1; AAC82612.
type:sequence conflict  description:In Ref. 1; AAC82612.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.612protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.613protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.614protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
====== NO.615protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.616protein ======
type:domain  description:Pyr_redox_2
type:coiled-coil region  description:None
type:non-terminal residue  description:None
====== NO.617protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.618protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.619protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.620protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.621protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.622protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.623protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.624protein ======
type:transmembrane region  description:Helical
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.625protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.626protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.627protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.628protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.629protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.630protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.631protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.632protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.633protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.634protein ======
type:domain  description:Tr-type G
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
====== NO.635protein ======
type:transmembrane region  description:Helical
type:domain  description:Ricin B-type lectin
====== NO.636protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.637protein ======
type:transmembrane region  description:Helical
type:domain  description:PSI
====== NO.638protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.639protein ======
type:domain  description:WW
type:domain  description:WW
type:domain  description:WW
type:domain  description:HECT
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:active site  description:Glycyl thioester intermediate
====== NO.640protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.641protein ======
type:domain  description:Q_MOTIF
type:domain  description:Helicase ATP-binding
type:domain  description:Helicase C-terminal
type:short sequence motif  description:Q motif
====== NO.642protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.643protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.644protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.645protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.646protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.647protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.648protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.649protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.650protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.651protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.652protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.653protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.654protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.655protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.656protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.657protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.658protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.659protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.660protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.661protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.662protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.663protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.664protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.665protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.666protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.667protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.668protein ======
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.669protein ======
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.670protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.671protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.672protein ======
type:domain  description:Nuclear receptor
type:non-terminal residue  description:None
====== NO.673protein ======
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.674protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.675protein ======
type:signal peptide  description:None
type:chain  description:Transforming growth factor beta
type:domain  description:TGF_BETA_2
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
====== NO.676protein ======
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.677protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.678protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:Cation_ATPase_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.679protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:non-terminal residue  description:None
====== NO.680protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.681protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:TGF_BETA_2
type:region of interest  description:Disordered
====== NO.682protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:non-terminal residue  description:None
====== NO.683protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.684protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.685protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.686protein ======
type:domain  description:Nuclear receptor
====== NO.687protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:non-terminal residue  description:None
====== NO.688protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.689protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.690protein ======
type:signal peptide  description:None
type:chain  description:T-cell surface antigen T4/Leu-3
type:transmembrane region  description:Helical
type:domain  description:Ig-like
====== NO.691protein ======
type:domain  description:Pyr_redox_2
====== NO.692protein ======
type:domain  description:Nuclear receptor
type:non-terminal residue  description:None
====== NO.693protein ======
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.694protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.695protein ======
type:domain  description:Ubiquitin-like
====== NO.696protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.697protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.698protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.699protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.700protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.701protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.702protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.703protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.704protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.705protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.706protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.707protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.708protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.709protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.710protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.711protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.712protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.713protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.714protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.715protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.716protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.717protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.718protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.719protein ======
====== NO.720protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.721protein ======
====== NO.722protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.723protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.724protein ======
type:signal peptide  description:None
type:chain  description:Mediator of RNA polymerase II transcription subunit 1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.725protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
====== NO.726protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.727protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.728protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.729protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.730protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.731protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.732protein ======
====== NO.733protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.734protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.735protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.736protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.737protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.738protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.739protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.740protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.741protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.742protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.743protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.744protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.745protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.746protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.747protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.748protein ======
====== NO.749protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.750protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.751protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.752protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.753protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.754protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.755protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.756protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.757protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.758protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.759protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.760protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.761protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.762protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.763protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.764protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.765protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.766protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.767protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.768protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.769protein ======
====== NO.770protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.771protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.772protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.773protein ======
====== NO.774protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.775protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.776protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.777protein ======
====== NO.778protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.779protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.780protein ======
====== NO.781protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.782protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.783protein ======
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.784protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.785protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.786protein ======
type:transmembrane region  description:Helical
====== NO.787protein ======
====== NO.788protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.789protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.790protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.791protein ======
====== NO.792protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.793protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.794protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.795protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.796protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.797protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.798protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.799protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.800protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.801protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.802protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.803protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.804protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.805protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.806protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.807protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.808protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.809protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.810protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.811protein ======
type:signal peptide  description:None
type:chain  description:None
====== NO.812protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.813protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.814protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.815protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.816protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.817protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.818protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.819protein ======
type:coiled-coil region  description:None
====== NO.820protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.821protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.822protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.823protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.824protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.825protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.826protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.827protein ======
type:transmembrane region  description:Helical
====== NO.828protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.829protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.830protein ======
====== NO.831protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.832protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.833protein ======
====== NO.834protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.835protein ======
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.836protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.837protein ======
====== NO.838protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.839protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.840protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.841protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.842protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.843protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.844protein ======
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.845protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.846protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.847protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.848protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.849protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.850protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.851protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.852protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.853protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.854protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.855protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.856protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.857protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.858protein ======
====== NO.859protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.860protein ======
type:domain  description:Med1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.861protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.862protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.863protein ======
type:signal peptide  description:None
type:chain  description:None
type:coiled-coil region  description:None
====== NO.864protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.865protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.866protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.867protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.868protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.869protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.870protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.871protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.872protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.873protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.874protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.875protein ======
====== NO.876protein ======
====== NO.877protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.878protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.879protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.880protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.881protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.882protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.883protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.884protein ======
====== NO.885protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.886protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.887protein ======
====== NO.888protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.889protein ======
type:transmembrane region  description:Helical
====== NO.890protein ======
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.891protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.892protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.893protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.894protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.895protein ======
type:domain  description:Med1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.896protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.897protein ======
type:transmembrane region  description:Helical
====== NO.898protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.899protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.900protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.901protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.902protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.903protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.904protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.905protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.906protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.907protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.908protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.909protein ======
====== NO.910protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.911protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.912protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.913protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.914protein ======
type:transmembrane region  description:Helical
====== NO.915protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.916protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.917protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.918protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.919protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.920protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
====== NO.921protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.922protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
====== NO.923protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.924protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.925protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.926protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.927protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.928protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.929protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.930protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.931protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.932protein ======
====== NO.933protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.934protein ======
type:transmembrane region  description:Helical
====== NO.935protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.936protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.937protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.938protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.939protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.940protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.941protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.942protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.943protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.944protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.945protein ======
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.946protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.947protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.948protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.949protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.950protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.951protein ======
====== NO.952protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.953protein ======
====== NO.954protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.955protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.956protein ======
type:domain  description:Protein kinase
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.957protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.958protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.959protein ======
====== NO.960protein ======
====== NO.961protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.962protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.963protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.964protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.965protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.966protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.967protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.968protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.969protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.970protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.971protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.972protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.973protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.974protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.975protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.976protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.977protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.978protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.979protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.980protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.981protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.982protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.983protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.984protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.985protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.986protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.987protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.988protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.989protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.990protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.991protein ======
====== NO.992protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.993protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.994protein ======
====== NO.995protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.996protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.997protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.998protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.999protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1000protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1001protein ======
type:transmembrane region  description:Helical
====== NO.1002protein ======
type:domain  description:Pyr_redox_2
====== NO.1003protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1004protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1005protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:FZ
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1006protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1007protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1008protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1009protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1010protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1011protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1012protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1013protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.1014protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1015protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1016protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1017protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.1018protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1019protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1020protein ======
type:transmembrane region  description:Helical
====== NO.1021protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1022protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1023protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1024protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1025protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:non-terminal residue  description:None
====== NO.1026protein ======
type:region of interest  description:Disordered
====== NO.1027protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1028protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1029protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1030protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Acidic
====== NO.1031protein ======
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1032protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.1033protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1034protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1035protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1036protein ======
====== NO.1037protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1038protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1039protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1040protein ======
====== NO.1041protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1042protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1043protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1044protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1045protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1046protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1047protein ======
====== NO.1048protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1049protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1050protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1051protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1052protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1053protein ======
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
====== NO.1054protein ======
====== NO.1055protein ======
====== NO.1056protein ======
type:transmembrane region  description:Helical
====== NO.1057protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1058protein ======
type:transmembrane region  description:Helical
====== NO.1059protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1060protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1061protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1062protein ======
====== NO.1063protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1064protein ======
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1065protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1066protein ======
type:domain  description:Nuclear receptor
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Polar
====== NO.1067protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1068protein ======
====== NO.1069protein ======
type:transmembrane region  description:Helical
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
====== NO.1070protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1071protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1072protein ======
type:signal peptide  description:None
type:chain  description:Ferredoxin--NADP(+) reductase
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1073protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1074protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1075protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
====== NO.1076protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1077protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1078protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1079protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1080protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1081protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1082protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:modified residue  description:Phosphoserine
====== NO.1083protein ======
type:chain  description:B box and SPRY domain-containing protein
type:domain  description:B30.2/SPRY
type:zinc finger region  description:B box-type
type:compositionally biased region  description:Pro-rich
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 2; BAC29115.
type:sequence conflict  description:In Ref. 2; BAE36097.
type:sequence conflict  description:In Ref. 2; BAE36097.
====== NO.1084protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:modified residue  description:Phosphoserine
====== NO.1085protein ======
type:initiator methionine  description:Removed
type:chain  description:Plasma membrane calcium-transporting ATPase 1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Calmodulin-binding subdomain A
type:active site  description:4-aspartylphosphate intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium; via carbonyl oxygen
type:metal ion-binding site  description:Magnesium
type:modified residue  description:Phosphothreonine; by PKC
type:sequence conflict  description:In Ref. 2; AAK14839.
type:sequence conflict  description:In Ref. 2; AAK14839.
====== NO.1086protein ======
type:chain  description:Probable cytochrome P450 522A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.1087protein ======
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
====== NO.1088protein ======
type:chain  description:Probable cytochrome P450 516A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.1089protein ======
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
====== NO.1090protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 7.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform Long.
type:sequence variant  description:In dbSNP:rs28365947.
type:sequence variant  description:In dbSNP:rs690514.
type:sequence variant  description:In dbSNP:rs35692345.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In dbSNP:rs35072974.
type:sequence variant  description:In dbSNP:rs34038065.
type:sequence variant  description:In dbSNP:rs34118765.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In dbSNP:rs35660143.
type:sequence variant  description:In dbSNP:rs35696549.
type:sequence variant  description:In ANOA.
type:sequence variant  description:In dbSNP:rs35769464.
type:sequence conflict  description:In Ref. 4; BAG56748.
====== NO.1091protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1092protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1093protein ======
type:domain  description:SAP
type:domain  description:PINIT
type:domain  description:SP-RING-type
type:zinc finger region  description:SP-RING-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1094protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1095protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1096protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1097protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1098protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1099protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1100protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1101protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1102protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1103protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1104protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1105protein ======
====== NO.1106protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1107protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1108protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1109protein ======
====== NO.1110protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1111protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1112protein ======
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1113protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1114protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1115protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1116protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1117protein ======
====== NO.1118protein ======
====== NO.1119protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1120protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1121protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1122protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1123protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1124protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1125protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1126protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1127protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1128protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1129protein ======
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1130protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:coiled-coil region  description:None
====== NO.1131protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1132protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1133protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1134protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1135protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1136protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1137protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1138protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1139protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1140protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1141protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1142protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1143protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1144protein ======
====== NO.1145protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1146protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1147protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1148protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1149protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Polar
====== NO.1150protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1151protein ======
====== NO.1152protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1153protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1154protein ======
====== NO.1155protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.1156protein ======
type:domain  description:SAP
type:domain  description:PINIT
type:domain  description:SP-RING-type
type:zinc finger region  description:SP-RING-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.1157protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1158protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1159protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1160protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1161protein ======
type:transmembrane region  description:Helical
====== NO.1162protein ======
type:transmembrane region  description:Helical
====== NO.1163protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.1164protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1165protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1166protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1167protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1168protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1169protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1170protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1171protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1172protein ======
====== NO.1173protein ======
====== NO.1174protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
====== NO.1175protein ======
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1176protein ======
type:domain  description:UBC core
type:region of interest  description:Disordered
type:active site  description:Glycyl thioester intermediate
====== NO.1177protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1178protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1179protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1180protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1181protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1182protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1183protein ======
====== NO.1184protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1185protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1186protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1187protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1188protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1189protein ======
====== NO.1190protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1191protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1192protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1193protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1194protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1195protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1196protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1197protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1198protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1199protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1200protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1201protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1202protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1203protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1204protein ======
====== NO.1205protein ======
====== NO.1206protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1207protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1208protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1209protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1210protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1211protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1212protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1213protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1214protein ======
====== NO.1215protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Polyampholyte
====== NO.1216protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1217protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1218protein ======
type:domain  description:UBC core
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:active site  description:Glycyl thioester intermediate
====== NO.1219protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1220protein ======
====== NO.1221protein ======
type:domain  description:SAP
type:domain  description:PINIT
type:domain  description:SP-RING-type
type:zinc finger region  description:SP-RING-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
====== NO.1222protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1223protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1224protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1225protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1226protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polyampholyte
====== NO.1227protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1228protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1229protein ======
====== NO.1230protein ======
type:region of interest  description:Disordered
====== NO.1231protein ======
====== NO.1232protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
====== NO.1233protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1234protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1235protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1236protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1237protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1238protein ======
====== NO.1239protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1240protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1241protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1242protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1243protein ======
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1244protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1245protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:FZ
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1246protein ======
====== NO.1247protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1248protein ======
====== NO.1249protein ======
type:domain  description:Med1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1250protein ======
====== NO.1251protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1252protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1253protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1254protein ======
type:domain  description:TAFII28
====== NO.1255protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1256protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1257protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1258protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1259protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1260protein ======
====== NO.1261protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1262protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1263protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1264protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1265protein ======
====== NO.1266protein ======
====== NO.1267protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1268protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1269protein ======
====== NO.1270protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1271protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1272protein ======
====== NO.1273protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1274protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
====== NO.1275protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1276protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1277protein ======
type:domain  description:Pyr_redox_2
====== NO.1278protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1279protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1280protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1281protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1282protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1283protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1284protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1285protein ======
type:domain  description:Pyr_redox_2
====== NO.1286protein ======
type:domain  description:Pyr_redox_2
====== NO.1287protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1288protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1289protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1290protein ======
type:domain  description:Pyr_redox_2
====== NO.1291protein ======
====== NO.1292protein ======
type:transmembrane region  description:Helical
====== NO.1293protein ======
====== NO.1294protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1295protein ======
type:domain  description:Albumin
====== NO.1296protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1297protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1298protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1299protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1300protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1301protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1302protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1303protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1304protein ======
====== NO.1305protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:coiled-coil region  description:None
====== NO.1306protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1307protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1308protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1309protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1310protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1311protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.1312protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1313protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1314protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1315protein ======
====== NO.1316protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1317protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:non-terminal residue  description:None
====== NO.1318protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1319protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1320protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1321protein ======
====== NO.1322protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1323protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1324protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1325protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:non-terminal residue  description:None
====== NO.1326protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1327protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1328protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1329protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1330protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1331protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1332protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1333protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.1334protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1335protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1336protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1337protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1338protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1339protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1340protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1341protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1342protein ======
====== NO.1343protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1344protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1345protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1346protein ======
====== NO.1347protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1348protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1349protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1350protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1351protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1352protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1353protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1354protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1355protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1356protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1357protein ======
type:transmembrane region  description:Helical
====== NO.1358protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1359protein ======
====== NO.1360protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1361protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:non-terminal residue  description:None
====== NO.1362protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1363protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1364protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1365protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1366protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1367protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1368protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1369protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1370protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1371protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1372protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1373protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1374protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1375protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1376protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1377protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1378protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1379protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1380protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1381protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1382protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1383protein ======
type:transmembrane region  description:Helical
====== NO.1384protein ======
type:transmembrane region  description:Helical
====== NO.1385protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1386protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1387protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1388protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1389protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1390protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1391protein ======
====== NO.1392protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1393protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1394protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1395protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1396protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1397protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1398protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1399protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1400protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1401protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1402protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1403protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1404protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1405protein ======
type:transmembrane region  description:Helical
====== NO.1406protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1407protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1408protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1409protein ======
type:transmembrane region  description:Helical
====== NO.1410protein ======
type:transmembrane region  description:Helical
====== NO.1411protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1412protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1413protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1414protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1415protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1416protein ======
====== NO.1417protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1418protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1419protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.1420protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1421protein ======
====== NO.1422protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1423protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1424protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1425protein ======
====== NO.1426protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1427protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1428protein ======
type:domain  description:VitD-bind_III
type:non-terminal residue  description:None
====== NO.1429protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1430protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1431protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1432protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1433protein ======
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1434protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1435protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1436protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1437protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1438protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1439protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1440protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1441protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1442protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1443protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1444protein ======
type:domain  description:FZ
type:domain  description:NTR
type:region of interest  description:Disordered
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1445protein ======
====== NO.1446protein ======
type:domain  description:FZ
type:domain  description:NTR
type:region of interest  description:Disordered
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1447protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1448protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1449protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1450protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1451protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1452protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1453protein ======
====== NO.1454protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1455protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1456protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1457protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1458protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1459protein ======
====== NO.1460protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1461protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1462protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1463protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1464protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1465protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1466protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1467protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1468protein ======
====== NO.1469protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1470protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.1471protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1472protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1473protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1474protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1475protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1476protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1477protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1478protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1479protein ======
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1480protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1481protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1482protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1483protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1484protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1485protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1486protein ======
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1487protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1488protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1489protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1490protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1491protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1492protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1493protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1494protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1495protein ======
type:transmembrane region  description:Helical
====== NO.1496protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1497protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1498protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
====== NO.1499protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1500protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1501protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1502protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1503protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1504protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1505protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1506protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.1507protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1508protein ======
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
====== NO.1509protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1510protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1511protein ======
====== NO.1512protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1513protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1514protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1515protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1516protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
====== NO.1517protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1518protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1519protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1520protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1521protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1522protein ======
====== NO.1523protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1524protein ======
type:domain  description:Albumin
====== NO.1525protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1526protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1527protein ======
====== NO.1528protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1529protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1530protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1531protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1532protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1533protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1534protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1535protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1536protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1537protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1538protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1539protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1540protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1541protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1542protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1543protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1544protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1545protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1546protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:non-terminal residue  description:None
====== NO.1547protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1548protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
====== NO.1549protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1550protein ======
type:transmembrane region  description:Helical
====== NO.1551protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1552protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1553protein ======
====== NO.1554protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1555protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1556protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1557protein ======
type:transmembrane region  description:Helical
====== NO.1558protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1559protein ======
====== NO.1560protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1561protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1562protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1563protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1564protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1565protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1566protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1567protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1568protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1569protein ======
type:region of interest  description:Disordered
====== NO.1570protein ======
type:transmembrane region  description:Helical
type:domain  description:EGF-like
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:domain  description:EGF-like
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:domain  description:EGF-like
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:domain  description:EGF-like
type:domain  description:EGF-like
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:repeat  description:LDL-receptor class B
type:domain  description:EGF-like
type:region of interest  description:Disordered
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1571protein ======
====== NO.1572protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1573protein ======
====== NO.1574protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1575protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1576protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1577protein ======
type:region of interest  description:Disordered
====== NO.1578protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:coiled-coil region  description:None
====== NO.1579protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1580protein ======
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1581protein ======
====== NO.1582protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1583protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1584protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1585protein ======
====== NO.1586protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1587protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1588protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1589protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1590protein ======
====== NO.1591protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1592protein ======
====== NO.1593protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1594protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1595protein ======
====== NO.1596protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1597protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1598protein ======
====== NO.1599protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1600protein ======
====== NO.1601protein ======
====== NO.1602protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1603protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1604protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1605protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1606protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1607protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1608protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1609protein ======
type:transmembrane region  description:Helical
====== NO.1610protein ======
====== NO.1611protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1612protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1613protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1614protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1615protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1616protein ======
type:region of interest  description:Disordered
====== NO.1617protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1618protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1619protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1620protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1621protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1622protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1623protein ======
====== NO.1624protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1625protein ======
====== NO.1626protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1627protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1628protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:NADP; via amide nitrogen
====== NO.1629protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
type:non-terminal residue  description:None
====== NO.1630protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1631protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1632protein ======
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1633protein ======
====== NO.1634protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1635protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
type:calcium-binding region  description:None
====== NO.1636protein ======
type:coiled-coil region  description:None
====== NO.1637protein ======
====== NO.1638protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1639protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1640protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1641protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1642protein ======
====== NO.1643protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1644protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1645protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1646protein ======
====== NO.1647protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1648protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1649protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1650protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1651protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1652protein ======
====== NO.1653protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1654protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1655protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1656protein ======
====== NO.1657protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1658protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1659protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1660protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1661protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1662protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1663protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1664protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1665protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:EGF-like
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:domain  description:CUB
type:coiled-coil region  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1666protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1667protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1668protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1669protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1670protein ======
====== NO.1671protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1672protein ======
type:transmembrane region  description:Helical
====== NO.1673protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:domain  description:INTEIN_C_TER
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1674protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1675protein ======
====== NO.1676protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1677protein ======
====== NO.1678protein ======
====== NO.1679protein ======
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1680protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.1681protein ======
====== NO.1682protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1683protein ======
type:transmembrane region  description:Helical
====== NO.1684protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1685protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1686protein ======
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1687protein ======
====== NO.1688protein ======
====== NO.1689protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1690protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1691protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1692protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1693protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1694protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1695protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1696protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1697protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1698protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1699protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1700protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1701protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1702protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1703protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1704protein ======
====== NO.1705protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1706protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1707protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1708protein ======
====== NO.1709protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1710protein ======
type:transmembrane region  description:Helical
====== NO.1711protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1712protein ======
====== NO.1713protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1714protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1715protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1716protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1717protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1718protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1719protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1720protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1721protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1722protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1723protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1724protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1725protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1726protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
type:region of interest  description:Disordered
====== NO.1727protein ======
====== NO.1728protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1729protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1730protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1731protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1732protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1733protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1734protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1735protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1736protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
====== NO.1737protein ======
type:transmembrane region  description:Helical
====== NO.1738protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1739protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1740protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1741protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1742protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1743protein ======
type:domain  description:ANK_REP_REGION
type:repeat  description:ANK
====== NO.1744protein ======
type:transmembrane region  description:Helical
====== NO.1745protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1746protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1747protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1748protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1749protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
====== NO.1750protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1751protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1752protein ======
====== NO.1753protein ======
====== NO.1754protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1755protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1756protein ======
type:domain  description:EF-hand
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1757protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Acidic
====== NO.1758protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1759protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1760protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1761protein ======
====== NO.1762protein ======
type:domain  description:Pyr_redox_2
====== NO.1763protein ======
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1764protein ======
====== NO.1765protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1766protein ======
type:signal peptide  description:None
type:chain  description:None
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1767protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1768protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1769protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1770protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1771protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1772protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1773protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1774protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1775protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1776protein ======
type:domain  description:Albumin
====== NO.1777protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
====== NO.1778protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1779protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1780protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1781protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1782protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1783protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1784protein ======
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1785protein ======
type:transmembrane region  description:Helical
====== NO.1786protein ======
====== NO.1787protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1788protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1789protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1790protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1791protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1792protein ======
====== NO.1793protein ======
====== NO.1794protein ======
type:transmembrane region  description:Helical
====== NO.1795protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1796protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1797protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1798protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1799protein ======
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1800protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1801protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1802protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1803protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1804protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1805protein ======
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1806protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1807protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1808protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1809protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1810protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1811protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1812protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Basic
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1813protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1814protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1815protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1816protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1817protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1818protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1819protein ======
====== NO.1820protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1821protein ======
====== NO.1822protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1823protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1824protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1825protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1826protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1827protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1828protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1829protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1830protein ======
====== NO.1831protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1832protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1833protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1834protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1835protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1836protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1837protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1838protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1839protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1840protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1841protein ======
type:domain  description:TAFII28
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polyampholyte
====== NO.1842protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1843protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1844protein ======
type:domain  description:RING-type
type:domain  description:B box-type
type:domain  description:B box-type
type:domain  description:PHD-type
type:domain  description:Bromo
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
====== NO.1845protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1846protein ======
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1847protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1848protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1849protein ======
====== NO.1850protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1851protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1852protein ======
type:domain  description:Med1
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
====== NO.1853protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1854protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1855protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1856protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
====== NO.1857protein ======
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:domain  description:C2H2-type
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1858protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1859protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1860protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1861protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1862protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1863protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1864protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1865protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1866protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1867protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1868protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1869protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:coiled-coil region  description:None
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1870protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1871protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1872protein ======
====== NO.1873protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.1874protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1875protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1876protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1877protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1878protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:coiled-coil region  description:None
====== NO.1879protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1880protein ======
type:domain  description:Anti_prolifrtn
type:domain  description:Anti_prolifrtn
type:region of interest  description:Disordered
type:region of interest  description:Disordered
====== NO.1881protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1882protein ======
type:transmembrane region  description:Helical
====== NO.1883protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Fibronectin type-III
type:domain  description:Fibronectin type-III
type:domain  description:Ig-like
type:domain  description:Fibronectin type-III
type:domain  description:Ig-like
type:region of interest  description:Disordered
====== NO.1884protein ======
type:domain  description:JmjC
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1885protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor
====== NO.1886protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:region of interest  description:Disordered
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1887protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1888protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1889protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1890protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1891protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1892protein ======
====== NO.1893protein ======
type:transmembrane region  description:Helical
====== NO.1894protein ======
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1895protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1896protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1897protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1898protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1899protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1900protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:active site  description:Proton acceptor
====== NO.1901protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1902protein ======
type:transmembrane region  description:Helical
====== NO.1903protein ======
type:domain  description:Protein kinase
====== NO.1904protein ======
type:domain  description:Pyr_redox_2
type:region of interest  description:Disordered
====== NO.1905protein ======
====== NO.1906protein ======
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1907protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1908protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1909protein ======
type:domain  description:Pyr_redox_2
====== NO.1910protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1911protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1912protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1913protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1914protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1915protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1916protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1917protein ======
====== NO.1918protein ======
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1919protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1920protein ======
type:domain  description:Pyr_redox_2
====== NO.1921protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1922protein ======
type:domain  description:Pyr_redox_2
====== NO.1923protein ======
====== NO.1924protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1925protein ======
type:domain  description:Pyr_redox_2
====== NO.1926protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1927protein ======
type:domain  description:Pyr_redox_2
====== NO.1928protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1929protein ======
type:domain  description:Albumin
====== NO.1930protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1931protein ======
====== NO.1932protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1933protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1934protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1935protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1936protein ======
type:domain  description:Pyr_redox_2
====== NO.1937protein ======
type:domain  description:Q_MOTIF
type:domain  description:Helicase ATP-binding
type:domain  description:Helicase C-terminal
type:short sequence motif  description:Q motif
====== NO.1938protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
====== NO.1939protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1940protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1941protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1942protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1943protein ======
====== NO.1944protein ======
type:domain  description:Pyr_redox_2
====== NO.1945protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1946protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1947protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1948protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1949protein ======
type:region of interest  description:Disordered
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1950protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1951protein ======
type:transmembrane region  description:Helical
====== NO.1952protein ======
type:signal peptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
====== NO.1953protein ======
type:domain  description:Pyr_redox_2
====== NO.1954protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.1955protein ======
type:non-terminal residue  description:None
====== NO.1956protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.1957protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1958protein ======
====== NO.1959protein ======
====== NO.1960protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1961protein ======
type:signal peptide  description:None
type:chain  description:None
type:non-terminal residue  description:None
====== NO.1962protein ======
type:domain  description:F-BAR
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
====== NO.1963protein ======
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1964protein ======
type:signal peptide  description:None
type:chain  description:None
type:non-terminal residue  description:None
====== NO.1965protein ======
type:domain  description:Pyr_redox_2
====== NO.1966protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1967protein ======
type:signal peptide  description:None
type:chain  description:None
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Basic
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Acidic
====== NO.1968protein ======
type:transmembrane region  description:Helical
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Ig-like
type:domain  description:Protein kinase
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Acidic
type:compositionally biased region  description:Polar
type:active site  description:Proton acceptor
====== NO.1969protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1970protein ======
type:domain  description:BHLH
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.1971protein ======
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
====== NO.1972protein ======
====== NO.1973protein ======
====== NO.1974protein ======
====== NO.1975protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1976protein ======
type:transmembrane region  description:Helical
====== NO.1977protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1978protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1979protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.1980protein ======
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1981protein ======
====== NO.1982protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1983protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
====== NO.1984protein ======
type:transmembrane region  description:Helical
====== NO.1985protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:non-terminal residue  description:None
====== NO.1986protein ======
type:domain  description:Pyr_redox_2
====== NO.1987protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1988protein ======
type:signal peptide  description:None
type:chain  description:None
====== NO.1989protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:non-terminal residue  description:None
====== NO.1990protein ======
====== NO.1991protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:compositionally biased region  description:Polyampholyte
====== NO.1992protein ======
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
====== NO.1993protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1994protein ======
type:domain  description:Nuclear receptor
type:domain  description:NR LBD
type:region of interest  description:Disordered
type:coiled-coil region  description:None
====== NO.1995protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.1996protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.1997protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
====== NO.1998protein ======
type:domain  description:Pyr_redox_2
====== NO.1999protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
type:region of interest  description:Disordered
====== NO.2000protein ======
type:domain  description:Med1
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:region of interest  description:Disordered
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.2001protein ======
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.2002protein ======
type:signal peptide  description:None
type:chain  description:Gc-globulin
type:domain  description:Albumin
type:domain  description:Albumin
====== NO.2003protein ======
type:domain  description:EF-hand
type:calcium-binding region  description:None
====== NO.2004protein ======
type:domain  description:Pyr_redox_2
====== NO.2005protein ======
type:domain  description:TAFII55_N
type:region of interest  description:Disordered
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Polar
type:compositionally biased region  description:Polyampholyte
====== NO.2006protein ======
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
====== NO.2007protein ======
type:transmembrane region  description:Helical
====== NO.2008protein ======
type:signal peptide  description:None
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:domain  description:Pyr_redox_2
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.2009protein ======
type:signal peptide  description:None
type:chain  description:Tenascin
type:domain  description:EGF-like 1; incomplete
type:domain  description:EGF-like 2
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4
type:domain  description:EGF-like 5
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7
type:domain  description:EGF-like 8
type:domain  description:EGF-like 9
type:domain  description:EGF-like 10
type:domain  description:EGF-like 11
type:domain  description:EGF-like 12
type:domain  description:EGF-like 13
type:domain  description:EGF-like 14
type:domain  description:EGF-like 15
type:domain  description:Fibronectin type-III 1
type:domain  description:Fibronectin type-III 2
type:domain  description:Fibronectin type-III 3
type:domain  description:Fibronectin type-III 4
type:domain  description:Fibronectin type-III 5
type:domain  description:Fibronectin type-III 6
type:domain  description:Fibronectin type-III 7
type:domain  description:Fibronectin type-III 8
type:domain  description:Fibronectin type-III 9
type:domain  description:Fibronectin type-III 10
type:domain  description:Fibronectin type-III 11
type:domain  description:Fibronectin type-III 12
type:domain  description:Fibronectin type-III 13
type:domain  description:Fibronectin type-III 14
type:domain  description:Fibronectin type-III 15
type:domain  description:Fibrinogen C-terminal
type:coiled-coil region  description:None
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 2 and isoform 3.
type:splice variant  description:In isoform 2 and isoform 4.
type:sequence variant  description:In dbSNP:rs7020958.
type:sequence variant  description:In dbSNP:rs1757095.
type:sequence variant  description:In dbSNP:rs3827816.
type:sequence variant  description:In dbSNP:rs1061494.
type:sequence variant  description:In dbSNP:rs3748169.
type:sequence variant  description:In dbSNP:rs2104772.
type:sequence variant  description:In DFNA56; dbSNP:rs137933052.
type:sequence variant  description:In dbSNP:rs2274750.
type:sequence variant  description:In DFNA56; dbSNP:rs431905513.
type:sequence variant  description:In dbSNP:rs13321.
type:sequence conflict  description:In Ref. 2; CAA39628.
type:sequence conflict  description:In Ref. 1; no nucleotide entry, 3; AAA88083 and 4; CAA55309.
type:sequence conflict  description:In Ref. 1; no nucleotide entry, 3; AAA88083 and 7; AAA52703.
type:sequence conflict  description:In Ref. 1; no nucleotide entry, 3; AAA88083 and 7; AAA52703.
type:sequence conflict  description:In Ref. 1; no nucleotide entry and 3; AAA88083.
type:sequence conflict  description:In Ref. 7; AAA52703.
type:sequence conflict  description:In Ref. 2; CAA39628.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2010protein ======
type:signal peptide  description:None
type:chain  description:Tenascin
type:domain  description:EGF-like 1; incomplete
type:domain  description:EGF-like 2
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4
type:domain  description:EGF-like 5
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7
type:domain  description:EGF-like 8
type:domain  description:EGF-like 9
type:domain  description:EGF-like 10
type:domain  description:EGF-like 11
type:domain  description:EGF-like 12
type:domain  description:EGF-like 13
type:domain  description:EGF-like 14
type:domain  description:EGF-like 15
type:domain  description:Fibronectin type-III 1
type:domain  description:Fibronectin type-III 2
type:domain  description:Fibronectin type-III 3
type:domain  description:Fibronectin type-III 4
type:domain  description:Fibronectin type-III 5
type:domain  description:Fibronectin type-III 6
type:domain  description:Fibronectin type-III 7
type:domain  description:Fibronectin type-III 8
type:domain  description:Fibronectin type-III 9
type:domain  description:Fibronectin type-III 10
type:domain  description:Fibronectin type-III 11
type:domain  description:Fibronectin type-III 12
type:domain  description:Fibronectin type-III 13
type:domain  description:Fibronectin type-III 14
type:domain  description:Fibrinogen C-terminal
type:coiled-coil region  description:None
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 2; CAA39751.
type:sequence conflict  description:In Ref. 2; CAA39751.
type:sequence conflict  description:In Ref. 2; CAA39751.
type:sequence conflict  description:In Ref. 2; CAA39751.
type:sequence conflict  description:In Ref. 2; CAA39751.
====== NO.2011protein ======
type:signal peptide  description:None
type:chain  description:Latency-associated peptide
type:chain  description:Transforming growth factor beta-1
type:region of interest  description:Straightjacket domain
type:region of interest  description:Arm domain
type:region of interest  description:Bowtie tail
type:short sequence motif  description:Cell attachment site
type:site  description:Cleavage; by FURIN
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:Interchain (with C-1359 or C-1384 in LTBP1); in inactive form
type:disulfide bond  description:Interchain (with C-225)
type:disulfide bond  description:Interchain (with C-223)
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
====== NO.2012protein ======
type:chain  description:Thioredoxin reductase 1, cytoplasmic
type:domain  description:Glutaredoxin
type:nucleotide phosphate-binding region  description:FAD
type:active site  description:Proton acceptor
type:non-standard amino acid  description:Selenocysteine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:Phosphotyrosine
type:disulfide bond  description:Redox-active
type:cross-link  description:Cysteinyl-selenocysteine (Cys-Sec)
type:splice variant  description:In isoform 7.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1127954.
type:sequence conflict  description:In Ref. 4; AAQ62473.
type:sequence conflict  description:In Ref. 6; AAF15900.
type:sequence conflict  description:In Ref. 6; AAF15900.
type:sequence conflict  description:In Ref. 4; AAQ62469.
type:sequence conflict  description:In Ref. 4; AAQ62463.
type:sequence conflict  description:In Ref. 4; AAQ62463.
type:sequence conflict  description:In Ref. 7; BAH11490.
type:sequence conflict  description:In Ref. 1; AAB35418/CAA62629 and 4; AAL15432.
type:sequence conflict  description:In Ref. 3; AAC69621.
type:sequence conflict  description:In Ref. 7; BAH12374.
type:sequence conflict  description:In Ref. 7; BAH12374.
type:sequence conflict  description:In Ref. 8; CAG38744.
type:sequence conflict  description:In Ref. 3; AAC69621.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:modified residue  description:N-acetylmethionine
====== NO.2013protein ======
type:chain  description:Transcription initiation factor TFIID subunit 11
type:modified residue  description:N-acetylmethionine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs15922.
type:sequence variant  description:In dbSNP:rs11537996.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2014protein ======
type:initiator methionine  description:Removed
type:chain  description:SNW domain-containing protein 1
type:region of interest  description:Interaction with PPIL1
type:region of interest  description:SNW
type:compositionally biased region  description:Pro-rich
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.2015protein ======
type:chain  description:Zinc finger protein SNAI1
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4; atypical
type:region of interest  description:SNAG domain
type:region of interest  description:Required and sufficient for interaction with KDM1A
type:region of interest  description:LATS2 binding
type:region of interest  description:Required for FBXL14-triggered degradation
type:region of interest  description:Required for nuclear localization and interaction with KPNB1, NOTCH1 and PARP1
type:short sequence motif  description:Destruction motif
type:compositionally biased region  description:Ser-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GlcNAc) serine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:sequence conflict  description:In Ref. 2; CAA47675.
====== NO.2016protein ======
type:chain  description:Transcription initiation factor TFIID subunit 7
type:coiled-coil region  description:None
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2017protein ======
type:chain  description:Protein Tob2
type:modified residue  description:Phosphoserine
====== NO.2018protein ======
type:chain  description:Uridine phosphorylase 1
type:region of interest  description:Phosphate binding
type:region of interest  description:Uridine binding
type:region of interest  description:Uridine binding
type:binding site  description:Phosphate; via amide nitrogen
type:binding site  description:Phosphate
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2019protein ======
type:chain  description:Zinc finger protein SNAI2
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5; atypical
type:region of interest  description:SNAG domain
====== NO.2020protein ======
type:chain  description:Retinoic acid receptor RXR-beta
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Hinge
type:modified residue  description:Omega-N-methylarginine
type:splice variant  description:In isoform Short.
type:sequence conflict  description:In Ref. 4; AAA40081.
type:sequence conflict  description:In Ref. 5; AAA37772.
type:sequence conflict  description:In Ref. 4; AAA40081.
====== NO.2021protein ======
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:chain  description:Protein S100-G, minor isoform
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:N-acetylalanine; in Protein S100-G, minor isoform
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 2; AA sequence.
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2022protein ======
type:signal peptide  description:None
type:chain  description:Stanniocalcin-2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2023protein ======
type:signal peptide  description:None
type:chain  description:Stanniocalcin-2
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphothreonine; by FAM20C
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2024protein ======
type:signal peptide  description:None
type:chain  description:Latency-associated peptide
type:chain  description:Transforming growth factor beta-2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:splice variant  description:In isoform TGF-beta2A.
type:splice variant  description:In isoform TGF-beta2A.
type:sequence conflict  description:In Ref. 2; CAB42003.
type:sequence conflict  description:In Ref. 3; AAD24484.
type:sequence conflict  description:In Ref. 2; CAB42003 and 4; CAA50723.
====== NO.2025protein ======
type:chain  description:Transcription factor E2-alpha
type:domain  description:bHLH
type:region of interest  description:Leucine-zipper
type:short sequence motif  description:Nuclear localization signal
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform E47.
type:sequence conflict  description:In Ref. 1; CAA44199.
type:sequence conflict  description:In Ref. 3; AAB21103.
type:sequence conflict  description:In Ref. 3; AAB21103.
type:sequence conflict  description:In Ref. 3; AAB21103.
type:sequence conflict  description:In Ref. 3; AAB21103.
type:modified residue  description:Phosphothreonine
====== NO.2026protein ======
type:initiator methionine  description:Removed
type:chain  description:Thyroid hormone receptor-associated protein 3
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Required for mRNA splicing activation
type:region of interest  description:Required for mRNA decay activity
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Arg-rich
type:modified residue  description:N-acetylserine
type:modified residue  description:Dimethylated arginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-methyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:sequence variant  description:In dbSNP:rs6425977.
type:mutagenesis site  description:Reduces phosphorylation upon DNA damage; when associated with A-408.
type:mutagenesis site  description:Reduces phosphorylation upon DNA damage; when associated with A-406.
====== NO.2027protein ======
type:chain  description:Retinoic acid receptor RXR-alpha
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Nuclear localization signal
type:region of interest  description:Hinge
type:region of interest  description:Required for nuclear export
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:binding site  description:9-cis retinoic acid
type:binding site  description:9-cis retinoic acid; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphothreonine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
====== NO.2028protein ======
type:chain  description:Transcription initiation factor TFIID subunit 7
type:coiled-coil region  description:None
type:short sequence motif  description:[KR]-[STA]-K motif
type:compositionally biased region  description:Poly-Ser
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence variant  description:None
type:mutagenesis site  description:Abolishes methylation in vitro.
type:mutagenesis site  description:Reduced H3 acetylation and transcription at target promoters.
type:mutagenesis site  description:50% reduction in TAF1-binding, reduced incorporation of TAF7 into TFIID complexes.
type:sequence conflict  description:In Ref. 2; AAB60347.
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2029protein ======
type:signal peptide  description:None
type:chain  description:Latency-associated peptide
type:chain  description:Transforming growth factor beta-1
type:region of interest  description:Straightjacket domain
type:region of interest  description:Arm domain
type:region of interest  description:Bowtie tail
type:short sequence motif  description:Cell attachment site
type:site  description:Cleavage; by FURIN
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:Interchain (with C-1359 or C-1384 in LTBP1); in inactive form
type:disulfide bond  description:Interchain (with C-225)
type:disulfide bond  description:Interchain (with C-223)
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
====== NO.2030protein ======
type:chain  description:Transcription factor E2-alpha
type:domain  description:bHLH
type:region of interest  description:Leucine-zipper
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform E47.
type:sequence variant  description:None
type:sequence conflict  description:In Ref. 1; AAK18618.
type:sequence conflict  description:In Ref. 1; AAK18618.
type:sequence conflict  description:In Ref. 3; AAH18260.
type:sequence conflict  description:In Ref. 2; BAB30842.
type:sequence conflict  description:In Ref. 3; AAH06860.
type:helix  description:None
type:helix  description:None
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
====== NO.2031protein ======
type:chain  description:Transcription factor E2-alpha
type:domain  description:bHLH
type:region of interest  description:Leucine-zipper
type:short sequence motif  description:9aaTAD
type:short sequence motif  description:Nuclear localization signal
type:site  description:Breakpoint for translocation to form TCF3-PBX1 oncogene
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform E47.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation; dbSNP:rs376780559.
type:sequence variant  description:In dbSNP:rs35354874.
type:sequence variant  description:In dbSNP:rs11879402.
type:sequence variant  description:In dbSNP:rs1052692.
type:sequence conflict  description:In Ref. 6; CAA36297.
type:sequence conflict  description:In Ref. 5; AAA56830.
type:sequence conflict  description:In Ref. 1; AAA36764.
type:sequence conflict  description:In Ref. 5; AAA56830.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:modified residue  description:Phosphothreonine
type:sequence variant  description:In AGM8, localizes normally to the nucleus, does not perform proper DNA binding, acts in a dominant-negative manner when coexpressed with wild-type) (Ref.29.
====== NO.2032protein ======
type:chain  description:Protein Tob2
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 1; BAA10971.
type:sequence conflict  description:In Ref. 1; BAA10971.
type:sequence conflict  description:In Ref. 1; BAA10971.
====== NO.2033protein ======
type:initiator methionine  description:Removed
type:chain  description:SUMO-conjugating enzyme UBC9
type:domain  description:UBC core
type:region of interest  description:Interaction with SUMO1
type:active site  description:Glycyl thioester intermediate
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Interaction with RANBP2
type:site  description:Substrate binding
type:modified residue  description:N-acetylserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine; by CDK1
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2034protein ======
type:chain  description:Probable cytochrome P450 555A1
type:transmembrane region  description:Helical
type:compositionally biased region  description:Asn-rich
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2035protein ======
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform CDK2-alpha.
type:mutagenesis site  description:Loss of tyrosine phosphorylation by WEE1 and CABLES1.
====== NO.2036protein ======
type:signal peptide  description:None
type:chain  description:Dentin matrix acidic phosphoprotein 1
type:short sequence motif  description:Cell attachment site
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs10019009.
type:sequence variant  description:In one individual with tumoral calcinosis; dbSNP:rs140719182.
type:sequence variant  description:In dbSNP:rs145237146.
type:sequence variant  description:In dbSNP:rs34661425.
====== NO.2037protein ======
type:chain  description:Probable cytochrome P450 517A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2038protein ======
type:chain  description:Ketimine reductase mu-crystallin
type:nucleotide phosphate-binding region  description:NADP
type:binding site  description:NADP
type:binding site  description:NADP
====== NO.2039protein ======
type:chain  description:Probable cytochrome P450 508A4
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2040protein ======
type:chain  description:Probable cytochrome P450 516B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2041protein ======
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
type:sequence conflict  description:In Ref. 2; AAA31431.
====== NO.2042protein ======
type:signal peptide  description:None
type:chain  description:Afamin
type:domain  description:Albumin 1
type:domain  description:Albumin 2
type:domain  description:Albumin 3
type:region of interest  description:Binding pocket for hydrophobic ligands
type:glycosylation site  description:N-linked (GlcNAc...) (complex) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) (complex) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) (complex) asparagine; atypical
type:glycosylation site  description:N-linked (GlcNAc...) (complex) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs41265665.
type:sequence variant  description:In dbSNP:rs2276444.
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2043protein ======
type:chain  description:Cyclin-dependent kinase 4 inhibitor D
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:modified residue  description:N-acetylmethionine
type:sequence conflict  description:In Ref. 1; AAC52194.
type:sequence conflict  description:In Ref. 2; AAA85437.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2044protein ======
type:initiator methionine  description:Removed
type:chain  description:Cytochrome P450 1A1
type:chain  description:Cytochrome P450MT2A
type:chain  description:Cytochrome P450MT2B
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
type:mutagenesis site  description:No proteolytic cleavage.
type:sequence conflict  description:In Ref. 5; AA sequence.
type:sequence conflict  description:In Ref. 2; CAA25153.
type:sequence conflict  description:In Ref. 3; AAA41025.
====== NO.2045protein ======
type:chain  description:Cyclin-dependent kinase 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:site  description:CDK7 binding
type:modified residue  description:N-acetylmethionine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by WEE1
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphothreonine; by CAK and CCRK
====== NO.2046protein ======
type:chain  description:Neo-calmodulin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:non-terminal residue  description:None
type:non-terminal residue  description:None
====== NO.2047protein ======
type:chain  description:Probable cytochrome P450 554A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2048protein ======
type:signal peptide  description:None
type:chain  description:T-cell surface glycoprotein CD4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like V-type
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:S-palmitoyl cysteine
type:lipid moiety-binding region  description:S-palmitoyl cysteine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:No change in secretion; when associated with S-297.
type:mutagenesis site  description:No change in secretion; when associated with T-186.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.2049protein ======
====== NO.2050protein ======
type:signal peptide  description:None
type:chain  description:Legumain
type:propeptide  description:None
type:active site  description:None
type:active site  description:Nucleophile
type:site  description:Cleavage; by autolysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In dbSNP:rs2236264.
type:mutagenesis site  description:Increases catalytic activity at pH 5.5.
type:mutagenesis site  description:Loss of autoactivation.
type:sequence conflict  description:In Ref. 2; BAA09530.
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2051protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:modified residue  description:4-hydroxyproline
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:disulfide bond  description:None
====== NO.2052protein ======
type:signal peptide  description:None
type:chain  description:Alkaline phosphatase, tissue-nonspecific isozyme
type:propeptide  description:Removed in mature form
type:active site  description:Phosphoserine intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1; via tele nitrogen
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:GPI-anchor amidated serine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPSI; 7% of activity.
type:sequence variant  description:In HOPS; 7.2% of wild-type activity; dbSNP:rs121918005.
type:sequence variant  description:In HOPS; 2% of activity; dbSNP:rs770093969.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs1470389268.
type:sequence variant  description:In HOPS; moderate; 27% of activity.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of activity.
type:sequence variant  description:In HOPSC; severe allele.
type:sequence variant  description:In HOPS; 35% of alkaline phosphatase activity; dbSNP:rs121918001.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs121918003.
type:sequence variant  description:In HOPS; dbSNP:rs121918003.
type:sequence variant  description:In HOPSC; severe allele; dbSNP:rs121918001.
type:sequence variant  description:In HOPS; severe; 3.5% of activity; dbSNP:rs1304394441.
type:sequence variant  description:In HOPS; dbSNP:rs1057521085.
type:sequence variant  description:In HOPS; 0.4% of alkaline phosphatase activity; severe allele; no effect on subcellular location; fails to assemble into dimeric structure; dominant negative effect; dbSNP:rs121918015.
type:sequence variant  description:In HOPS; odonto; 50% of alkaline phosphatase activity; dbSNP:rs773257111.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs121918013.
type:sequence variant  description:In HOPS; dbSNP:rs954135116.
type:sequence variant  description:In HOPS; dbSNP:rs1159854007.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; requires 2 nucleotide substitutions; dbSNP:rs786204530.
type:sequence variant  description:In HOPS; 9% of activity; dbSNP:rs780583917.
type:sequence variant  description:In HOPS; moderate; 33% of activity; dbSNP:rs121918011.
type:sequence variant  description:In HOPS; dbSNP:rs1376937780.
type:sequence variant  description:In HOPS; lethal form; benign variant; dbSNP:rs149344982.
type:sequence variant  description:In HOPS; dbSNP:rs760029254.
type:sequence variant  description:In HOPS; severe; 1% of activity; dbSNP:rs121918012.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs778232217.
type:sequence variant  description:In HOPS; severe; 2% of activity.
type:sequence variant  description:In HOPS; 30% of alkaline phosphatase activity; dbSNP:rs121918019.
type:sequence variant  description:In HOPS and HOPSC; moderate allele; dbSNP:rs199669988.
type:sequence variant  description:In HOPS; dbSNP:rs121918000.
type:sequence variant  description:In HOPS; 1% of activity; dbSNP:rs199590449.
type:sequence variant  description:In HOPS; loss of activity; dbSNP:rs763159520.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; odonto.
type:sequence variant  description:In HOPS; moderate; frequent mutation in European countries; 56% of alkaline phosphatase activity; dbSNP:rs121918007.
type:sequence variant  description:In HOPS; weak alkaline phosphatase activity; severely affects homodimerization; reduced cell surface expression.
type:sequence variant  description:In HOPS; dbSNP:rs121918004.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; odonto.
type:sequence variant  description:In HOPS; dbSNP:rs199665722.
type:sequence variant  description:In HOPS and HOPSC; 3% of activity; severe allele; dbSNP:rs766076920.
type:sequence variant  description:In HOPSI; partial loss of activity; dbSNP:rs1226800998.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; 4% of activity; dbSNP:rs1223142821.
type:sequence variant  description:In HOPS; partial loss of activity; dbSNP:rs121918018.
type:sequence variant  description:Common polymorphism; dbSNP:rs3200254.
type:sequence variant  description:In HOPS; 6.8% of wild-type activity; dbSNP:rs781272386.
type:sequence variant  description:In HOPS; dbSNP:rs781272386.
type:sequence variant  description:In HOPSC; severe allele; dbSNP:rs1237252052.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; moderate; 8% of activity; dbSNP:rs786204473.
type:sequence variant  description:In HOPS; 4% of wild-type activity; dbSNP:rs765458125.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs121918002.
type:sequence variant  description:In HOPS; dbSNP:rs1553414079.
type:sequence variant  description:In HOPS; 8.5% of wild-type activity; dbSNP:rs1220125702.
type:sequence variant  description:In HOPS; 1.3% of wild-type activity.
type:sequence variant  description:In HOPSI; dbSNP:rs121918017.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs763457259.
type:sequence variant  description:In HOPS; in a patient carrying also K-291.
type:sequence variant  description:In HOPS; requires 2 nucleotide substitutions.
type:sequence variant  description:In HOPS and HOPSI; dbSNP:rs121918010.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs121918009.
type:sequence variant  description:In HOPS; weak alkaline phosphatase activity.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity.
type:sequence variant  description:In HOPS; dbSNP:rs1553414563.
type:sequence variant  description:In HOPS; dbSNP:rs1553414568.
type:sequence variant  description:In HOPS; loss of activity; dbSNP:rs121918008.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs771540767.
type:sequence variant  description:In HOPS; moderate; 4-10% of alkaline phosphatase activity; dbSNP:rs371243939.
type:sequence variant  description:In HOPSC and HOPS; severe allele; loss of alkaline phosphatase activity; dbSNP:rs1442918125.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; 15% of activity.
type:sequence variant  description:In HOPS; absence of residual enzymatic activity.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity.
type:sequence variant  description:In HOPS; very low alkaline phosphatase activity; does not affect subcellular location; fails to assemble into dimeric structure; dbSNP:rs121918014.
type:sequence variant  description:In HOPS; very low alkaline phosphatase activity; does not affect subcellular location.
type:sequence variant  description:In HOPS; very low alkaline phosphatase activity; does not affect subcellular location.
type:sequence variant  description:In HOPS; 16% alkaline of phosphatase activity.
type:sequence variant  description:In HOPSI; partial loss of activity.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; dbSNP:rs121918006.
type:sequence variant  description:In HOPS; severe; 2% of activity; dbSNP:rs1553415041.
type:sequence variant  description:In HOPS; severe; 4% of activity; dbSNP:rs138690664.
type:sequence variant  description:In HOPS; dbSNP:rs150799088.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity; dbSNP:rs966212736.
type:sequence variant  description:In HOPSI; loss of activity; dbSNP:rs121918016.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity.
type:sequence variant  description:In HOPSI; dbSNP:rs1054159992.
type:sequence variant  description:In HOPS; dbSNP:rs1196976671.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; loss of alkaline phosphatase activity.
type:sequence variant  description:In HOPS.
type:sequence variant  description:In HOPS; 9% of activity.
type:sequence variant  description:In HOPS; reduces alkaline phosphatase activity.
type:sequence variant  description:In HOPS; odonto; partial loss of activity.
type:sequence variant  description:In HOPS; dbSNP:rs1413274209.
type:sequence variant  description:In dbSNP:rs34605986.
type:sequence conflict  description:In Ref. 10; AA sequence.
type:sequence conflict  description:In Ref. 3; CAA32376.
type:sequence conflict  description:In Ref. 1; BAA32129.
type:sequence conflict  description:In Ref. 1; BAA32129.
====== NO.2053protein ======
type:chain  description:Progesterone receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating, Pro-Rich
type:region of interest  description:AF3; mediates transcriptional activation (in isoform B)
type:region of interest  description:Mediates transcriptional transrepression (in isoform A)
type:region of interest  description:AF1; mediates transcriptional activation
type:region of interest  description:AF2; mediates transcriptional activation
type:short sequence motif  description:LXXL motif 1
type:short sequence motif  description:LXXL motif 2
type:short sequence motif  description:Nuclear localization signal
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK1
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine; by CDK2
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform A.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 5.
type:sequence variant  description:In dbSNP:rs11571143.
type:sequence variant  description:In dbSNP:rs11571144.
type:sequence variant  description:In dbSNP:rs11571145.
type:sequence variant  description:In dbSNP:rs11571146.
type:sequence variant  description:In dbSNP:rs3740753.
type:sequence variant  description:In dbSNP:rs11571147.
type:sequence variant  description:In dbSNP:rs11571150.
type:sequence variant  description:In dbSNP:rs11571151.
type:sequence variant  description:In dbSNP:rs11571152.
type:sequence variant  description:In dbSNP:rs2020874.
type:sequence variant  description:In dbSNP:rs11571222.
type:sequence variant  description:In dbSNP:rs1042838.
type:sequence variant  description:In dbSNP:rs2020880.
type:mutagenesis site  description:Some loss of sumoylation; when associated with R-531. Complete loss of sumoylation; when associated with R-388 and R-531.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-58 and A-59.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-55 and A-59.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-55 and A-58.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-118 and A-119.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-115 and A-119.
type:mutagenesis site  description:Reduces transcriptional activation; when associated with A-115 and A-118.
type:mutagenesis site  description:Reduces transcriptional activation.
type:mutagenesis site  description:No effect on interaction with CUEDC2. Impaired progesterone-induced transcriptional activity. No CUEDC2- nor progestin-mediated protein degradation. No change in sumoylation; when associated with A-344 and A-345.
type:mutagenesis site  description:Decreases protein stability and increases progesterone-induced transcriptional activity.
type:mutagenesis site  description:No interaction with SP1. No change in progestin-induced protein degradation; when associated with A-345. No change in sumoylation; when associated with A-294 and A-345.
type:mutagenesis site  description:No change in progestin-induced protein degradation; when associated with A-344. No change in sumoylation; when associated with A-294 and A-344.
type:mutagenesis site  description:Great loss of sumoylation; when associated with R-7. Completely abolishes sumoylation; when associated with R-7 and R-531. Loss of CUEDC2-mediated protein degradation. Increased ligand-dependent transcriptional activity.
type:mutagenesis site  description:Abolishes CDK2-induced activity in the absence, but not in the presence, of progestin. Delayed nuclear translocation in presence of progestin.
type:mutagenesis site  description:Some loss of sumoylation; when associated with R-7. Completely abolishes sumoylation; when associated with R-7 and R-388.
type:sequence conflict  description:In Ref. 1; CAA36018.
type:sequence conflict  description:In Ref. 1; CAA36018.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
====== NO.2054protein ======
type:chain  description:Nuclear receptor coactivator 6
type:region of interest  description:NCOA1-binding region
type:region of interest  description:CREBBP-binding region
type:region of interest  description:TBP/GTF2A-binding region
type:region of interest  description:NCOA6IP-binding region
type:short sequence motif  description:LXXLL motif
type:compositionally biased region  description:Poly-Lys
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Poly-Met
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:mutagenesis site  description:Abolishes interaction with nuclear receptors.
type:non-terminal residue  description:None
====== NO.2055protein ======
type:signal peptide  description:None
type:chain  description:Low-density lipoprotein receptor-related protein 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:LDL-receptor class A 1
type:domain  description:LDL-receptor class A 2
type:domain  description:LDL-receptor class A 3
type:domain  description:LDL-receptor class A 4
type:domain  description:LDL-receptor class A 5
type:domain  description:LDL-receptor class A 6
type:domain  description:LDL-receptor class A 7
type:domain  description:EGF-like 1; calcium-binding
type:repeat  description:LDL-receptor class B 1
type:repeat  description:LDL-receptor class B 2
type:repeat  description:LDL-receptor class B 3
type:repeat  description:LDL-receptor class B 4
type:repeat  description:LDL-receptor class B 5
type:repeat  description:LDL-receptor class B 6
type:repeat  description:LDL-receptor class B 7
type:repeat  description:LDL-receptor class B 8
type:domain  description:LDL-receptor class A 8
type:domain  description:LDL-receptor class A 9
type:domain  description:LDL-receptor class A 10
type:domain  description:LDL-receptor class A 11
type:domain  description:LDL-receptor class A 12
type:domain  description:LDL-receptor class A 13
type:domain  description:LDL-receptor class A 14
type:domain  description:LDL-receptor class A 15
type:repeat  description:LDL-receptor class B 9
type:repeat  description:LDL-receptor class B 10
type:repeat  description:LDL-receptor class B 11
type:repeat  description:LDL-receptor class B 12
type:repeat  description:LDL-receptor class B 13
type:repeat  description:LDL-receptor class B 14
type:repeat  description:LDL-receptor class B 15
type:repeat  description:LDL-receptor class B 16
type:repeat  description:LDL-receptor class B 17
type:repeat  description:LDL-receptor class B 18
type:repeat  description:LDL-receptor class B 19
type:repeat  description:LDL-receptor class B 20
type:repeat  description:LDL-receptor class B 21
type:repeat  description:LDL-receptor class B 22
type:repeat  description:LDL-receptor class B 23
type:repeat  description:LDL-receptor class B 24
type:repeat  description:LDL-receptor class B 25
type:repeat  description:LDL-receptor class B 26
type:repeat  description:LDL-receptor class B 27
type:domain  description:LDL-receptor class A 16
type:domain  description:LDL-receptor class A 17
type:domain  description:LDL-receptor class A 18
type:domain  description:LDL-receptor class A 19
type:domain  description:LDL-receptor class A 20
type:domain  description:LDL-receptor class A 21
type:domain  description:LDL-receptor class A 22
type:domain  description:LDL-receptor class A 23
type:domain  description:LDL-receptor class A 24
type:domain  description:LDL-receptor class A 25
type:domain  description:EGF-like 2; calcium-binding
type:repeat  description:LDL-receptor class B 28
type:repeat  description:LDL-receptor class B 29
type:repeat  description:LDL-receptor class B 30
type:repeat  description:LDL-receptor class B 31
type:repeat  description:LDL-receptor class B 32
type:domain  description:LDL-receptor class A 26
type:domain  description:LDL-receptor class A 27
type:domain  description:LDL-receptor class A 28
type:domain  description:LDL-receptor class A 29
type:domain  description:LDL-receptor class A 30
type:domain  description:LDL-receptor class A 31
type:domain  description:LDL-receptor class A 32
type:domain  description:LDL-receptor class A 33
type:domain  description:LDL-receptor class A 34
type:domain  description:LDL-receptor class A 35
type:domain  description:LDL-receptor class A 36
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4; calcium-binding
type:repeat  description:LDL-receptor class B 33
type:repeat  description:LDL-receptor class B 34
type:repeat  description:LDL-receptor class B 35
type:domain  description:EGF-like 5
type:region of interest  description:Interaction with DAB2
type:short sequence motif  description:SH3-binding
type:short sequence motif  description:PxLPxI/L motif 1; mediates interaction with ANKRA2
type:short sequence motif  description:PxLPxI/L motif 2; mediates interaction with ANKRA2
type:short sequence motif  description:Endocytosis signal
type:short sequence motif  description:NPXY motif
type:short sequence motif  description:SH2-binding
type:short sequence motif  description:SH3-binding
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2056protein ======
type:chain  description:Nuclear receptor subfamily 5 group A member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Lipid binding
type:short sequence motif  description:FTZ-F1 box
type:binding site  description:Lipid headgroup
type:binding site  description:Lipid headgroup
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 1.
type:splice variant  description:In isoform 3.
type:mutagenesis site  description:Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-168 and A-172.
type:mutagenesis site  description:Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-96 and A-172.
type:mutagenesis site  description:Reduced DNA binding. Loss of transactivation.
type:mutagenesis site  description:Slightly reduced DNA binding. Strongly reduced transactivation; when associated with A-96 and A-168.
type:mutagenesis site  description:Impaired ability to act as an anti-inflammatory role during the hepatic acute phase response.
type:mutagenesis site  description:Reduced phospholipid binding. Strongly reduced transactivation; when associated with W-416.
type:mutagenesis site  description:Reduced phospholipid binding. Strongly reduced transactivation; when associated with W-342.
type:sequence conflict  description:In Ref. 9; AAD03155.
type:sequence conflict  description:In Ref. 9; AAD03155.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2057protein ======
type:initiator methionine  description:Removed
type:chain  description:Plasma membrane calcium-transporting ATPase 1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Calmodulin-binding subdomain A
type:region of interest  description:Required for basolateral membrane targeting
type:compositionally biased region  description:Poly-Glu
type:active site  description:4-aspartylphosphate intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium; via carbonyl oxygen
type:metal ion-binding site  description:Magnesium
type:modified residue  description:N-acetylglycine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by PKC
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform K.
type:splice variant  description:In isoform C.
type:splice variant  description:In isoform D.
type:splice variant  description:In isoform A and isoform E.
type:splice variant  description:In isoform A.
type:splice variant  description:In isoform E.
type:sequence conflict  description:In Ref. 2; AAD46085.
====== NO.2058protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:modified residue  description:Hydroxyproline
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:disulfide bond  description:None
====== NO.2059protein ======
type:chain  description:Cytosolic phospholipase A2
type:domain  description:C2
type:domain  description:PLA2c
type:region of interest  description:Phospholipid binding
type:active site  description:Nucleophile
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
type:sequence conflict  description:In Ref. 3; AAC21591.
====== NO.2060protein ======
type:initiator methionine  description:Removed
type:chain  description:Plasma membrane calcium-transporting ATPase 1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Calmodulin-binding subdomain A
type:region of interest  description:Required for basolateral membrane targeting
type:active site  description:4-aspartylphosphate intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium; via carbonyl oxygen
type:metal ion-binding site  description:Magnesium
type:modified residue  description:N-acetylglycine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by PKC
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2061protein ======
type:initiator methionine  description:Removed
type:chain  description:Nuclear receptor coactivator 3
type:domain  description:bHLH
type:domain  description:PAS
type:region of interest  description:Interaction with CREBBP
type:region of interest  description:Acetyltransferase
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Poly-Gln
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by CK1
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
====== NO.2062protein ======
type:signal peptide  description:None
type:peptide  description:Synenkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(114-133)
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(143-185)
type:peptide  description:Met-enkephalin-Arg-Gly-Leu
type:propeptide  description:None
type:peptide  description:Met-enkephalin
type:propeptide  description:None
type:peptide  description:Leu-enkephalin
type:peptide  description:PENK(239-260)
type:peptide  description:Met-enkephalin-Arg-Phe
type:modified residue  description:Phosphoserine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 2; AAA60734 and 5; CAA68804.
====== NO.2063protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Legumain
type:propeptide  description:None
type:active site  description:None
type:active site  description:Nucleophile
type:site  description:Cleavage; by autolysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 2; AAI11118.
====== NO.2064protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform Long.
type:sequence conflict  description:In Ref. 6; AA sequence.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 2; AAA30362.
type:sequence conflict  description:In Ref. 6; AA sequence.
type:sequence conflict  description:In Ref. 5; AAX46664.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2065protein ======
type:signal peptide  description:None
type:chain  description:Protein disulfide-isomerase A3
type:domain  description:Thioredoxin 1
type:domain  description:Thioredoxin 2
type:short sequence motif  description:Prevents secretion from ER
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:site  description:Lowers pKa of C-terminal Cys of first active site
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:site  description:Lowers pKa of C-terminal Cys of second active site
type:modified residue  description:N6-methyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:disulfide bond  description:Redox-active
type:disulfide bond  description:Interchain (with C-115 in TAPBP); in linked form
type:disulfide bond  description:None
type:disulfide bond  description:Redox-active
type:mutagenesis site  description:Failure to prevent secretion from ER.
type:mutagenesis site  description:Failure to prevent secretion from ER.
type:sequence conflict  description:In Ref. 1.
type:sequence conflict  description:In Ref. 1; CAA30916.
type:sequence conflict  description:In Ref. 1; CAA30916.
type:sequence conflict  description:In Ref. 2; BAA09695.
====== NO.2066protein ======
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:sequence variant  description:In a colorectal adenocarcinoma sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs35760989.
type:sequence variant  description:In dbSNP:rs200523275.
type:sequence variant  description:In dbSNP:rs33989191.
type:mutagenesis site  description:Increased kinase activity.
type:mutagenesis site  description:Decreased kinase activity.
type:mutagenesis site  description:Decreased kinase activity.
type:mutagenesis site  description:Decreased kinase activity.
type:sequence conflict  description:In Ref. 2; AAA60089.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
====== NO.2067protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Parathyroid hormone
type:region of interest  description:Important for receptor binding
type:sequence variant  description:In FIH; dominant; leads to inefficient processing of the precursor; the expressed mutant hormone is trapped intracellularly in the endoplasmic reticulum resulting in apoptosis; mutant protein-expressing cells also show marked up-regulation of the endoplasmic reticulum stress-responsive hormones HSPA5 and EIF2AK3 and the proapoptotic transcription factor DDIT3; dbSNP:rs104894271.
type:sequence variant  description:In FIH; recessive; might lead to inefficient processing of the precursor; dbSNP:rs104894272.
type:mutagenesis site  description:Abolishes processing of the precursor; when associated with variant R-18.
type:mutagenesis site  description:Reduced affinity for PTH1R.
type:mutagenesis site  description:Strongly reduced affinity for PTH1R.
type:mutagenesis site  description:Strongly reduced affinity for PTH1R.
type:mutagenesis site  description:Reduced affinity for PTH1R.
type:mutagenesis site  description:Strongly reduced affinity for PTH1R.
type:sequence conflict  description:In Ref. 8; AA sequence.
type:helix  description:None
type:helix  description:None
====== NO.2068protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:NADPH:adrenodoxin oxidoreductase, mitochondrial
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:FAD; via amide nitrogen and carbonyl oxygen
type:binding site  description:NADP
type:binding site  description:FAD; via amide nitrogen
type:binding site  description:NADP; via amide nitrogen
====== NO.2069protein ======
type:chain  description:Lysine-specific demethylase hairless
type:domain  description:JmjC
type:zinc finger region  description:C6-type
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Poly-Gly
type:metal ion-binding site  description:Iron; catalytic
type:metal ion-binding site  description:Iron; catalytic
type:metal ion-binding site  description:Iron; catalytic
type:sequence conflict  description:In Ref. 1; CAA83587.
====== NO.2070protein ======
type:initiator methionine  description:Removed
type:chain  description:Calbindin
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:domain  description:EF-hand 3
type:domain  description:EF-hand 4
type:domain  description:EF-hand 5
type:calcium-binding region  description:1
type:calcium-binding region  description:2
type:calcium-binding region  description:3
type:calcium-binding region  description:4
type:region of interest  description:Interaction with RANBP9
type:modified residue  description:N-acetylalanine
====== NO.2071protein ======
type:chain  description:Probable cytochrome P450 508B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2072protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 16
type:repeat  description:WD 1
type:repeat  description:WD 2
type:repeat  description:WD 3
type:repeat  description:WD 4
type:repeat  description:WD 5
type:repeat  description:WD 6
type:repeat  description:WD 7
type:repeat  description:WD 8
type:repeat  description:WD 9
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 2 and isoform 3.
type:sequence variant  description:In dbSNP:rs34859566.
type:sequence variant  description:In dbSNP:rs13090.
type:sequence conflict  description:In Ref. 1; AAD30032.
type:sequence conflict  description:In Ref. 2; AAD31087.
type:sequence conflict  description:In Ref. 1; AAD30032.
====== NO.2073protein ======
type:chain  description:Nuclear receptor subfamily 2 group C member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:mutagenesis site  description:Enhanced transcriptional activation; Greatly enhanced transcriptional activation; when associated with A-68.
type:mutagenesis site  description:Some repression of transcriptional activation; Repressed transcriptional activity by about 10-fold; when associated with E-68.
type:mutagenesis site  description:No effect on transcriptional activation.
type:mutagenesis site  description:Enhanced transcriptional activation; Greatly enhanced transcriptional activation; when associated with A-15.
type:mutagenesis site  description:Some repression of transcriptional activation; Repressed transcriptional activity by about 10-fold; when associated with E-19.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
type:sequence conflict  description:In Ref. 2; AAC18408.
====== NO.2074protein ======
type:initiator methionine  description:Removed
type:chain  description:E3 SUMO-protein ligase PIAS4
type:domain  description:SAP
type:domain  description:PINIT
type:zinc finger region  description:SP-RING-type
type:short sequence motif  description:LXXLL motif
type:compositionally biased region  description:Asp/Glu-rich (acidic)
type:modified residue  description:N-acetylalanine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:mutagenesis site  description:Abrogates sumoylation of LEF1 and increases LEF1-mediated transcriptional activity; when associated with S-335; A-337 and S-340.
type:mutagenesis site  description:Abrogates sumoylation of LEF1 and increases LEF1-mediated transcriptional activity; when associated with S-330; A-337 and S-340.
type:mutagenesis site  description:Abrogates sumoylation of LEF1 and increases LEF1-mediated transcriptional activity; when associated with S-330; S-335 and S-340.
type:mutagenesis site  description:Abrogates sumoylation of LEF1 and increases LEF1-mediated transcriptional activity; when associated with S-330; S-335 and A-337.
type:mutagenesis site  description:No effect on sumoylation of LEF1, nor on LEF1-binding.
type:sequence conflict  description:In Ref. 1; AAF72040.
type:sequence conflict  description:In Ref. 1; AAF72040.
type:sequence conflict  description:In Ref. 1; AAF72040.
====== NO.2075protein ======
type:chain  description:Arrestin domain-containing protein 3
type:short sequence motif  description:PPxY motif 1
type:short sequence motif  description:PPxY motif 2
type:mutagenesis site  description:Abolishes interaction with ADRB2; when associated with E-52; E-85 and E-139.
type:mutagenesis site  description:Abolishes interaction with ADRB2; when associated with E-48; E-85 and E-139.
type:mutagenesis site  description:Nearly abolishes interaction with ADRB2; when associated with E-58; E-135 and E-153.
type:mutagenesis site  description:Nearly abolishes interaction with ADRB2; when associated with E-56; E-135 and E-153.
type:mutagenesis site  description:Abolishes interaction with ADRB2; when associated with E-48; E-52 and E-139.
type:mutagenesis site  description:Nearly abolishes interaction with ADRB2; when associated with E-56; E-58 and E-153.
type:mutagenesis site  description:Abolishes interaction with ADRB2; when associated with E-48; E-52 and E-85.
type:mutagenesis site  description:Nearly abolishes interaction with ADRB2; when associated with E-56; E-58 and E-135.
type:mutagenesis site  description:Strongly reduces interaction with NEDD4. Abolishes interaction with NEDD4; when associated with 391-A--A-394. Abolishes interaction with HGS; when associated with 391-A--A-394.
type:mutagenesis site  description:Abolishes interaction with NEDD4; when associated with 346-A--A-349.
type:sequence conflict  description:In Ref. 2; BAF84442.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2076protein ======
type:signal peptide  description:None
type:chain  description:Prostaglandin G/H synthase 2
type:domain  description:EGF-like
type:active site  description:Proton acceptor
type:active site  description:For cyclooxygenase activity
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:binding site  description:Substrate
type:site  description:Aspirin-acetylated serine
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:O-acetylserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
type:sequence conflict  description:In Ref. 4 and 5.
====== NO.2077protein ======
type:signal peptide  description:None
type:chain  description:Alkaline phosphatase, tissue-nonspecific isozyme
type:propeptide  description:Removed in mature form
type:active site  description:Phosphoserine intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1; via tele nitrogen
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:GPI-anchor amidated serine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAA30380.
type:sequence conflict  description:In Ref. 1; AAA30380.
====== NO.2078protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Interleukin-15
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform IL15-S21AA.
type:sequence conflict  description:In Ref. 4; AAB97518.
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2079protein ======
type:chain  description:Nitric oxide synthase, inducible
type:domain  description:Flavodoxin-like
type:domain  description:FAD-binding FR-type
type:nucleotide phosphate-binding region  description:FMN
type:nucleotide phosphate-binding region  description:FAD
type:nucleotide phosphate-binding region  description:FAD
type:nucleotide phosphate-binding region  description:NADP
type:nucleotide phosphate-binding region  description:NADP
type:region of interest  description:Calmodulin-binding
type:short sequence motif  description:DINNN-motif; mediates interaction with SPSB1, SPSB2 and SPSB4
type:metal ion-binding site  description:Zinc
type:metal ion-binding site  description:Zinc
type:metal ion-binding site  description:Iron (heme axial ligand)
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine
type:sequence conflict  description:In Ref. 7; BAA07994.
type:sequence conflict  description:In Ref. 1; BAA03138.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 3 and 5.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 1; BAA03138.
type:sequence conflict  description:In Ref. 6; CAA54208.
type:sequence conflict  description:In Ref. 2, 7, 8 and 9; AAC83553/AAC83554.
type:sequence conflict  description:In Ref. 4; BAA02090.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 13.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 9; AAC83553/AAC83554.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 5 and 10.
type:sequence conflict  description:In Ref. 12; AAB31028.
type:sequence conflict  description:In Ref. 1 and 6.
type:sequence conflict  description:In Ref. 2; AAA85861.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 1; BAA03138.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 2, 7, 8, 9; AAC83553/AAC83554 and 10; AAC16401.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 6.
type:sequence conflict  description:In Ref. 1, 6 and 11.
type:sequence conflict  description:In Ref. 11.
type:sequence conflict  description:In Ref. 11; AAB18620.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 6; CAA54208.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 1; BAA03138.
type:sequence conflict  description:In Ref. 4; BAA02090.
type:sequence conflict  description:In Ref. 3; AAC13747.
type:sequence conflict  description:In Ref. 8; BAA12035.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 2, 7 and 9; AAC83553/AAC83554.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 5.
type:sequence conflict  description:In Ref. 8.
type:sequence conflict  description:In Ref. 5 and 8.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 9; AAC83553.
type:sequence conflict  description:In Ref. 6; CAA54208.
type:sequence conflict  description:In Ref. 9; AAC83554.
type:sequence conflict  description:In Ref. 2, 7 and 9; AAC83553/AAC83554.
type:sequence conflict  description:In Ref. 2, 7 and 9; AAC83553/AAC83554.
====== NO.2080protein ======
type:chain  description:Nuclear receptor subfamily 1 group I member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Hinge
type:short sequence motif  description:Bipartite nuclear localization signal
type:binding site  description:Agonist
type:binding site  description:Agonist
type:binding site  description:Agonist
type:binding site  description:Agonist
type:binding site  description:Agonist
type:splice variant  description:In isoform 1B and isoform 2B.
type:splice variant  description:In isoform 1C and isoform 2C.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2A, isoform 2B and isoform 2C.
type:sequence variant  description:In dbSNP:rs1063955.
type:sequence variant  description:In dbSNP:rs59371185.
type:sequence variant  description:In allele PXR*2; dbSNP:rs12721613.
type:sequence variant  description:In allele PXR*3; dbSNP:rs12721607.
type:sequence variant  description:In dbSNP:rs72551371.
type:sequence variant  description:In allele PXR*4; rare polymorphism; dbSNP:rs12721608.
type:sequence variant  description:In dbSNP:rs72551373.
type:sequence variant  description:In dbSNP:rs35761343.
type:sequence variant  description:In dbSNP:rs72551375.
type:sequence variant  description:In dbSNP:rs72551376.
type:mutagenesis site  description:Abolishes nuclear localization; when associated with 91-A-A-92.
type:mutagenesis site  description:Abolishes nuclear localization; when associated with 66-A-A-67.
type:sequence conflict  description:In Ref. 5; CAB55489/CAB55490/CAB55491/CAB55492/CAB55493/CAB55494.
type:sequence conflict  description:In Ref. 8; AAH17304.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2081protein ======
type:chain  description:Inositol polyphosphate 5-phosphatase OCRL
type:domain  description:PH
type:domain  description:Rho-GAP
type:region of interest  description:5-phosphatase
type:region of interest  description:ASH
type:short sequence motif  description:Clathrin box 1
type:short sequence motif  description:Clathrin box 2
type:splice variant  description:In isoform B.
type:sequence variant  description:In OCRL; dbSNP:rs137853828.
type:sequence variant  description:In OCRL; dbSNP:rs137853829.
type:sequence variant  description:In OCRL; dbSNP:rs137853830.
type:sequence variant  description:In DD2 and OCRL; dbSNP:rs137853263.
type:sequence variant  description:In OCRL; associated with I-361; dbSNP:rs137853831.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In DD2; dbSNP:rs137853833.
type:sequence variant  description:In OCRL; uncertain pathological significance; dbSNP:rs137853854.
type:sequence variant  description:In OCRL; associated with C-337; dbSNP:rs137853832.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; dbSNP:rs137853834.
type:sequence variant  description:In OCRL; dbSNP:rs137853835.
type:sequence variant  description:In OCRL; dbSNP:rs137853836.
type:sequence variant  description:In OCRL; dbSNP:rs137853848.
type:sequence variant  description:In OCRL; dbSNP:rs137853837.
type:sequence variant  description:In OCRL; dbSNP:rs137853855.
type:sequence variant  description:In OCRL; dbSNP:rs137853856.
type:sequence variant  description:In OCRL; dbSNP:rs137853850.
type:sequence variant  description:In OCRL; dbSNP:rs137853838.
type:sequence variant  description:In OCRL; dbSNP:rs137853839.
type:sequence variant  description:In OCRL; dbSNP:rs137853851.
type:sequence variant  description:In OCRL; dbSNP:rs137853841.
type:sequence variant  description:In OCRL; dbSNP:rs137853840.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In DD2; dbSNP:rs137853262.
type:sequence variant  description:In DD2; dbSNP:rs137853846.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; dbSNP:rs137853857.
type:sequence variant  description:In OCRL; dbSNP:rs137853842.
type:sequence variant  description:In OCRL; dbSNP:rs398123287.
type:sequence variant  description:In OCRL; dbSNP:rs137853260.
type:sequence variant  description:In OCRL; dbSNP:rs137853843.
type:sequence variant  description:In OCRL; dbSNP:rs137853849.
type:sequence variant  description:In OCRL; dbSNP:rs137853847.
type:sequence variant  description:In OCRL; dbSNP:rs137853853.
type:sequence variant  description:In OCRL; dbSNP:rs137853261.
type:sequence variant  description:In OCRL; dbSNP:rs137853852.
type:sequence variant  description:In OCRL; dbSNP:rs137853858.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; dbSNP:rs137853844.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; uncertain pathological significance; abolishes FAM109A-, FAM109B- and APPL1-binding.
type:sequence variant  description:In OCRL; uncertain pathological significance.
type:sequence variant  description:In DD2.
type:sequence variant  description:In OCRL.
type:sequence variant  description:In OCRL; dbSNP:rs137853845.
type:mutagenesis site  description:Does not affect interaction with RAB8A.
type:mutagenesis site  description:Does not affect interaction with RAB8A.
type:mutagenesis site  description:Does not interact with RAB8A. Does not localize to cilia.
type:sequence conflict  description:In Ref. 4; BAF85796.
type:sequence conflict  description:In Ref. 7; AAI44107.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2082protein ======
type:initiator methionine  description:Removed
type:chain  description:Mediator of RNA polymerase II transcription subunit 30
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:modified residue  description:N-acetylserine
type:splice variant  description:In isoform 2.
====== NO.2083protein ======
type:signal peptide  description:None
type:chain  description:Prostaglandin G/H synthase 2
type:domain  description:EGF-like
type:active site  description:Proton acceptor
type:active site  description:For cyclooxygenase activity
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:binding site  description:Substrate
type:site  description:Aspirin-acetylated serine
type:site  description:Not glycosylated
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:O-acetylserine; by SPHK1
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:Impairs peroxidase and cyclooxygenase activities toward 2-arachidonoyl glycerol.
type:mutagenesis site  description:Slightly reduced activity.
type:mutagenesis site  description:Decreases acetylation by SPHK1.
type:mutagenesis site  description:Loss of glycosylation site.
type:sequence conflict  description:In Ref. 1; AAA39924.
type:sequence conflict  description:In Ref. 3; AAA39918.
type:sequence conflict  description:In Ref. 7; no nucleotide entry.
type:sequence conflict  description:In Ref. 3; AAA39918.
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
====== NO.2084protein ======
type:signal peptide  description:None
type:chain  description:Prostaglandin G/H synthase 2
type:domain  description:EGF-like
type:active site  description:Proton acceptor
type:active site  description:For cyclooxygenase activity
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:binding site  description:Substrate
type:site  description:Aspirin-acetylated serine
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:O-acetylserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs3218622.
type:sequence variant  description:In dbSNP:rs4648279.
type:sequence variant  description:In dbSNP:rs5272.
type:sequence variant  description:In dbSNP:rs5273.
type:sequence variant  description:In dbSNP:rs3218625.
type:mutagenesis site  description:Increases two-electron hydroperoxide reduction. Has no effect on cyclooxygenase activity.
type:mutagenesis site  description:Impairs two-electron hydroperoxide reduction and cyclooxygenase activity.
type:mutagenesis site  description:Impairs two-electron hydroperoxide reduction.
type:mutagenesis site  description:Reduces two-electron hydroperoxide reduction and cyclooxygenase activity. Catalyzes predominantly one-electron hydroperoxide reduction.
type:mutagenesis site  description:Decreased protein stability. Increased decrease of protein stability; when associated with A-516.
type:mutagenesis site  description:No effect on protein stability. Increased decrease of protein stability; when associated with A-371.
type:mutagenesis site  description:Decreased enzyme activity with arachidonic acid. Loss of cyclooxygenase activity; when associated with V-519.
type:mutagenesis site  description:Loss of cyclooxygenase activity. Loss of cyclooxygenase activity; when associated with T-516.
type:mutagenesis site  description:Prevents activation by nitric oxid (NO).
type:mutagenesis site  description:Abolishes enzyme activity.
type:mutagenesis site  description:Does not affect activation by nitric oxid (NO).
type:sequence conflict  description:In Ref. 2; AAA58433.
type:sequence conflict  description:In Ref. 1; AAA35803.
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2085protein ======
type:initiator methionine  description:Removed
type:chain  description:E3 SUMO-protein ligase PIAS4
type:domain  description:SAP
type:domain  description:PINIT
type:zinc finger region  description:SP-RING-type
type:short sequence motif  description:LXXLL motif
type:compositionally biased region  description:Asp/Glu-rich (acidic)
type:modified residue  description:N-acetylalanine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:mutagenesis site  description:Loss of repression of AR- and STAT1-induced transcription; no effect on AR- and STAT1-binding.
type:mutagenesis site  description:Complete loss of sumoylation. No enhancement of TCF4 sumoylation. No effect on interaction with TCF4. Colocalizes with SUMO1 in nucleus but concentrated into nuclear granules.
type:mutagenesis site  description:Some loss of sumoylation.
type:mutagenesis site  description:Inhibits TCF4 sumoylation. Inhibits beta-catenin-mediated TCF7L2/TCF4 activity. No colocalization with TCF7L2/TCF4 in nuclear punctate structures; when associated with A-347.
type:mutagenesis site  description:Inhibits TCF4 sumoylation. Inhibits beta-catenin-mediated TCF7L2/TCF4 activity. No colocalization with TCF7L2/TCF4 in nuclear punctate structures; when associated with A-342. AR- and STAT1-binding.
type:sequence conflict  description:In Ref. 1.
type:sequence conflict  description:In Ref. 1 and 3.
type:sequence conflict  description:In Ref. 2; AAH66895.
====== NO.2086protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Parathyroid hormone
type:region of interest  description:Important for receptor binding
type:sequence conflict  description:In Ref. 3; AAA57156.
type:sequence conflict  description:In Ref. 3; AAA57156.
type:sequence conflict  description:In Ref. 3; AAA57156.
type:sequence conflict  description:In Ref. 3; AAA57156.
====== NO.2087protein ======
type:initiator methionine  description:Removed
type:chain  description:Nuclear receptor coactivator 3
type:domain  description:bHLH
type:domain  description:PAS
type:region of interest  description:Interaction with CREBBP
type:region of interest  description:Acetyltransferase
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Met-rich
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by CK1
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 3 and isoform 4.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 2, isoform 3 and isoform 4.
type:splice variant  description:In isoform 3, isoform 4 and isoform 5.
type:sequence variant  description:In dbSNP:rs6094752.
type:sequence variant  description:In dbSNP:rs72645252.
type:sequence variant  description:In dbSNP:rs6094756.
type:sequence variant  description:In dbSNP:rs1052765.
type:sequence variant  description:In dbSNP:rs72645272.
type:sequence variant  description:In dbSNP:rs2230781.
type:sequence variant  description:In dbSNP:rs2230782.
type:sequence variant  description:In dbSNP:rs2230783.
type:sequence variant  description:In dbSNP:rs72645299.
type:sequence variant  description:In dbSNP:rs72645298.
type:sequence variant  description:None
type:mutagenesis site  description:Strongly reduces acetylation by CREBBP.
type:mutagenesis site  description:Abolishes acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:mutagenesis site  description:Does not affect acetylation by CREBBP.
type:sequence conflict  description:In Ref. 4; AAC51663.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2088protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:modified residue  description:4-hydroxyproline; partial
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:disulfide bond  description:None
====== NO.2089protein ======
type:signal peptide  description:None
type:chain  description:Protein disulfide-isomerase A3
type:domain  description:Thioredoxin 1
type:domain  description:Thioredoxin 2
type:short sequence motif  description:Prevents secretion from ER
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:site  description:Lowers pKa of C-terminal Cys of first active site
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:site  description:Lowers pKa of C-terminal Cys of second active site
type:modified residue  description:N6-methyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:disulfide bond  description:Redox-active
type:disulfide bond  description:Interchain (with C-118 in TAPBP); in linked form
type:disulfide bond  description:None
type:disulfide bond  description:Redox-active
type:sequence conflict  description:In Ref. 3; BAC40527/BAE41259.
type:sequence conflict  description:In Ref. 1; AAA39944.
type:sequence conflict  description:In Ref. 1; AAA39944.
type:sequence conflict  description:In Ref. 1; AAA39944.
type:sequence conflict  description:In Ref. 3; BAE39834.
type:sequence conflict  description:In Ref. 1; AAA39944.
type:sequence conflict  description:In Ref. 3; BAE39834.
====== NO.2090protein ======
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2091protein ======
type:signal peptide  description:None
type:chain  description:Alkaline phosphatase, tissue-nonspecific isozyme
type:propeptide  description:Removed in mature form
type:active site  description:Phosphoserine intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1; via tele nitrogen
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:GPI-anchor amidated glycine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAA39928.
====== NO.2092protein ======
type:signal peptide  description:None
type:chain  description:Cartilage oligomeric matrix protein
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:EGF-like 4
type:repeat  description:TSP type-3 1
type:repeat  description:TSP type-3 2
type:repeat  description:TSP type-3 3
type:repeat  description:TSP type-3 4
type:repeat  description:TSP type-3 5
type:repeat  description:TSP type-3 6
type:repeat  description:TSP type-3 7
type:repeat  description:TSP type-3 8
type:domain  description:TSP C-terminal
type:region of interest  description:COMP N-terminal
type:region of interest  description:Mediates cell survival and induction of the IAP family of survival proteins
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:Interchain (with C-71)
type:disulfide bond  description:Interchain (with C-68)
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAD01972.
type:helix  description:None
====== NO.2093protein ======
type:signal peptide  description:None
type:peptide  description:Synenkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(114-133)
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(143-183)
type:peptide  description:Met-enkephalin-Arg-Gly-Leu
type:propeptide  description:None
type:peptide  description:Met-enkephalin
type:propeptide  description:None
type:peptide  description:Leu-enkephalin
type:peptide  description:PENK(237-258)
type:peptide  description:Met-enkephalin-Arg-Phe
type:modified residue  description:Phosphoserine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs11998459.
type:sequence variant  description:In dbSNP:rs1800567.
type:sequence conflict  description:In Ref. 4; CAG46627.
type:sequence conflict  description:In Ref. 4; CAG46607.
type:turn  description:None
====== NO.2094protein ======
type:initiator methionine  description:Removed
type:chain  description:Nuclear receptor coactivator 2
type:domain  description:bHLH
type:domain  description:PAS
type:region of interest  description:CASP8AP2-binding
type:region of interest  description:Interaction with ARNTL
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:short sequence motif  description:LXXLL motif 4
type:short sequence motif  description:LLXXLXXXL motif
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:mutagenesis site  description:Abolishes interaction with RORC; when associated with 689-A--A-694 and 744-A--A-749.
type:mutagenesis site  description:Abolishes interaction with RORC; when associated with 644-A-A-645 and 744-A--A-749.
type:mutagenesis site  description:Abolishes interaction with RORC; when associated with 644-A-A-645 and 689-A--A-694.
type:sequence conflict  description:In Ref. 1; AAC53151.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 1; AAC53151.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:sequence conflict  description:In Ref. 1; AAC53151.
type:sequence conflict  description:In Ref. 2; AAB61575.
type:helix  description:None
type:helix  description:None
====== NO.2095protein ======
type:chain  description:Nuclear receptor subfamily 2 group C member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.2096protein ======
type:chain  description:Serine/threonine-protein kinase Sgk1
type:domain  description:Protein kinase
type:domain  description:AGC-kinase C-terminal
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Necessary for localization to the mitochondria
type:short sequence motif  description:Nuclear localization signal
type:compositionally biased region  description:Glu/Lys-rich
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK7
type:modified residue  description:Phosphothreonine; by PDPK1
type:modified residue  description:Phosphothreonine; by PKA
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:disulfide bond  description:Interchain (with C-258)
type:disulfide bond  description:Interchain (with C-193)
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 5.
type:sequence variant  description:In dbSNP:rs34133418.
type:sequence variant  description:In dbSNP:rs55932330.
type:mutagenesis site  description:Abolishes enzymatic activity.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:Abolishes interaction with NEDD4 and NEDD4L.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:10-fold activation.
type:sequence conflict  description:In Ref. 4; CAR58097.
type:sequence conflict  description:In Ref. 4; CAR58096.
type:sequence conflict  description:In Ref. 4; CAR58095.
type:sequence conflict  description:In Ref. 6; BAH12848.
type:sequence conflict  description:In Ref. 4; CAR58097.
type:sequence conflict  description:In Ref. 1; CAA71138 and 2; CAA04146.
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2097protein ======
type:chain  description:Nuclear receptor coactivator 6
type:region of interest  description:NCOA1-binding region
type:region of interest  description:CREBBP-binding region
type:region of interest  description:TBP/GTF2A-binding region
type:region of interest  description:NCOA6IP-binding region
type:region of interest  description:EP300/CRSP3-binding region
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Lys
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine; by MAPK; in vitro
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In dbSNP:rs6060031.
type:sequence variant  description:In dbSNP:rs17092079.
type:sequence variant  description:In a breast cancer sample; somatic mutation.
type:sequence variant  description:In a breast cancer sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs6060022.
type:mutagenesis site  description:Reduced binding to THRB, RXRA, ESR2 and ESR1.
type:mutagenesis site  description:Reduced binding to THRB, RXRA, ESR2 and ESR1.
type:mutagenesis site  description:Reduced binding to THRB, RXRA, ESR2 and ESR1.
type:mutagenesis site  description:Strong increase in binding to THRB, RXRA and ESR2, but dramatic decrease in binding to ESR1.
type:mutagenesis site  description:Reduced binding to THRB, RXRA, ESR2 and ESR1.
====== NO.2098protein ======
type:chain  description:Nuclear receptor coactivator 6
type:region of interest  description:NCOA1-binding region
type:region of interest  description:CREBBP-binding region
type:region of interest  description:TBP/GTF2A-binding region
type:region of interest  description:NCOA6IP-binding region
type:region of interest  description:EP300/CRSP3-binding region
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Gln-rich
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Lys
type:compositionally biased region  description:Ser-rich
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Abolishes interaction with nuclear receptors.
type:sequence conflict  description:In Ref. 2; AAH31113.
type:sequence conflict  description:In Ref. 2; AAH31113.
type:sequence conflict  description:In Ref. 2; AAH31113.
type:sequence conflict  description:In Ref. 2; AAH31113.
type:sequence conflict  description:In Ref. 3; AAF35973.
type:sequence conflict  description:In Ref. 3; AAF35973.
====== NO.2099protein ======
type:chain  description:Nuclear factor NF-kappa-B p105 subunit
type:chain  description:Nuclear factor NF-kappa-B p50 subunit
type:domain  description:RHD
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:repeat  description:ANK 5
type:repeat  description:ANK 6
type:repeat  description:ANK 7
type:domain  description:Death
type:region of interest  description:GRR
type:region of interest  description:Interaction with CFLAR
type:region of interest  description:Essential for interaction with HIF1AN
type:short sequence motif  description:Nuclear localization signal
type:compositionally biased region  description:Gly-rich
type:site  description:Cleavage (when cotranslationally processed)
type:modified residue  description:S-nitrosocysteine; alternate
type:modified residue  description:Phosphoserine; by PKA
type:modified residue  description:N6-acetyllysine; by EP300
type:modified residue  description:N6-acetyllysine; by EP300
type:modified residue  description:N6-acetyllysine; by EP300
type:modified residue  description:Phosphoserine
type:modified residue  description:(3S)-3-hydroxyasparagine; by HIF1AN; partial
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by GSK3-beta; in vitro
type:modified residue  description:Phosphoserine; by GSK3-beta; in vitro
type:modified residue  description:Phosphoserine; by IKKB
type:modified residue  description:Phosphoserine; by IKKB
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:lipid moiety-binding region  description:S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine; alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In dbSNP:rs4648065.
type:sequence variant  description:In dbSNP:rs4648072.
type:sequence variant  description:In dbSNP:rs4648085.
type:sequence variant  description:In dbSNP:rs4648086.
type:sequence variant  description:In dbSNP:rs4648099.
type:sequence variant  description:In dbSNP:rs4648118.
type:mutagenesis site  description:Suppresses S-nitrosylation-induced inhibition of DNA-binding activity. Loss of S-(15-deoxy-Delta12,14-prostaglandin J2-9-yl)cysteine-induced inhibition of DNA-binding activity.
type:mutagenesis site  description:Fails to promote HIF1AN-dependent 2-oxoglutarate decarboxylation.
type:mutagenesis site  description:Prevents p105 proteolysis in response to TNF-alpha.
type:mutagenesis site  description:Prevents p105 proteolysis in response to TNF-alpha.
type:mutagenesis site  description:Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-923 and A-932.
type:mutagenesis site  description:Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-921 and A-932.
type:mutagenesis site  description:Decrease in stimuli-induced phosphorylation. Loss of phosphorylation; when associated with A-921 and A-923.
type:sequence conflict  description:In Ref. 4; CAB94757.
type:sequence conflict  description:In Ref. 7; CAH18336.
type:sequence conflict  description:In Ref. 4; CAB94757.
type:sequence conflict  description:In Ref. 6; BAF84139.
type:sequence conflict  description:In Ref. 4; CAB94757.
type:sequence conflict  description:In Ref. 7; CAH18336.
type:sequence conflict  description:In Ref. 4; CAB94757.
type:sequence conflict  description:In Ref. 1; AAA36361, 3; AAA36360 and 4; CAB94757.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2100protein ======
type:signal peptide  description:None
type:chain  description:Osteopontin
type:short sequence motif  description:Cell attachment site
type:compositionally biased region  description:Poly-Asp
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:sequence conflict  description:In Ref. 2; AAA41762.
====== NO.2101protein ======
type:chain  description:Retinoic acid receptor RXR-beta
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Hinge
type:non-terminal residue  description:None
====== NO.2102protein ======
type:signal peptide  description:None
type:chain  description:Osteocrin
type:peptide  description:Processed Osteocrin
type:modified residue  description:Arginine amide
====== NO.2103protein ======
type:initiator methionine  description:Removed
type:chain  description:SNW domain-containing protein 1
type:region of interest  description:Interaction with PPIL1
type:region of interest  description:SNW
type:compositionally biased region  description:Pro-rich
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
====== NO.2104protein ======
type:chain  description:Nuclear receptor subfamily 2 group C member 2
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine; by MAPK
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Reduces interaction with JAZF1.
type:sequence conflict  description:In Ref. 3; BAH02299.
type:sequence conflict  description:In Ref. 2; AAA21474.
type:sequence conflict  description:In Ref. 3; BAH02299.
type:sequence conflict  description:In Ref. 2; AAA21474.
type:sequence conflict  description:In Ref. 2; AAA21474.
type:sequence conflict  description:In Ref. 2; AAA21474.
type:sequence conflict  description:In Ref. 2; AAA21474 and 3; BAH02299.
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2105protein ======
type:signal peptide  description:None
type:chain  description:Osteopontin
type:short sequence motif  description:Cell attachment site
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphothreonine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:modified residue  description:Phosphoserine; by FAM20C
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:splice variant  description:In isoform C.
type:splice variant  description:In isoform B.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform D.
type:sequence variant  description:In dbSNP:rs7435825.
type:sequence variant  description:In dbSNP:rs4660.
type:sequence conflict  description:In Ref. 6; BAA05949/BAA05950/BAA05951.
type:sequence conflict  description:In Ref. 6; BAA05949/BAA05950/BAA05951.
type:sequence conflict  description:In Ref. 2.
type:strand  description:None
====== NO.2106protein ======
type:initiator methionine  description:Removed
type:chain  description:Protein S100-G
type:domain  description:EF-hand 1
type:domain  description:EF-hand 2
type:calcium-binding region  description:1; low affinity
type:calcium-binding region  description:2; high affinity
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2107protein ======
type:signal peptide  description:None
type:chain  description:Alkaline phosphatase, tissue-nonspecific isozyme
type:propeptide  description:Removed in mature form
type:active site  description:Phosphoserine intermediate
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1; via tele nitrogen
type:metal ion-binding site  description:Zinc 2; via tele nitrogen
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:GPI-anchor amidated serine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAA41845.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 1; AAA41845.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 2.
type:sequence conflict  description:In Ref. 2; CAA68703.
type:sequence conflict  description:In Ref. 2; CAA68703.
====== NO.2108protein ======
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2109protein ======
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Loss of autophosphorylation and kinase activity.
type:sequence conflict  description:In Ref. 1; AAA39930.
====== NO.2110protein ======
type:signal peptide  description:None
type:chain  description:Pleiotrophin
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate A binding
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2111protein ======
type:signal peptide  description:None
type:chain  description:Pleiotrophin
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate binding
type:region of interest  description:Chondroitin sulfate A binding
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2112protein ======
type:chain  description:Zinc finger protein SNAI2
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5; atypical
type:region of interest  description:SNAG domain
====== NO.2113protein ======
type:chain  description:Probable cytochrome P450 508A1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2114protein ======
type:initiator methionine  description:Removed
type:chain  description:Nuclear receptor coactivator 1
type:domain  description:bHLH
type:domain  description:PAS
type:region of interest  description:Interaction with STAT3
type:region of interest  description:Interaction with CREBBP
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:short sequence motif  description:LXXLL motif 4
type:short sequence motif  description:LXXLL motif 5
type:short sequence motif  description:LXXLL motif 6
type:short sequence motif  description:LXXLL motif 7
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Gln-rich
type:site  description:Breakpoint for translocation to form PAX3-NCOA1 oncogene
type:modified residue  description:N-acetylserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1049015.
type:sequence variant  description:In dbSNP:rs1049016.
type:sequence variant  description:In dbSNP:rs1049018.
type:sequence variant  description:In dbSNP:rs1049020.
type:sequence variant  description:In dbSNP:rs1049021.
type:sequence variant  description:In dbSNP:rs1049025.
type:sequence variant  description:In dbSNP:rs1049032.
type:sequence variant  description:In dbSNP:rs1049038.
type:sequence variant  description:In dbSNP:rs56099330.
type:sequence variant  description:In dbSNP:rs1804645.
type:mutagenesis site  description:Slightly affects interactions with steroid receptors. Abolishes interactions with steroid receptors; when associated with A-693; A-694; A-752 and A-753.
type:mutagenesis site  description:Slightly affects interactions with steroid receptors. Abolishes interactions with steroid receptors; when associated with A-636; A-637; A-752 and A-753.
type:mutagenesis site  description:Abolishes sumoylation; when associated with R-774.
type:mutagenesis site  description:Slightly affects interactions with steroid receptors. Abolishes interactions with steroid receptors; when associated with A-636; A-637; A-693 and A-694.
type:mutagenesis site  description:Abolishes sumoylation; when associated with R-732.
type:mutagenesis site  description:Does not affect sumoylation of the protein.
type:mutagenesis site  description:Does not affect sumoylation of the protein.
type:mutagenesis site  description:Does not affect sumoylation of the protein.
type:sequence conflict  description:In Ref. 10; AAT47737.
type:sequence conflict  description:In Ref. 9; AAA64187.
type:sequence conflict  description:In Ref. 10; AAT47737.
type:sequence conflict  description:In Ref. 3; AAB50242.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
====== NO.2115protein ======
type:chain  description:Serine/threonine-protein kinase pim-1
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP; via carbonyl oxygen
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2116protein ======
type:signal peptide  description:None
type:chain  description:Interferon gamma
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2117protein ======
type:signal peptide  description:None
type:chain  description:Klotho
type:chain  description:Klotho peptide
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Glycosyl hydrolase-1 1
type:region of interest  description:Glycosyl hydrolase-1 2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1052018.
type:sequence variant  description:In dbSNP:rs1052019.
type:sequence variant  description:In HFTC3; impairs the ability to form a ternary complex with FGF23 and FGFR1c; impairs KL-dependent FGF23 signaling; dbSNP:rs121908423.
type:sequence variant  description:In allele KL-VS; associated with S-370; dbSNP:rs9536314.
type:sequence variant  description:In allele KL-VS; associated with V-352; dbSNP:rs9527025.
type:sequence variant  description:In dbSNP:rs3752472.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation; dbSNP:rs139939367.
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2118protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 24
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:short sequence motif  description:LXXLL motif 4
type:short sequence motif  description:LXXLL motif 5
type:short sequence motif  description:LXXLL motif 6
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:sequence conflict  description:In Ref. 3; BAB32051.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
type:sequence conflict  description:In Ref. 1; AAD42776.
====== NO.2119protein ======
type:propeptide  description:None
type:chain  description:Interleukin-1 beta
type:site  description:Important for interaction with integrin
type:site  description:Important for interaction with integrin
type:site  description:Important for interaction with integrin
type:site  description:Important for interaction with integrin
====== NO.2120protein ======
type:chain  description:Nuclear receptor coactivator 3
type:region of interest  description:Interaction with CREBBP
type:region of interest  description:Acetyltransferase
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:LXXLL motif 3
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Gln-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine; by CREBBP
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Phosphoserine
type:non-terminal residue  description:None
====== NO.2121protein ======
type:initiator methionine  description:Removed
type:chain  description:NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4
type:modified residue  description:Phosphoserine
type:lipid moiety-binding region  description:N-myristoyl glycine
====== NO.2122protein ======
type:signal peptide  description:None
type:chain  description:Low-density lipoprotein receptor-related protein 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:LDL-receptor class A 1
type:domain  description:LDL-receptor class A 2
type:domain  description:LDL-receptor class A 3
type:domain  description:LDL-receptor class A 4
type:domain  description:LDL-receptor class A 5
type:domain  description:LDL-receptor class A 6
type:domain  description:LDL-receptor class A 7
type:repeat  description:LDL-receptor class B 1
type:repeat  description:LDL-receptor class B 2
type:repeat  description:LDL-receptor class B 3
type:repeat  description:LDL-receptor class B 4
type:repeat  description:LDL-receptor class B 5
type:repeat  description:LDL-receptor class B 6
type:repeat  description:LDL-receptor class B 7
type:repeat  description:LDL-receptor class B 8
type:domain  description:LDL-receptor class A 8
type:domain  description:LDL-receptor class A 9
type:domain  description:LDL-receptor class A 10
type:domain  description:LDL-receptor class A 11
type:domain  description:LDL-receptor class A 12
type:domain  description:LDL-receptor class A 13
type:domain  description:LDL-receptor class A 14
type:domain  description:LDL-receptor class A 15
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:repeat  description:LDL-receptor class B 9
type:repeat  description:LDL-receptor class B 10
type:repeat  description:LDL-receptor class B 11
type:repeat  description:LDL-receptor class B 12
type:repeat  description:LDL-receptor class B 13
type:repeat  description:LDL-receptor class B 14
type:repeat  description:LDL-receptor class B 15
type:repeat  description:LDL-receptor class B 16
type:repeat  description:LDL-receptor class B 17
type:repeat  description:LDL-receptor class B 18
type:repeat  description:LDL-receptor class B 19
type:repeat  description:LDL-receptor class B 20
type:repeat  description:LDL-receptor class B 21
type:repeat  description:LDL-receptor class B 22
type:repeat  description:LDL-receptor class B 23
type:repeat  description:LDL-receptor class B 24
type:repeat  description:LDL-receptor class B 25
type:repeat  description:LDL-receptor class B 26
type:repeat  description:LDL-receptor class B 27
type:repeat  description:LDL-receptor class B 28
type:domain  description:LDL-receptor class A 16
type:domain  description:LDL-receptor class A 17
type:domain  description:LDL-receptor class A 18
type:domain  description:LDL-receptor class A 19
type:domain  description:LDL-receptor class A 20
type:domain  description:LDL-receptor class A 21
type:domain  description:LDL-receptor class A 22
type:domain  description:LDL-receptor class A 23
type:domain  description:LDL-receptor class A 24
type:domain  description:LDL-receptor class A 25
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4; calcium-binding
type:repeat  description:LDL-receptor class B 29
type:repeat  description:LDL-receptor class B 30
type:repeat  description:LDL-receptor class B 31
type:repeat  description:LDL-receptor class B 32
type:repeat  description:LDL-receptor class B 33
type:domain  description:LDL-receptor class A 26
type:domain  description:LDL-receptor class A 27
type:domain  description:LDL-receptor class A 28
type:domain  description:LDL-receptor class A 29
type:domain  description:LDL-receptor class A 30
type:domain  description:LDL-receptor class A 31
type:domain  description:LDL-receptor class A 32
type:domain  description:LDL-receptor class A 33
type:domain  description:LDL-receptor class A 34
type:domain  description:LDL-receptor class A 35
type:domain  description:LDL-receptor class A 36
type:domain  description:EGF-like 5; calcium-binding
type:repeat  description:LDL-receptor class B 34
type:repeat  description:LDL-receptor class B 35
type:repeat  description:LDL-receptor class B 36
type:domain  description:EGF-like 6
type:region of interest  description:Interaction with DAB2
type:short sequence motif  description:SH3-binding
type:short sequence motif  description:PxLPxI/L motif 1; mediates interaction with ANKRA2
type:short sequence motif  description:PxLPxI/L motif 2; mediates interaction with ANKRA2
type:short sequence motif  description:Endocytosis signal
type:short sequence motif  description:NPXY motif
type:short sequence motif  description:SH2-binding
type:short sequence motif  description:SH3-binding
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 3; CAA69877.
====== NO.2123protein ======
type:signal peptide  description:None
type:chain  description:Osteopontin
type:short sequence motif  description:Cell attachment site
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
====== NO.2124protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Osteocalcin
type:domain  description:Gla
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:site  description:Not hydroxylated
type:modified residue  description:4-carboxyglutamate; partial
type:modified residue  description:4-carboxyglutamate
type:modified residue  description:4-carboxyglutamate
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs34702397.
type:sequence conflict  description:In Ref. 2; CAA27763.
====== NO.2125protein ======
type:signal peptide  description:None
type:chain  description:Interferon gamma
type:modified residue  description:Pyrrolidone carboxylic acid
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2126protein ======
type:signal peptide  description:None
type:chain  description:Insulin receptor subunit alpha
type:chain  description:Insulin receptor subunit beta
type:topological domain  description:Extracellular
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Fibronectin type-III 1
type:domain  description:Fibronectin type-III 2
type:domain  description:Fibronectin type-III 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Insulin-binding
type:region of interest  description:Important for interaction with IRS1, SHC1 and STAT5B
type:region of interest  description:PIK3R1 binding
type:compositionally biased region  description:Leu-rich
type:active site  description:Proton donor/acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:Insulin-binding
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain
type:disulfide bond  description:None
type:splice variant  description:In isoform Short.
type:helix  description:None
====== NO.2127protein ======
type:chain  description:Iroquois-class homeodomain protein IRX-5
type:DNA-binding region  description:Homeobox; TALE-type
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Gly
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In HMMS; hypomorphic mutation; dbSNP:rs387907198.
type:sequence variant  description:In HMMS; hypomorphic mutation; dbSNP:rs786200931.
type:sequence conflict  description:In Ref. 2; AAB50007.
type:sequence conflict  description:In Ref. 2; AAB50002.
====== NO.2128protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 1
type:region of interest  description:Interaction with the Mediator complex and THRA
type:region of interest  description:Interaction with ESR1
type:region of interest  description:Interaction with the Mediator complex
type:region of interest  description:Interaction with the Mediator complex
type:region of interest  description:Interaction with THRA
type:region of interest  description:Interaction with VDR
type:region of interest  description:Interaction with GATA1
type:region of interest  description:Interaction with PPARGC1A and THRA
type:region of interest  description:Interaction with ESR1
type:region of interest  description:Interaction with TP53
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:short sequence motif  description:Integrase domain-binding motif (IBM)
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Lys-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by MAPK1 or MAPK3
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine; by MAPK1 or MAPK3
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In strain: ISS and 129/Ola.
type:sequence variant  description:In strain: ISS and 129/Ola.
type:sequence conflict  description:In Ref. 1; AAC31118.
type:sequence conflict  description:In Ref. 6; AAH21440.
type:sequence conflict  description:In Ref. 4; BAE27757.
type:sequence conflict  description:In Ref. 1; AAC31118.
type:sequence conflict  description:In Ref. 4; BAC35779.
type:sequence conflict  description:In Ref. 4; BAC33607.
type:sequence conflict  description:In Ref. 4; BAC33607.
type:sequence conflict  description:In Ref. 1; AAC31118.
type:sequence conflict  description:In Ref. 1; AAC31118.
type:helix  description:None
====== NO.2129protein ======
type:signal peptide  description:None
type:chain  description:Sodium/calcium exchanger 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:repeat  description:Alpha-1
type:domain  description:Calx-beta 1
type:domain  description:Calx-beta 2
type:repeat  description:Alpha-2
type:region of interest  description:Putative calmodulin-binding region
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Glu
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 4
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 5
type:metal ion-binding site  description:Calcium 5
type:metal ion-binding site  description:Calcium 6
type:metal ion-binding site  description:Calcium 6
type:metal ion-binding site  description:Calcium 5; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 6
type:metal ion-binding site  description:Calcium 5
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2130protein ======
type:chain  description:Nuclear hormone receptor HR96
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
====== NO.2131protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 17
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs2848477.
type:sequence variant  description:In dbSNP:rs35313315.
type:sequence variant  description:In MCPHSBA; dbSNP:rs267607232.
type:sequence conflict  description:In Ref. 3; BAB13973.
type:sequence conflict  description:In Ref. 3; BAB13973.
type:sequence conflict  description:In Ref. 2; AAD30856.
type:sequence conflict  description:In Ref. 1; AA sequence.
type:sequence conflict  description:In Ref. 6; AAD12723.
====== NO.2132protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 23
type:splice variant  description:In isoform 2 and isoform 3.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 6.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3 and isoform 4.
type:splice variant  description:In isoform 5.
type:sequence variant  description:In MRT18; specifically impairs the response of JUN and FOS immediate early genes to serum mitogens by altering the interaction between enhancer-bound transcription factors TCF7L2 and ELK1 and the Mediator complex.
type:sequence conflict  description:In Ref. 9; AAH60759.
type:sequence conflict  description:In Ref. 1; AAD31729.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:sequence conflict  description:In Ref. 2; AAD30202.
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2133protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Ig-like C2-type 4
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Poly-Asp
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2134protein ======
type:chain  description:Nuclear receptor corepressor 1
type:domain  description:SANT 1
type:domain  description:SANT 2
type:region of interest  description:Interaction with ZBTB33 and HEXIM1
type:region of interest  description:Interaction with SIN3A/B
type:region of interest  description:Interaction with ETO
type:region of interest  description:Interaction with C1D
type:region of interest  description:ID1
type:region of interest  description:Required for interaction with RARA in the absence of its ligand
type:region of interest  description:ID2
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:short sequence motif  description:CORNR box 1
type:short sequence motif  description:CORNR box 2
type:short sequence motif  description:CORNR box 3
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Poly-Pro
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Ser
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2 and isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 2; AAO32942.
type:sequence conflict  description:In Ref. 1; AAC33550.
type:sequence conflict  description:In Ref. 1; AAC33550.
type:sequence conflict  description:In Ref. 1; AAC33550.
type:sequence conflict  description:In Ref. 1; AAC33550.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2135protein ======
type:chain  description:Nuclear hormone receptor family member daf-12
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:short sequence motif  description:Nuclear localization signal
type:splice variant  description:In isoform c.
type:splice variant  description:In isoform b.
type:splice variant  description:In isoform d.
type:mutagenesis site  description:In sa156; no transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:In m420; no transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:In m421; no transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:In m116 and m423; no transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:Defective nuclear localization; when associated with A-198.
type:mutagenesis site  description:Defective nuclear localization; when associated with A-198.
type:mutagenesis site  description:Small reduction in DNA binding in vitro.
type:mutagenesis site  description:Severely reduced DNA binding and reduced transcriptional activity in vitro.
type:mutagenesis site  description:In m424; reduced DNA binding affinity and transcriptional activity in vitro. Defective dauer formation.
type:mutagenesis site  description:Defective nuclear localization; when associated with A-195 or A-196.
type:mutagenesis site  description:In rh286; mild gonadal heterochrony.
type:mutagenesis site  description:In m25; defective dauer formation.
type:mutagenesis site  description:In rh62 and rh274; dauer-constitutive phenotype with gonadal heterochrony.
type:mutagenesis site  description:In rh273; dauer-constitutive phenotype with gonadal heterochrony.
type:mutagenesis site  description:In rh193; temperature sensitive mutant.
type:mutagenesis site  description:In rh284; temperature sensitive mutation that prevents transcriptional activity and with gonadal heterochrony.
====== NO.2136protein ======
type:chain  description:Mineralocorticoid receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Hinge
type:region of interest  description:Important for coactivator binding
type:binding site  description:Steroid
type:binding site  description:Steroid
type:binding site  description:Steroid
type:binding site  description:Steroid
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:mutagenesis site  description:Lowers homodimerization and decreases receptor activity.
type:mutagenesis site  description:Lowers homodimerization and decreases receptor activity.
type:sequence conflict  description:In Ref. 3.
type:sequence conflict  description:In Ref. 3.
type:sequence conflict  description:In Ref. 3.
====== NO.2137protein ======
type:signal peptide  description:None
type:chain  description:Low-density lipoprotein receptor-related protein 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:LDL-receptor class A 1
type:domain  description:LDL-receptor class A 2
type:domain  description:LDL-receptor class A 3
type:domain  description:LDL-receptor class A 4
type:domain  description:LDL-receptor class A 5
type:domain  description:LDL-receptor class A 6
type:domain  description:LDL-receptor class A 7
type:domain  description:EGF-like 1; calcium-binding
type:repeat  description:LDL-receptor class B 1
type:repeat  description:LDL-receptor class B 2
type:repeat  description:LDL-receptor class B 3
type:repeat  description:LDL-receptor class B 4
type:repeat  description:LDL-receptor class B 5
type:repeat  description:LDL-receptor class B 6
type:repeat  description:LDL-receptor class B 7
type:repeat  description:LDL-receptor class B 8
type:domain  description:LDL-receptor class A 8
type:domain  description:LDL-receptor class A 9
type:domain  description:LDL-receptor class A 10
type:domain  description:LDL-receptor class A 11
type:domain  description:LDL-receptor class A 12
type:domain  description:LDL-receptor class A 13
type:domain  description:LDL-receptor class A 14
type:domain  description:LDL-receptor class A 15
type:domain  description:EGF-like 2
type:domain  description:EGF-like 3; calcium-binding
type:repeat  description:LDL-receptor class B 9
type:repeat  description:LDL-receptor class B 10
type:repeat  description:LDL-receptor class B 11
type:repeat  description:LDL-receptor class B 12
type:repeat  description:LDL-receptor class B 13
type:repeat  description:LDL-receptor class B 14
type:repeat  description:LDL-receptor class B 15
type:repeat  description:LDL-receptor class B 16
type:repeat  description:LDL-receptor class B 17
type:repeat  description:LDL-receptor class B 18
type:repeat  description:LDL-receptor class B 19
type:repeat  description:LDL-receptor class B 20
type:repeat  description:LDL-receptor class B 21
type:repeat  description:LDL-receptor class B 22
type:repeat  description:LDL-receptor class B 23
type:repeat  description:LDL-receptor class B 24
type:repeat  description:LDL-receptor class B 25
type:repeat  description:LDL-receptor class B 26
type:repeat  description:LDL-receptor class B 27
type:domain  description:LDL-receptor class A 16
type:domain  description:LDL-receptor class A 17
type:domain  description:LDL-receptor class A 18
type:domain  description:LDL-receptor class A 19
type:domain  description:LDL-receptor class A 20
type:domain  description:LDL-receptor class A 21
type:domain  description:LDL-receptor class A 22
type:domain  description:LDL-receptor class A 23
type:domain  description:LDL-receptor class A 24
type:domain  description:LDL-receptor class A 25
type:domain  description:EGF-like 4
type:domain  description:EGF-like 5; calcium-binding
type:repeat  description:LDL-receptor class B 28
type:repeat  description:LDL-receptor class B 29
type:repeat  description:LDL-receptor class B 30
type:repeat  description:LDL-receptor class B 31
type:repeat  description:LDL-receptor class B 32
type:domain  description:LDL-receptor class A 26
type:domain  description:LDL-receptor class A 27
type:domain  description:LDL-receptor class A 28
type:domain  description:LDL-receptor class A 29
type:domain  description:LDL-receptor class A 30
type:domain  description:LDL-receptor class A 31
type:domain  description:LDL-receptor class A 32
type:domain  description:LDL-receptor class A 33
type:domain  description:LDL-receptor class A 34
type:domain  description:LDL-receptor class A 35
type:domain  description:LDL-receptor class A 36
type:domain  description:EGF-like 6
type:domain  description:EGF-like 7; calcium-binding
type:repeat  description:LDL-receptor class B 33
type:repeat  description:LDL-receptor class B 34
type:repeat  description:LDL-receptor class B 35
type:domain  description:EGF-like 8
type:region of interest  description:Interaction with DAB2
type:short sequence motif  description:SH3-binding
type:short sequence motif  description:PxLPxI/L motif 1; mediates interaction with ANKRA2
type:short sequence motif  description:PxLPxI/L motif 2; mediates interaction with ANKRA2
type:short sequence motif  description:Endocytosis signal
type:short sequence motif  description:NPXY motif
type:short sequence motif  description:SH2-binding
type:short sequence motif  description:SH3-binding
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:mutagenesis site  description:Reduced interaction with ARH and dynein.
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2138protein ======
type:initiator methionine  description:Removed
type:chain  description:Mediator of RNA polymerase II transcription subunit 4
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Poly-Ser
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 8; AAH05189.
type:sequence conflict  description:In Ref. 5; CAG46629.
type:sequence conflict  description:In Ref. 6; BAD96737.
type:sequence conflict  description:In Ref. 5; CAG33557.
type:sequence conflict  description:In Ref. 2; AAF37289.
type:sequence conflict  description:In Ref. 6; BAD96433.
type:sequence conflict  description:In Ref. 8; AAH05189.
type:sequence conflict  description:In Ref. 2; AAF37289 and 5; CAG46629.
====== NO.2139protein ======
type:chain  description:Methylsterol monooxygenase 1
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:domain  description:Fatty acid hydroxylase
type:short sequence motif  description:Histidine box-1
type:short sequence motif  description:Histidine box-2
type:short sequence motif  description:Histidine box-3
type:splice variant  description:In isoform 2.
type:sequence variant  description:In MCCPD; unknown pathological significance; dbSNP:rs1310714454.
type:sequence variant  description:In dbSNP:rs34499452.
type:sequence variant  description:In MCCPD; dbSNP:rs869025576.
type:sequence variant  description:In MCCPD; dbSNP:rs760048191.
====== NO.2140protein ======
type:chain  description:Ecdysone receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:compositionally biased region  description:Gly-rich
type:compositionally biased region  description:Poly-Gly
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Gln/Pro-rich
type:splice variant  description:In isoform ECR-A.
type:splice variant  description:In isoform ECR-B2.
type:sequence conflict  description:In Ref. 4; AAL68274.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2141protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Asp/Glu-rich (highly acidic)
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 3; no nucleotide entry.
====== NO.2142protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Heparin-binding
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:Breakpoint for translocation to form CEP43-FGFR1 or FGFR1-CEP43 fusion proteins
type:site  description:Breakpoint for translocation to form CNTRL-FGFR1 OR FGFR1-CNTRL fusion proteins
type:site  description:Breakpoint for translocation to form FGFR1OP2-FGFR1
type:site  description:Mediates interaction with PLCG1 and SHB
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 10, isoform 11, isoform 12 and isoform 13.
type:splice variant  description:In isoform 20.
type:splice variant  description:In isoform 21.
type:splice variant  description:In isoform 6, isoform 7, isoform 8, isoform 9, isoform 15, isoform 17 and isoform 18.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 19.
type:splice variant  description:In isoform 16.
type:splice variant  description:In isoform 14, isoform 15, isoform 18, isoform 19 and isoform 21.
type:splice variant  description:In isoform 16.
type:splice variant  description:In isoform 17 and isoform 18.
type:splice variant  description:In isoform 19.
type:splice variant  description:In isoform 17 and isoform 18.
type:splice variant  description:In isoform 20.
type:splice variant  description:In isoform 4, isoform 5, isoform 8, isoform 9, isoform 12 and isoform 13.
type:splice variant  description:In isoform 2, isoform 5, isoform 7, isoform 9, isoform 11 and isoform 13.
type:splice variant  description:In isoform 2, isoform 5, isoform 7, isoform 9, isoform 11 and isoform 13.
type:sequence variant  description:In HH2; unknown pathological significance; dbSNP:rs760884357.
type:sequence variant  description:In dbSNP:rs17175750.
type:sequence variant  description:In HH2; phenotype consistent with normosmic idiopathic hypogonadotropic hypogonadism; dbSNP:rs121909640.
type:sequence variant  description:In HH2; dbSNP:rs140254426.
type:sequence variant  description:In dbSNP:rs767195580.
type:sequence variant  description:In HH2; dbSNP:rs1554570706.
type:sequence variant  description:In HH2; unknown pathological significance.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression; dbSNP:rs727505373.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; dbSNP:rs55642501.
type:sequence variant  description:In HH2; dbSNP:rs747842199.
type:sequence variant  description:In HH2; some patients also carry GNRHR mutations; dbSNP:rs780765366.
type:sequence variant  description:In a breast infiltrating ductal carcinoma sample; somatic mutation; dbSNP:rs121913473.
type:sequence variant  description:In HH2; dbSNP:rs765615419.
type:sequence variant  description:In HRTFDS; dbSNP:rs397515481.
type:sequence variant  description:In HH2; with cleft palate, corpus callosum agenesis, unilateral deafness and fusion of fourth and fifth metacarpal bones; dbSNP:rs121909630.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; with severe ear anomalies.
type:sequence variant  description:In HRTFDS; dbSNP:rs869025669.
type:sequence variant  description:In dbSNP:rs17851623.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; some patients also carry KISS1R mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; with or without anosmia; also found in a family member with isolated anosmia; may impair proper folding; dbSNP:rs121909635.
type:sequence variant  description:In HH2; some patients also carry PROKR2 and GNRH1 mutations; impairs the tertiary folding resulting in incomplete glycosylation and reduced cell surface expression.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; with or without anosmia; results in Kallmann syndrome in the presence of HS6ST1 mutation TRP-306; reduces receptor affinity for fibroblast growth factor; dbSNP:rs121909645.
type:sequence variant  description:In HH2.
type:sequence variant  description:In PS and JWS; dbSNP:rs121909627.
type:sequence variant  description:In a lung bronchoalveolar carcinoma sample; somatic mutation; dbSNP:rs121913472.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; dbSNP:rs1131691929.
type:sequence variant  description:In HH2; also found in a family member with isolated anosmia; dbSNP:rs727505369.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In TRIGNO1; dbSNP:rs121909633.
type:sequence variant  description:In HH2.
type:sequence variant  description:In OGD; dbSNP:rs121909632.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a splice site mutation in NSMF; dbSNP:rs121909638.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; also found in a family member with isolated anosmia.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a mutation in IL17RD; dbSNP:rs886037634.
type:sequence variant  description:In HH2; with or without anosmia; dbSNP:rs121909641.
type:sequence variant  description:In OGD; elevated basal activity and increased FGF2-mediated activity; dbSNP:rs121909631.
type:sequence variant  description:In OGD; dbSNP:rs121909634.
type:sequence variant  description:In HH2; some patients also carry GNRHR mutations; dbSNP:rs121909637.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in SPRY4; dbSNP:rs397515444.
type:sequence variant  description:In HRTFDS; dbSNP:rs869025670.
type:sequence variant  description:In HH2; dbSNP:rs749758370.
type:sequence variant  description:In HH2.
type:sequence variant  description:In ECCL; somatic mutation; activating mutation; strongly increased speed of the first autophosphorylation and loss of the normal sequential order of autophosphorylation; dbSNP:rs779707422.
type:sequence variant  description:None
type:sequence variant  description:In HH2; with bimanual synkinesis; dbSNP:rs121909629.
type:sequence variant  description:In HH2; some patients also carry GNRHR mutations; impairs tyrosine kinase activity.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; with severe ear anomalies; dbSNP:rs121909628.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HRTFDS; dbSNP:rs398122946.
type:sequence variant  description:In HRTFDS; dbSNP:rs869025671.
type:sequence variant  description:In HRTFDS; dbSNP:rs869025672.
type:sequence variant  description:In ECCL; somatic mutation; dbSNP:rs869320694.
type:sequence variant  description:In HH2.
type:sequence variant  description:In a lung large cell carcinoma sample; somatic mutation.
type:sequence variant  description:In HH2; with cleft palate.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in FLRT3; dbSNP:rs397515446.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; dbSNP:rs727505376.
type:sequence variant  description:In HH2; phenotype consistent with Kallmann syndrome; the patient also carries a rare variant in DUSP6; dbSNP:rs397515445.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; dbSNP:rs768957161.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; unknown pathological significance; dbSNP:rs1085307879.
type:sequence variant  description:In HH2; associated with K-724; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606805.
type:sequence variant  description:In HH2; dbSNP:rs121909642.
type:sequence variant  description:In HH2; associated with H-722; also found in a family member with isolated anosmia; reduced tyrosine kinase activity; dbSNP:rs267606806.
type:sequence variant  description:In HRTFDS; dbSNP:rs398122945.
type:sequence variant  description:In HH2.
type:sequence variant  description:In HH2; the patient also carries a rare variant in FGF8; dbSNP:rs121909644.
type:sequence variant  description:In dbSNP:rs2956723.
type:sequence variant  description:In dbSNP:rs56234888.
type:sequence variant  description:In HH2; also found in a family member with isolated anosmia; dbSNP:rs781328162.
type:sequence variant  description:In dbSNP:rs17182456.
type:sequence variant  description:In dbSNP:rs17182463.
type:mutagenesis site  description:Loss of kinase activity.
type:mutagenesis site  description:Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity.
type:mutagenesis site  description:Abolishes interaction with PLCG1.
type:mutagenesis site  description:Loss of kinase activity.
type:mutagenesis site  description:No effect on kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-654.
type:mutagenesis site  description:Reduced kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-653.
type:mutagenesis site  description:Abolishes interaction with PLCG1.
type:mutagenesis site  description:Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and MAP kinase signaling and stimulation of cell proliferation.
type:sequence conflict  description:In Ref. 8; AAA35958/AAA35959.
type:sequence conflict  description:In Ref. 3; AAA35837.
type:sequence conflict  description:In Ref. 5; AAA35835.
type:sequence conflict  description:In Ref. 16; no nucleotide entry.
type:sequence conflict  description:In Ref. 12; BAD96438.
type:sequence conflict  description:In Ref. 8; AAA35958/AAA35959.
type:sequence conflict  description:In Ref. 18; CAA68679.
type:sequence conflict  description:In Ref. 1; AAA75007.
type:sequence conflict  description:In Ref. 12; BAD96438.
type:sequence conflict  description:In Ref. 12; BAD96438.
type:sequence conflict  description:In Ref. 4; CAA36101.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:sequence variant  description:In HH2, unknown pathological significance.
====== NO.2143protein ======
type:initiator methionine  description:Removed
type:chain  description:Glutamine synthetase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ADP
type:region of interest  description:L-glutamate binding
type:metal ion-binding site  description:Manganese 1
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 1; via pros nitrogen
type:metal ion-binding site  description:Manganese 1
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:L-glutamate
type:binding site  description:ATP
type:binding site  description:L-glutamate
type:modified residue  description:N-acetylthreonine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In CSGD; reduced glutamine synthetase activity; dbSNP:rs80358214.
type:sequence variant  description:In CSGD; suggests reduced glutamine synthetase activity; dbSNP:rs80358215.
type:mutagenesis site  description:Reduced ability to mediate autopalmitoylation.
type:mutagenesis site  description:Decreases ribolosomal 40S subunit synthesis. Loss of nucleolar location of BYSL.
type:sequence conflict  description:In Ref. 7; AAH31964.
type:sequence conflict  description:In Ref. 5; CAD97626.
type:sequence conflict  description:In Ref. 7; AAH31964.
type:sequence conflict  description:In Ref. 1; CAA68457.
type:sequence conflict  description:In Ref. 2; CAA42495.
type:sequence conflict  description:In Ref. 2; CAA42495.
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2144protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 1
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Ser-rich
type:compositionally biased region  description:Gly-rich
type:helix  description:None
====== NO.2145protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 16
type:repeat  description:WD 1
type:repeat  description:WD 2
type:repeat  description:WD 3
type:repeat  description:WD 4
type:repeat  description:WD 5
type:sequence conflict  description:In Ref. 2; AAH57056.
type:sequence conflict  description:In Ref. 2; AAH57056.
type:sequence conflict  description:In Ref. 2; AAH57056.
====== NO.2146protein ======
type:signal peptide  description:None
type:chain  description:Klotho
type:chain  description:Klotho peptide
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Glycosyl hydrolase-1 1
type:region of interest  description:Glycosyl hydrolase-1 2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
====== NO.2147protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1966265.
type:sequence variant  description:In dbSNP:rs376618.
type:sequence variant  description:In dbSNP:rs55675160.
type:sequence variant  description:In PC; also found in other types of cancer; associated with increased disease susceptibility, accelerated cancer progression and poor prognosis; results in prolonged FGFR4 activity; causes increased cell motility and tumor cell invasion possibly due to increased stability of the protease MMP14; increased interaction with STAT3; results in STAT3 phosphorylation and signaling activation; dbSNP:rs351855.
type:sequence variant  description:In dbSNP:rs55879131.
type:sequence variant  description:In dbSNP:rs34158682.
type:sequence variant  description:In dbSNP:rs34284947.
type:sequence variant  description:In breast pleomorphic lobular sample; somatic mutation; dbSNP:rs774571806.
type:sequence variant  description:In a lung adenocarcinoma sample; somatic mutation.
type:sequence variant  description:In a lung neuroendocrine carcinoma sample; somatic mutation.
type:mutagenesis site  description:Loss of kinase activity.
type:mutagenesis site  description:Loss of interaction with PLCG1.
type:sequence conflict  description:In Ref. 3; AAF27432.
type:sequence conflict  description:In Ref. 3; AAF27432.
type:sequence conflict  description:In Ref. 1; CAA40490.
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2148protein ======
type:initiator methionine  description:Removed
type:chain  description:Glutamine synthetase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ADP
type:region of interest  description:L-glutamate binding
type:metal ion-binding site  description:Manganese 1
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 2
type:metal ion-binding site  description:Manganese 1; via pros nitrogen
type:metal ion-binding site  description:Manganese 1
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:L-glutamate
type:binding site  description:ATP
type:binding site  description:L-glutamate
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 4; AAH61559.
type:sequence conflict  description:In Ref. 3; AAC42038.
====== NO.2149protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 12
type:region of interest  description:Interaction with CTNNB1 and GLI3
type:compositionally biased region  description:Pro-rich
type:compositionally biased region  description:Gln-rich
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Asymmetric dimethylarginine; alternate
type:modified residue  description:Omega-N-methylarginine; alternate
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:modified residue  description:Asymmetric dimethylarginine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In OKS; dbSNP:rs80338758.
type:sequence variant  description:In LUJFRYS; dbSNP:rs80338759.
type:sequence variant  description:In OHDOX; dbSNP:rs387907360.
type:sequence variant  description:In OHDOX; dbSNP:rs387907361.
type:sequence variant  description:In dbSNP:rs1139013.
type:sequence variant  description:In OHDOX; dbSNP:rs387907362.
type:sequence variant  description:Found in a family with X-linked intellectual disability; unknown pathological significance; dbSNP:rs879255528.
type:sequence conflict  description:In Ref. 1; AAD22033.
type:sequence conflict  description:In Ref. 6; AA sequence.
type:sequence conflict  description:In Ref. 5; AAD44162.
====== NO.2150protein ======
type:signal peptide  description:None
type:chain  description:Low-density lipoprotein receptor-related protein 2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:LDL-receptor class A 1
type:domain  description:LDL-receptor class A 2
type:domain  description:LDL-receptor class A 3
type:domain  description:LDL-receptor class A 4
type:domain  description:LDL-receptor class A 5
type:domain  description:LDL-receptor class A 6
type:domain  description:LDL-receptor class A 7
type:repeat  description:LDL-receptor class B 1
type:repeat  description:LDL-receptor class B 2
type:repeat  description:LDL-receptor class B 3
type:repeat  description:LDL-receptor class B 4
type:repeat  description:LDL-receptor class B 5
type:repeat  description:LDL-receptor class B 6
type:repeat  description:LDL-receptor class B 7
type:repeat  description:LDL-receptor class B 8
type:domain  description:LDL-receptor class A 8
type:domain  description:LDL-receptor class A 9
type:domain  description:LDL-receptor class A 10
type:domain  description:LDL-receptor class A 11
type:domain  description:LDL-receptor class A 12
type:domain  description:LDL-receptor class A 13
type:domain  description:LDL-receptor class A 14
type:domain  description:LDL-receptor class A 15
type:domain  description:EGF-like 1; calcium-binding
type:repeat  description:LDL-receptor class B 9
type:repeat  description:LDL-receptor class B 10
type:repeat  description:LDL-receptor class B 11
type:repeat  description:LDL-receptor class B 12
type:repeat  description:LDL-receptor class B 13
type:domain  description:EGF-like 2
type:repeat  description:LDL-receptor class B 14
type:repeat  description:LDL-receptor class B 15
type:repeat  description:LDL-receptor class B 16
type:repeat  description:LDL-receptor class B 17
type:repeat  description:LDL-receptor class B 18
type:repeat  description:LDL-receptor class B 19
type:repeat  description:LDL-receptor class B 20
type:repeat  description:LDL-receptor class B 21
type:repeat  description:LDL-receptor class B 22
type:repeat  description:LDL-receptor class B 23
type:repeat  description:LDL-receptor class B 24
type:repeat  description:LDL-receptor class B 25
type:repeat  description:LDL-receptor class B 26
type:repeat  description:LDL-receptor class B 27
type:domain  description:LDL-receptor class A 16
type:domain  description:LDL-receptor class A 17
type:domain  description:LDL-receptor class A 18
type:domain  description:LDL-receptor class A 19
type:domain  description:LDL-receptor class A 20
type:domain  description:LDL-receptor class A 21
type:domain  description:LDL-receptor class A 22
type:domain  description:LDL-receptor class A 23
type:domain  description:LDL-receptor class A 24
type:domain  description:LDL-receptor class A 25
type:domain  description:EGF-like 3
type:domain  description:EGF-like 4; calcium-binding
type:repeat  description:LDL-receptor class B 28
type:repeat  description:LDL-receptor class B 29
type:repeat  description:LDL-receptor class B 30
type:repeat  description:LDL-receptor class B 31
type:repeat  description:LDL-receptor class B 32
type:domain  description:LDL-receptor class A 26
type:domain  description:LDL-receptor class A 27
type:domain  description:LDL-receptor class A 28
type:domain  description:LDL-receptor class A 29
type:domain  description:LDL-receptor class A 30
type:domain  description:LDL-receptor class A 31
type:domain  description:LDL-receptor class A 32
type:domain  description:LDL-receptor class A 33
type:domain  description:LDL-receptor class A 34
type:domain  description:LDL-receptor class A 35
type:domain  description:LDL-receptor class A 36
type:domain  description:EGF-like 5; calcium-binding
type:repeat  description:LDL-receptor class B 33
type:repeat  description:LDL-receptor class B 34
type:repeat  description:LDL-receptor class B 35
type:domain  description:EGF-like 6
type:region of interest  description:Interaction with DAB2
type:short sequence motif  description:SH3-binding
type:short sequence motif  description:PxLPxI/L motif 1; mediates interaction with ANKRA2
type:short sequence motif  description:PxLPxI/L motif 2; mediates interaction with ANKRA2
type:short sequence motif  description:Endocytosis signal
type:short sequence motif  description:NPXY motif
type:short sequence motif  description:SH2-binding
type:short sequence motif  description:SH3-binding
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs2229263.
type:sequence variant  description:Found in a renal cell carcinoma sample; somatic mutation.
type:sequence variant  description:In dbSNP:rs34693334.
type:sequence variant  description:In dbSNP:rs34291900.
type:sequence variant  description:In dbSNP:rs36082715.
type:sequence variant  description:In dbSNP:rs2302691.
type:sequence variant  description:In dbSNP:rs17848149.
type:sequence variant  description:None
type:sequence variant  description:In dbSNP:rs4667596.
type:sequence variant  description:In dbSNP:rs2228168.
type:sequence variant  description:In DBS; dbSNP:rs80338747.
type:sequence variant  description:In dbSNP:rs17848169.
type:sequence variant  description:In dbSNP:rs2228171.
type:sequence variant  description:In dbSNP:rs11674973.
type:sequence variant  description:In dbSNP:rs3213760.
type:sequence variant  description:Found in patients with mild intellectual disability, unknown pathological significance; dbSNP:rs199583537.
type:sequence variant  description:Found in patients with a phenotype suggestive of Stickler syndrome; unknown pathological significance.
type:sequence variant  description:In dbSNP:rs2075252.
type:sequence variant  description:In dbSNP:rs4667591.
type:sequence variant  description:In a colorectal cancer sample; somatic mutation.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:sequence conflict  description:In Ref. 3; AAB02882.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2151protein ======
type:signal peptide  description:None
type:chain  description:Osteopontin
type:short sequence motif  description:Cell attachment site
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:glycosylation site  description:O-linked (GalNAc...) threonine
type:sequence conflict  description:In Ref. 2; CAA34276.
type:sequence conflict  description:In Ref. 1; AAA57265.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 3; CAA32165 and 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
type:sequence conflict  description:In Ref. 5; AAH14284.
====== NO.2152protein ======
type:signal peptide  description:None
type:peptide  description:Synenkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(114-133)
type:peptide  description:Met-enkephalin
type:peptide  description:PENK(143-184)
type:peptide  description:Met-enkephalin-Arg-Ser-Leu
type:propeptide  description:None
type:peptide  description:Met-enkephalin
type:propeptide  description:None
type:peptide  description:Leu-enkephalin
type:peptide  description:PENK(238-259)
type:peptide  description:Met-enkephalin-Arg-Phe
type:modified residue  description:Phosphoserine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; AAA40128.
type:sequence conflict  description:In Ref. 1; AAA40128.
====== NO.2153protein ======
type:signal peptide  description:None
type:chain  description:Secreted frizzled-related protein 1
type:domain  description:FZ
type:domain  description:NTR
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2154protein ======
type:chain  description:Zinc finger protein SNAI2
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5; atypical
type:region of interest  description:SNAG domain
====== NO.2155protein ======
type:chain  description:Retinoic acid receptor RXR-alpha
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Nuclear localization signal
type:region of interest  description:Hinge
type:region of interest  description:Required for nuclear export
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 1
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:metal ion-binding site  description:Zinc 2
type:binding site  description:9-cis retinoic acid
type:binding site  description:9-cis retinoic acid; via amide nitrogen
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:modified residue  description:Phosphothreonine; by MAPK8 and MAPK9
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine; by EP300
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by MAPK8 and MAPK9
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs2234960.
type:sequence variant  description:In dbSNP:rs1805345.
type:sequence variant  description:In dbSNP:rs1805345.
type:sequence variant  description:In dbSNP:rs11542209.
type:mutagenesis site  description:Abolishes phosphorylation. No change in increase of RARA-mediated transcriptional activity.
type:mutagenesis site  description:Increase in RARA-mediated transcriptional activity.
type:mutagenesis site  description:Abolishes acetylation by EP300.
type:mutagenesis site  description:Abolishes acetylation by EP300, DNA binding and transcriptional activity. Impairs interaction with EP300.
type:mutagenesis site  description:Abolishes nuclear export.
type:mutagenesis site  description:Abolishes nuclear localization and transcriptional activity.
type:mutagenesis site  description:No impact on acetylation by EP300.
type:mutagenesis site  description:No impact on acetylation by EP300.
type:mutagenesis site  description:Abolishes nuclear export.
type:mutagenesis site  description:Abolishes nuclear localization.
type:mutagenesis site  description:As a heterodimer with NR1H4, impairs interaction with coactivator NCOA1. Impairs transcriptional activity.
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2156protein ======
type:chain  description:Small ubiquitin-related modifier 2
type:propeptide  description:None
type:domain  description:Ubiquitin-like
type:modified residue  description:N6-acetyllysine; alternate
type:cross-link  description:Peptide (Met-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs17850328.
type:mutagenesis site  description:Abolishes the formation of poly(SUMO) chains.
type:mutagenesis site  description:Significantly impairs sumoylation of MTA1.
type:mutagenesis site  description:Significantly impairs sumoylation of MTA1.
type:mutagenesis site  description:Significantly impairs sumoylation of MTA1.
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
====== NO.2157protein ======
type:chain  description:Thioredoxin
type:domain  description:Thioredoxin
type:active site  description:Nucleophile
type:active site  description:Nucleophile
type:site  description:Deprotonates C-terminal active site Cys
type:site  description:Contributes to redox potential value
type:site  description:Contributes to redox potential value
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:S-nitrosocysteine
type:modified residue  description:S-nitrosocysteine; alternate
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:disulfide bond  description:Redox-active
type:disulfide bond  description:Interchain; alternate
type:sequence conflict  description:In Ref. 4; BAB25256.
====== NO.2158protein ======
type:chain  description:Tumor necrosis factor, membrane form
type:chain  description:Intracellular domain 1
type:chain  description:Intracellular domain 2
type:chain  description:C-domain 1
type:chain  description:C-domain 2
type:chain  description:Tumor necrosis factor, soluble form
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by SPPL2A or SPPL2B
type:site  description:Cleavage; by ADAM17
type:modified residue  description:Phosphoserine; by CK1
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:lipid moiety-binding region  description:N6-myristoyl lysine
type:glycosylation site  description:O-linked (GalNAc...) serine; in soluble form
type:disulfide bond  description:None
type:sequence variant  description:In dbSNP:rs4645843.
type:sequence variant  description:In dbSNP:rs1800620.
type:mutagenesis site  description:Low activity.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:mutagenesis site  description:Biologically inactive.
type:sequence conflict  description:In Ref. 5; AAA61198.
type:sequence conflict  description:In Ref. 17; AAF71992.
type:sequence conflict  description:In Ref. 16; AAC03542.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.2159protein ======
type:signal peptide  description:None
type:chain  description:Interferon gamma
type:propeptide  description:None
type:modified residue  description:Pyrrolidone carboxylic acid
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine; in dimeric form
type:sequence variant  description:None
type:sequence variant  description:In dbSNP:rs201359065.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2160protein ======
type:chain  description:Iroquois-class homeodomain protein IRX-4
type:DNA-binding region  description:Homeobox; TALE-type
type:compositionally biased region  description:Poly-Ala
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Ala
type:sequence conflict  description:In Ref. 3; BAE21235.
====== NO.2161protein ======
type:signal peptide  description:None
type:chain  description:Klotho
type:chain  description:Klotho peptide
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:region of interest  description:Glycosyl hydrolase-1 1
type:region of interest  description:Glycosyl hydrolase-1 2
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence conflict  description:In Ref. 2; BAA25308.
type:sequence conflict  description:In Ref. 1; BAA23381 and 2; BAA25308.
====== NO.2162protein ======
type:chain  description:Mediator of RNA polymerase II transcription subunit 14
type:region of interest  description:Interaction with STAT2
type:region of interest  description:Interaction with SREBF1
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:compositionally biased region  description:Pro-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In a breast cancer sample; somatic mutation.
type:sequence conflict  description:In Ref. 4; AAD24360.
type:sequence conflict  description:In Ref. 1; BAA28626, 2; AAD12725 and 3; AAG22547.
type:sequence conflict  description:In Ref. 1; BAA28626, 2; AAD12725 and 3; AAG22547.
====== NO.2163protein ======
type:initiator methionine  description:Removed
type:chain  description:Protein kinase C beta type
type:domain  description:C2
type:domain  description:Protein kinase
type:domain  description:AGC-kinase C-terminal
type:zinc finger region  description:Phorbol-ester/DAG-type 1
type:zinc finger region  description:Phorbol-ester/DAG-type 2
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3
type:metal ion-binding site  description:Calcium 3; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 3
type:binding site  description:ATP
type:modified residue  description:N-acetylalanine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine; by autocatalysis
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphothreonine; by PDPK1
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphothreonine; by autocatalysis
type:modified residue  description:Phosphoserine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by SYK
type:splice variant  description:In isoform Beta-II.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:No effect; when associated with A-323.
type:mutagenesis site  description:No effect; when associated with A-313.
type:mutagenesis site  description:50% increase of enzymatic activity.
type:mutagenesis site  description:50% decrease of enzymatic activity.
type:mutagenesis site  description:Loss of enzymatic activity.
type:mutagenesis site  description:Loss of enzymatic activity; when associated with T-643 change in subcellular location, loss of PMA-induced down-regulation and loss of enzymatic activity.
type:mutagenesis site  description:Loss of enzymatic activity; when associated with T-636 change in subcellular location, loss of PMA-induced down-regulation and loss of enzymatic activity.
type:sequence conflict  description:In Ref. 3; AAA41868.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 1; AAA41875.
type:sequence conflict  description:In Ref. 3; AAA41868.
type:sequence conflict  description:In Ref. 2; CAA28035/CAA28036.
type:sequence conflict  description:In Ref. 1; AAA41865.
type:sequence conflict  description:In Ref. 1; AAA41865.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
====== NO.2164protein ======
type:signal peptide  description:None
type:chain  description:Latent-transforming growth factor beta-binding protein 1
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2
type:domain  description:TB 1
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:TB 2
type:domain  description:EGF-like 4; calcium-binding
type:domain  description:EGF-like 5; calcium-binding
type:domain  description:EGF-like 6; calcium-binding
type:domain  description:EGF-like 7; calcium-binding
type:domain  description:EGF-like 8; calcium-binding
type:domain  description:EGF-like 9; calcium-binding
type:domain  description:EGF-like 10; calcium-binding
type:domain  description:EGF-like 11; calcium-binding
type:domain  description:EGF-like 12; calcium-binding
type:domain  description:EGF-like 13; calcium-binding
type:domain  description:EGF-like 14; calcium-binding
type:domain  description:TB 3
type:domain  description:EGF-like 15; calcium-binding
type:domain  description:EGF-like 16; calcium-binding
type:domain  description:TB 4
type:domain  description:EGF-like 17
type:domain  description:EGF-like 18; calcium-binding
type:region of interest  description:8-Cys3 region
type:region of interest  description:C-terminal domain
type:compositionally biased region  description:Pro-rich
type:site  description:Cleavage
type:site  description:Cleavage
type:modified residue  description:(3R)-3-hydroxyasparagine
type:modified residue  description:(3R)-3-hydroxyasparagine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain (with C-33 in TGFB1); in linked form
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:Interchain (with C-33 in TGFB1); in linked form
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2165protein ======
type:chain  description:Iroquois-class homeodomain protein IRX-4
type:DNA-binding region  description:Homeobox; TALE-type
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Ala
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs2232376.
type:sequence conflict  description:In Ref. 6; AAB50004.
====== NO.2166protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Results in increased cell proliferation. Results in STAT3 phosphorylation and signaling activation.
type:sequence conflict  description:In Ref. 1; CAA42551.
type:sequence conflict  description:In Ref. 1; CAA42551.
type:sequence conflict  description:In Ref. 1; CAA42551.
type:sequence conflict  description:In Ref. 1; CAA42551.
type:sequence conflict  description:In Ref. 2; ABD43187, 3; BAC39292 and 4; AAH33313.
type:sequence conflict  description:In Ref. 4; AAH33313.
====== NO.2167protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 3
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 2.
type:mutagenesis site  description:Constitutively activated kinase.
type:sequence conflict  description:In Ref. 2; AAB25535.
type:sequence conflict  description:In Ref. 2; AAB25535.
====== NO.2168protein ======
type:chain  description:Peroxisomal acyl-coenzyme A oxidase 2
type:short sequence motif  description:Microbody targeting signal
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-succinyllysine
type:modified residue  description:N6-succinyllysine
type:sequence variant  description:In CBAS6; patient liver samples show absence of the protein; complete loss of fatty acid beta-oxidation activity.
type:sequence variant  description:In CBAS6; reduces fatty acid beta-oxidation activity; does not alter subcellular location; dbSNP:rs150832314.
====== NO.2169protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Asp
type:compositionally biased region  description:Poly-Ser
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2170protein ======
type:chain  description:General transcription and DNA repair factor IIH helicase subunit XPD
type:domain  description:Helicase ATP-binding
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Mediates interaction with MMS19
type:short sequence motif  description:DEAH box
type:short sequence motif  description:Nuclear localization signal
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:sequence variant  description:None
type:mutagenesis site  description:NER deficiency, no change in basal transcription activity.
type:mutagenesis site  description:NER deficiency.
type:mutagenesis site  description:NER deficiency associated to slight deficiency in basal transcription.
type:mutagenesis site  description:NER deficiency.
type:mutagenesis site  description:NER deficiency.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:No effect.
type:mutagenesis site  description:No effect.
====== NO.2171protein ======
type:signal peptide  description:None
type:chain  description:Frizzled-1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:domain  description:FZ
type:short sequence motif  description:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members
type:short sequence motif  description:PDZ-binding
type:compositionally biased region  description:Poly-Pro
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2172protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Poly-Ser
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2173protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Interleukin-15
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform Short.
====== NO.2174protein ======
type:signal peptide  description:None
type:chain  description:Integrin beta-1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:VWFA
type:repeat  description:I
type:repeat  description:II
type:repeat  description:III
type:repeat  description:IV
type:region of interest  description:CX3CL1-binding
type:region of interest  description:CX3CL1-binding
type:region of interest  description:Cysteine-rich tandem repeats
type:region of interest  description:Signal for sorting from recycling endosomes; interaction with ACAP1
type:region of interest  description:Interaction with ITGB1BP1
type:metal ion-binding site  description:Magnesium
type:metal ion-binding site  description:Calcium 1; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 1
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Calcium 2; via carbonyl oxygen
type:metal ion-binding site  description:Calcium 2
type:metal ion-binding site  description:Magnesium
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:N6-acetyllysine; alternate
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:sequence conflict  description:In Ref. 2; AAI31846.
type:sequence conflict  description:In Ref. 2; AAI31846.
====== NO.2175protein ======
type:signal peptide  description:None
type:propeptide  description:None
type:chain  description:Interleukin-15
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2176protein ======
type:chain  description:General transcription and DNA repair factor IIH helicase subunit XPD
type:domain  description:Helicase ATP-binding
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Mediates interaction with MMS19
type:short sequence motif  description:DEAH box
type:short sequence motif  description:Nuclear localization signal
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In XP-D; dbSNP:rs1360631927.
type:sequence variant  description:In XP-D.
type:sequence variant  description:In TTD1 and XP-D; dbSNP:rs121913020.
type:sequence variant  description:In dbSNP:rs1799791.
type:sequence variant  description:In dbSNP:rs1799792.
type:sequence variant  description:In XP-D; dbSNP:rs1340806384.
type:sequence variant  description:In TTD1; dbSNP:rs370454709.
type:sequence variant  description:In dbSNP:rs1799793.
type:sequence variant  description:In XP-D and TTD1; dbSNP:rs121913016.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In XP-D; the corresponding mutation in fission yeast causes complete loss of activity; dbSNP:rs121913025.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In TTD1; mild.
type:sequence variant  description:In XP-D; dbSNP:rs772572683.
type:sequence variant  description:In XP-D; mild; dbSNP:rs121913019.
type:sequence variant  description:In XP-D.
type:sequence variant  description:In XP-D.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In XP-D; dbSNP:rs140522180.
type:sequence variant  description:In XP-D; dbSNP:rs753641926.
type:sequence variant  description:In XP-D; combined with features of Cockayne syndrome; dbSNP:rs771824813.
type:sequence variant  description:None
type:sequence variant  description:In XP-D and TTD1; dbSNP:rs376556895.
type:sequence variant  description:In XP-D and COFS2; dbSNP:rs121913024.
type:sequence variant  description:In TTD1; dbSNP:rs121913021.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In TTD1; dbSNP:rs762141272.
type:sequence variant  description:In TTD1; dbSNP:rs770367713.
type:sequence variant  description:In XP-D; dbSNP:rs752510317.
type:sequence variant  description:In TTD1.
type:sequence variant  description:In XP-D/CS; severe form.
type:sequence variant  description:In XP-D and COFS2; dbSNP:rs121913023.
type:sequence variant  description:In XP-D; dbSNP:rs758439420.
type:sequence variant  description:In XP-D; vitamin D-mediated activation of CYP24A1 is impaired in patient fibroblasts due to altered TFIIH-dependent phosphorylation of ETS1, subsequent impaired cooperation of ETS1 with VDR and altered VDR recruitment to CYP24A1 promoter; dbSNP:rs41556519.
type:sequence variant  description:In TTD1; dbSNP:rs121913022.
type:sequence variant  description:In XP-D and TTD1.
type:sequence variant  description:In TTD1; dbSNP:rs121913026.
type:sequence variant  description:In TTD1; dbSNP:rs121913018.
type:sequence variant  description:Polymorphism; may be associated with increased susceptibility to DNA damage; dbSNP:rs13181.
type:mutagenesis site  description:Decreased transcriptional activity of the reconstituted TFIIH complex.
type:mutagenesis site  description:Reduced iron-sulfur-binding. Iron-sulfur-binding is further decreased in absence of MMS19.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2177protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 3
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 4.
type:sequence variant  description:In dbSNP:rs2305178.
type:sequence variant  description:In a lung adenocarcinoma sample; somatic mutation.
type:sequence variant  description:In a colorectal adenocarcinoma sample; somatic mutation.
type:sequence variant  description:In KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; severe and lethal; also found as somatic mutation in one patient with multiple myeloma; constitutive dimerization and kinase activation; dbSNP:rs121913482.
type:sequence variant  description:In KERSEB, BLC, cervical cancer and TD1; dbSNP:rs121913483.
type:sequence variant  description:In MNKS; also some individuals with autosomal dominant congenital sensorineural deafness without craniosynostosis; dbSNP:rs4647924.
type:sequence variant  description:In colorectal cancer; dbSNP:rs121913111.
type:sequence variant  description:None
type:sequence variant  description:In KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; dbSNP:rs121913479.
type:sequence variant  description:In KERSEB and TD1; dbSNP:rs121913484.
type:sequence variant  description:In KERSEB and TD1; disulfide-linked dimer with constitutive kinase activation; dbSNP:rs121913485.
type:sequence variant  description:In ACH; dbSNP:rs75790268.
type:sequence variant  description:In keratinocytic non-epidermolytic nevus and ACH; very common mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs28931614.
type:sequence variant  description:In dbSNP:rs17881656.
type:sequence variant  description:In CAN; dbSNP:rs28931615.
type:sequence variant  description:In dbSNP:rs17884368.
type:sequence variant  description:In LADDS; dbSNP:rs121913112.
type:sequence variant  description:In hypochondroplasia; dbSNP:rs80053154.
type:sequence variant  description:In hypochondroplasia; dbSNP:rs28933068.
type:sequence variant  description:In hypochondroplasia; mild; dbSNP:rs77722678.
type:sequence variant  description:In hypochondroplasia; dbSNP:rs77722678.
type:sequence variant  description:In CATSHLS; dbSNP:rs121913113.
type:sequence variant  description:None
type:sequence variant  description:In KERSEB, TD2, TGCT and BLC; bladder transitional cell carcinoma; somatic mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs78311289.
type:sequence variant  description:In KERSEB, ACH, TD1 and SADDAN; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs121913105.
type:sequence variant  description:In hypochondroplasia and BLC; in hypochondroplasia the form is milder than that seen in individuals with the K-540 or M-650 mutations; constitutively activated kinase; dbSNP:rs78311289.
type:sequence variant  description:In dbSNP:rs17882190.
type:sequence variant  description:In dbSNP:rs17880763.
type:mutagenesis site  description:Loss of kinase activity. Abolishes ubiquitination.
type:mutagenesis site  description:Minor effect on kinase activity.
type:mutagenesis site  description:Constitutively activated kinase.
type:mutagenesis site  description:Constitutively activated kinase.
type:mutagenesis site  description:Strongly reduced kinase activity. Strongly reduced mitogen activity.
type:mutagenesis site  description:Minor effect on kinase activity.
type:mutagenesis site  description:Minor effect on kinase activity. Increased mitogen activity.
type:sequence conflict  description:In Ref. 7; AAA58470.
type:sequence conflict  description:In Ref. 3; BAD92678.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2178protein ======
type:initiator methionine  description:Removed
type:chain  description:Heat shock cognate 71 kDa protein
type:region of interest  description:Nucleotide-binding domain (NBD)
type:region of interest  description:Substrate-binding domain (SBD)
type:modified residue  description:N-acetylserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:N6-acetyllysine; alternate
type:modified residue  description:N6-succinyllysine; alternate
type:modified residue  description:N6-acetyllysine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6,N6,N6-trimethyllysine; by METTL21A; in vitro
type:modified residue  description:N6,N6-dimethyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
====== NO.2179protein ======
type:chain  description:Heat shock 70 kDa protein 6
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Nucleotide-binding domain (NBD)
type:region of interest  description:Substrate-binding domain (SBD)
type:binding site  description:ATP
type:modified residue  description:N6,N6,N6-trimethyllysine; by METTL21A; in vitro
====== NO.2180protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:Cytochrome P450 315a1, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:sequence conflict  description:In Ref. 1; AAL86019.
type:sequence conflict  description:In Ref. 1; AAL86019.
====== NO.2181protein ======
type:chain  description:Ectonucleotide pyrophosphatase/phosphodiesterase family member 1
type:chain  description:Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Signal-anchor for type II membrane protein
type:topological domain  description:Extracellular
type:domain  description:SMB 1
type:domain  description:SMB 2
type:region of interest  description:Phosphodiesterase
type:region of interest  description:Linker
type:region of interest  description:Nuclease
type:short sequence motif  description:Di-leucine motif
type:active site  description:AMP-threonine intermediate
type:metal ion-binding site  description:Zinc 1; catalytic
type:metal ion-binding site  description:Zinc 1; catalytic
type:metal ion-binding site  description:Zinc 2; catalytic
type:metal ion-binding site  description:Zinc 2; via tele nitrogen; catalytic
type:metal ion-binding site  description:Zinc 1; catalytic
type:metal ion-binding site  description:Zinc 1; via tele nitrogen; catalytic
type:metal ion-binding site  description:Zinc 2; via tele nitrogen; catalytic
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium
type:metal ion-binding site  description:Calcium; via carbonyl oxygen
type:metal ion-binding site  description:Calcium
type:binding site  description:Substrate
type:binding site  description:Substrate
type:binding site  description:Substrate
type:binding site  description:Substrate
type:binding site  description:Substrate 2'-3'-cGAMP
type:binding site  description:Substrate 2'-3'-cGAMP
type:site  description:Cleavage
type:site  description:Essential for catalytic activity
type:modified residue  description:Phosphothreonine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence variant  description:In OPLL.
type:sequence variant  description:In ARHR2.
type:sequence variant  description:In COLED; impaired homodimerization.
type:sequence variant  description:In GACI1.
type:sequence variant  description:In COLED; impaired homodimerization.
type:sequence variant  description:In COLED; dbSNP:rs397518477.
type:sequence variant  description:In COLED; dbSNP:rs397518476.
type:sequence variant  description:Polymorphism; associated with NIDDM; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs1044498.
type:sequence variant  description:In COLED.
type:sequence variant  description:In COLED; dbSNP:rs397518475.
type:sequence variant  description:In dbSNP:rs2273411.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane; dbSNP:rs763457176.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs760786509.
type:sequence variant  description:In GACI1; dbSNP:rs1231182870.
type:sequence variant  description:In ARHR2; unknown pathological significance.
type:sequence variant  description:In GACI1; unknown pathological significance.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs754659608.
type:sequence variant  description:In GACI1.
type:sequence variant  description:In ARHR2; dbSNP:rs121908248.
type:sequence variant  description:In dbSNP:rs17847050.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs143771474.
type:sequence variant  description:In OPLL; dbSNP:rs190947144.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs374270497.
type:sequence variant  description:In GACI1; dbSNP:rs121918025.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs764735802.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs121918026.
type:sequence variant  description:In GACI1; dbSNP:rs765071179.
type:sequence variant  description:In GACI1; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs148462924.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs373044722.
type:sequence variant  description:In GACI1.
type:sequence variant  description:In GACI1; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs1243920034.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs387906673.
type:sequence variant  description:In GACI1; dbSNP:rs140248167.
type:sequence variant  description:In GACI1; unknown pathological significance; dbSNP:rs121918024.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane; dbSNP:rs777367269.
type:sequence variant  description:In dbSNP:rs79079368.
type:sequence variant  description:In GACI1; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs143393727.
type:sequence variant  description:Polymorphism; no effect on nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs115371819.
type:sequence variant  description:In GACI1.
type:sequence variant  description:Polymorphism; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs28933977.
type:sequence variant  description:In GACI1; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs147346173.
type:sequence variant  description:In dbSNP:rs1805138.
type:sequence variant  description:In ARHR2 and GACI1; dbSNP:rs370184526.
type:sequence variant  description:In GACI1.
type:sequence variant  description:Polymorphism; decreased nucleotide phosphodiesterase activity; no effect on localization to plasma membrane; dbSNP:rs367759638.
type:sequence variant  description:In dbSNP:rs8192683.
type:sequence variant  description:In GACI1; loss of nucleotide phosphodiesterase activity; loss of localization to plasma membrane; dbSNP:rs184483616.
type:sequence variant  description:In ARHR2; loss of activity; dbSNP:rs121908249.
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
====== NO.2182protein ======
type:signal peptide  description:None
type:chain  description:Frizzled-2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=1
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=2
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=3
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=5
type:topological domain  description:Cytoplasmic
type:transmembrane region  description:Helical; Name=6
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical; Name=7
type:topological domain  description:Cytoplasmic
type:domain  description:FZ
type:short sequence motif  description:Lys-Thr-X-X-X-Trp motif, mediates interaction with the PDZ domain of Dvl family members
type:short sequence motif  description:PDZ-binding
type:compositionally biased region  description:Poly-Gly
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2183protein ======
type:chain  description:General transcription and DNA repair factor IIH helicase subunit XPD
type:domain  description:Helicase ATP-binding
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Mediates interaction with MMS19
type:short sequence motif  description:DEAH box
type:short sequence motif  description:Nuclear localization signal
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
====== NO.2184protein ======
type:signal peptide  description:None
type:chain  description:Cartilage oligomeric matrix protein
type:domain  description:EGF-like 1
type:domain  description:EGF-like 2; calcium-binding
type:domain  description:EGF-like 3; calcium-binding
type:domain  description:EGF-like 4
type:repeat  description:TSP type-3 1
type:repeat  description:TSP type-3 2
type:repeat  description:TSP type-3 3
type:repeat  description:TSP type-3 4
type:repeat  description:TSP type-3 5
type:repeat  description:TSP type-3 6
type:repeat  description:TSP type-3 7
type:repeat  description:TSP type-3 8
type:domain  description:TSP C-terminal
type:region of interest  description:COMP N-terminal
type:region of interest  description:Mediates cell survival and induction of the IAP family of survival proteins
type:modified residue  description:Phosphoserine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:Interchain (with C-71)
type:disulfide bond  description:Interchain (with C-68)
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:helix  description:None
====== NO.2185protein ======
type:chain  description:Glucocorticoid receptor
type:domain  description:NR LBD
type:DNA-binding region  description:Nuclear receptor
type:zinc finger region  description:NR C4-type
type:zinc finger region  description:NR C4-type
type:region of interest  description:Modulating
type:region of interest  description:Interaction with CLOCK
type:region of interest  description:Hinge
type:region of interest  description:Interaction with CRY1
type:compositionally biased region  description:Poly-Gln
type:compositionally biased region  description:Glu/Pro/Ser/Thr-rich (PEST region)
type:modified residue  description:Omega-N-methylarginine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:modified residue  description:N6-acetyllysine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
type:splice variant  description:In isoform B.
type:sequence variant  description:In strain: Brown Norway/Crl.
type:sequence variant  description:In strain: SHR/OlaIpcv.
type:sequence variant  description:In strain: Sprague-Dawley.
type:sequence variant  description:In strain: SHR/OlaIpcv and Brown Norway/Crl.
type:sequence variant  description:In strain: SHR/OlaIpcv and Brown Norway/Crl.
type:mutagenesis site  description:Abolishes expression of A-type isoforms.
type:mutagenesis site  description:Abolishes expression of B-type isoforms.
type:mutagenesis site  description:Enhances transcriptional activity; when associated with R-313.
type:mutagenesis site  description:Enhances transcriptional activity; when associated with R-297.
type:mutagenesis site  description:Disrupts dimerization and decreases transcription transactivation.
type:mutagenesis site  description:Loss of chromatin specific function and reduces chromatin remodeling. Abolishes interaction with SMARD1.
type:mutagenesis site  description:Abolishes interaction with POU2F2.
type:mutagenesis site  description:Abrogates DNA-binding and transcription transactivation. Abolishes interaction with POU2F1 and POU2F2.
type:mutagenesis site  description:Strongly increases affinity for dexamethasone.
type:mutagenesis site  description:Abolishes the stimulatory effect of RWDD3 on its transcriptional activity. Diminishes NCOA2 coactivator activity.
type:mutagenesis site  description:Abolishes interaction with NCOA1 and reduces transcription transactivation; when associated with S-656.
type:sequence conflict  description:In Ref. 3; AAL78956.
type:sequence conflict  description:In Ref. 1; AAA41203.
type:sequence conflict  description:In Ref. 4; CAA68545.
type:sequence conflict  description:In Ref. 2; CAA72938 and 3; AAL66772/AAL78956.
type:sequence conflict  description:In Ref. 3; AAL66772/AAL78956.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2186protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Heparin-binding
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:Mediates interaction with PLCG1 and SHB
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2187protein ======
type:chain  description:Tyrosine-protein kinase Fes/Fps
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Important for interaction with membranes containing phosphoinositides
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphoserine
type:sequence conflict  description:In Ref. 1; CAA31138.
type:sequence conflict  description:In Ref. 1; CAA31138 and 2; AAN33122.
type:sequence conflict  description:In Ref. 1; CAA31138.
type:sequence conflict  description:In Ref. 1; CAA31138 and 2; AAN33122.
type:sequence conflict  description:In Ref. 1; CAA31138 and 2; AAN33122.
type:sequence conflict  description:In Ref. 1; CAA31138 and 2; AAN33122.
type:sequence conflict  description:In Ref. 1; CAA31138.
type:sequence conflict  description:In Ref. 1; CAA31138 and 5; AAA40012.
type:sequence conflict  description:In Ref. 5; AAA40012.
====== NO.2188protein ======
type:chain  description:Zinc finger protein Gfi-1
type:zinc finger region  description:C2H2-type 1
type:zinc finger region  description:C2H2-type 2
type:zinc finger region  description:C2H2-type 3
type:zinc finger region  description:C2H2-type 4
type:zinc finger region  description:C2H2-type 5
type:zinc finger region  description:C2H2-type 6
type:region of interest  description:SNAG domain
type:region of interest  description:Required for interaction with RELA
type:compositionally biased region  description:Ala/Gly-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:sequence variant  description:In dbSNP:rs34631763.
type:sequence variant  description:In SCN2; zero neutrophil count. marked monocytosis and reduced T- and B-lymphocyte number leading to recurrent infectious complications. Abolishes recognition of DNA binding site of zinc finger. Diminished repression activity and elevated ELA2 expression. No effect on repression of CDKN1A/p21 transcription; dbSNP:rs28936381.
type:sequence variant  description:In NI-CINA; Neutropenic and elevated monocytosis but no history of infectious complications. No effect on DNA binding but diminished GFI1 repression activity; dbSNP:rs28936382.
type:mutagenesis site  description:Abrogates transcriptional repression.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
type:sequence conflict  description:In Ref. 1; AAB37272.
====== NO.2189protein ======
type:chain  description:Lysine-specific demethylase hairless
type:domain  description:JmjC
type:zinc finger region  description:C6-type
type:short sequence motif  description:LXXLL motif 1
type:short sequence motif  description:LXXLL motif 2
type:metal ion-binding site  description:Iron; catalytic
type:metal ion-binding site  description:Iron; catalytic
type:metal ion-binding site  description:Iron; catalytic
type:mutagenesis site  description:Decreases RORA protein stability. Strongly decreases RORA protein stability; when associated with 752-L--A-756.
type:mutagenesis site  description:Decreases RORA protein stability. Strongly decreases RORA protein stability; when associated with 560-L--A-564.
====== NO.2190protein ======
type:chain  description:Cyclin-dependent kinase 4 inhibitor D
type:repeat  description:ANK 1
type:repeat  description:ANK 2
type:repeat  description:ANK 3
type:repeat  description:ANK 4
type:modified residue  description:N-acetylmethionine
====== NO.2191protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor 23
type:glycosylation site  description:O-linked (GalNAc) threonine
type:disulfide bond  description:None
====== NO.2192protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 1
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Heparin-binding
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:binding site  description:ATP
type:site  description:Mediates interaction with PLCG1 and SHB
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2, isoform 4 and isoform 5.
type:splice variant  description:In isoform 3, isoform 4, isoform 5 and isoform 6.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 5.
type:sequence conflict  description:In Ref. 4; AAA37622.
type:sequence conflict  description:In Ref. 1; AAA37290 and 3; AAA37620.
type:sequence conflict  description:In Ref. 5; AAC52183.
type:sequence conflict  description:In Ref. 4; AAA37622.
type:sequence conflict  description:In Ref. 3; AAA37620.
type:sequence conflict  description:In Ref. 2; CAA36175.
type:sequence conflict  description:In Ref. 5; AAC52183.
type:sequence conflict  description:In Ref. 3; AAA37620.
type:sequence conflict  description:In Ref. 4; AAA37622.
type:sequence conflict  description:In Ref. 6; AAF05312.
type:sequence conflict  description:In Ref. 6; AAF05312.
type:sequence conflict  description:In Ref. 1; AAA37290.
type:sequence conflict  description:In Ref. 5; AAC52183.
type:sequence conflict  description:In Ref. 4; AAA37622.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
====== NO.2193protein ======
type:initiator methionine  description:Removed
type:chain  description:Cytochrome P450 3A4
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
type:sequence variant  description:In allele CYP3A4*14; dbSNP:rs12721634.
type:sequence variant  description:In allele CYP3A4*7; dbSNP:rs56324128.
type:sequence variant  description:In dbSNP:rs3091339.
type:sequence variant  description:In allele CYP3A4*4; significant decrease in catalytic efficiency; dbSNP:rs55951658.
type:sequence variant  description:In allele CYP3A4*8; dbSNP:rs72552799.
type:sequence variant  description:In allele CYP3A4*15; dbSNP:rs4986907.
type:sequence variant  description:In allele CYP3A4*9; dbSNP:rs72552798.
type:sequence variant  description:In allele CYP3A4*10; dbSNP:rs4986908.
type:sequence variant  description:In allele CYP3A4*16; dbSNP:rs12721627.
type:sequence variant  description:In allele CYP3A4*17; exhibits lower turnover numbers for testosterone and chlorpyrifos; dbSNP:rs4987161.
type:sequence variant  description:In allele CYP3A4*5; dbSNP:rs55901263.
type:sequence variant  description:In allele CYP3A4*2; exhibits a lower intrinsic clearance toward nifedipine; dbSNP:rs55785340.
type:sequence variant  description:In dbSNP:rs3208363.
type:sequence variant  description:In allele CYP3A4*18; exhibits higher turnover numbers for testosterone and chlorpyrifos; dbSNP:rs28371759.
type:sequence variant  description:In dbSNP:rs10250778.
type:sequence variant  description:In allele CYP3A4*11; unstable form; dbSNP:rs67784355.
type:sequence variant  description:In allele CYP3A4*12; has an altered testosterone hydroxylase activity; dbSNP:rs12721629.
type:sequence variant  description:In allele CYP3A4*13; lack of expression; dbSNP:rs4986909.
type:sequence variant  description:In dbSNP:rs1041988.
type:sequence variant  description:In allele CYP3A4*3; dbSNP:rs4986910.
type:sequence variant  description:In allele CYP3A4*19; dbSNP:rs4986913.
type:sequence conflict  description:In Ref. 5; AAA35747.
type:sequence conflict  description:In Ref. 9; AAF13598.
type:sequence conflict  description:In Ref. 5; AAA35747.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 5; AAA35747.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742.
type:sequence conflict  description:In Ref. 9; AAF13598.
type:sequence conflict  description:In Ref. 1; BAA00001/AAA35742, 3; AAA35744, 4; CAA30944 and 5; AAA35747.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.2194protein ======
type:signal peptide  description:None
type:chain  description:C-X-C motif chemokine 10
type:chain  description:CXCL10(1-73)
type:modified residue  description:Citrulline; by PAD2
type:disulfide bond  description:None
type:disulfide bond  description:None
type:sequence conflict  description:In Ref. 1; CAA26370.
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
====== NO.2195protein ======
type:chain  description:General transcription and DNA repair factor IIH helicase subunit XPD
type:domain  description:Helicase ATP-binding
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Mediates interaction with MMS19
type:short sequence motif  description:DEAH box
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:metal ion-binding site  description:Iron-sulfur (4Fe-4S)
type:sequence conflict  description:In Ref. 2; BAB23443.
type:sequence conflict  description:In Ref. 1; AAB58296.
====== NO.2196protein ======
type:chain  description:Probable cytochrome P450 519E1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2197protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:sequence variant  description:In VDDR1A; dbSNP:rs868704228.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs28934604.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs28934605.
type:sequence variant  description:In dbSNP:rs8176344.
type:sequence variant  description:In VDDR1A; 22% of wild-type activity; dbSNP:rs118204012.
type:sequence variant  description:In VDDR1A; 11% of wild-type activity.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs118204007.
type:sequence variant  description:In VDDR1A.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs28934606.
type:sequence variant  description:In VDDR1A; 2.3% of wild-type activity; dbSNP:rs118204011.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs28934607.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs118204010.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs118204010.
type:sequence variant  description:In VDDR1A; complete loss of activity; dbSNP:rs118204009.
type:sequence variant  description:In VDDR1A; dbSNP:rs118204008.
type:sequence variant  description:In VDDR1A; dbSNP:rs568165874.
type:sequence variant  description:In VDDR1A; dbSNP:rs767480544.
type:sequence variant  description:In VDDR1A.
type:sequence variant  description:In VDDR1A; dbSNP:rs1161799032.
type:sequence conflict  description:In Ref. 7; BAG37458.
====== NO.2198protein ======
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 2.
type:splice variant  description:In isoform 3.
type:sequence variant  description:In dbSNP:rs4646422.
type:sequence variant  description:In dbSNP:rs35035798.
type:sequence variant  description:In dbSNP:rs17861094.
type:sequence variant  description:In dbSNP:rs2229150.
type:sequence variant  description:In dbSNP:rs28399427.
type:sequence variant  description:In dbSNP:rs34260157.
type:sequence variant  description:In dbSNP:rs4987133.
type:sequence variant  description:In allele CYP1A1*6; dbSNP:rs56313657.
type:sequence variant  description:In allele CYP1A1*8; dbSNP:rs72547509.
type:sequence variant  description:In allele CYP1A1*4; displays similar catalytic efficiency toward estrogens when compared to the wild-type enzyme.; dbSNP:rs1799814.
type:sequence variant  description:In allele CYP1A1*2B and allele CYP1A1*2C; displays 5.7- and 12-fold increase in catalytic efficiency in the formation of 2-hydroxylated estrogens, 17beta-estradiol and estrone respectively.; dbSNP:rs1048943.
type:sequence variant  description:In allele CYP1A1*9; dbSNP:rs41279188.
type:sequence variant  description:In allele CYP1A1*5; dbSNP:rs41279188.
type:sequence variant  description:In dbSNP:rs36121583.
type:sequence variant  description:In allele CYP1A1*10; dbSNP:rs56240201.
type:sequence variant  description:In dbSNP:rs28399429.
type:sequence variant  description:In allele CYP1A1*11; dbSNP:rs28399430.
type:sequence conflict  description:In Ref. 2; AAA52139.
type:sequence conflict  description:In Ref. 2; AAA52139.
type:sequence conflict  description:In Ref. 1; CAA26458.
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.2199protein ======
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
type:sequence conflict  description:In Ref. 2; AA sequence.
type:sequence conflict  description:In Ref. 2; AA sequence.
====== NO.2200protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2201protein ======
type:chain  description:Tyrosine-protein kinase Fes/Fps
type:domain  description:F-BAR
type:domain  description:SH2
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:region of interest  description:Important for interaction with membranes containing phosphoinositides
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphotyrosine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphoserine
type:splice variant  description:In isoform 2 and isoform 3.
type:splice variant  description:In isoform 2 and isoform 4.
type:sequence variant  description:In dbSNP:rs56041861.
type:sequence variant  description:In dbSNP:rs34573430.
type:sequence variant  description:In dbSNP:rs56296062.
type:mutagenesis site  description:Reduced binding to membranes containing phosphoinositides.
type:mutagenesis site  description:Reduced binding to membranes containing phosphoinositides.
type:mutagenesis site  description:Constitutively activated kinase that can act as oncogene. Promotes myeloid cell survival and proliferation.
type:mutagenesis site  description:Abolishes autophosphorylation.
type:mutagenesis site  description:Abolishes kinase activity.
type:mutagenesis site  description:Abolishes pTyr binding. Abolishes association with microtubules. Abolishes autophosphorylation. Reduced kinase activity.
type:mutagenesis site  description:Abolishes kinase activity. Fails to inhibit proliferation of melanoma cells.
type:mutagenesis site  description:Reduced autophosphorylation and strongly reduced kinase activity.
type:mutagenesis site  description:Negligible effect on autophosphorylation and kinase activity.
type:mutagenesis site  description:Reduces kinase activity by over 90%.
type:mutagenesis site  description:Strongly reduced autophosphorylation and kinase activity.
type:mutagenesis site  description:Reduced autophosphorylation and strongly reduced kinase activity.
type:sequence conflict  description:In Ref. 1; CAA36438 and 3; AAS82866/AAS82869/AAS82868.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2202protein ======
type:chain  description:Probable cytochrome P450 517A2
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2203protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor receptor 4
type:topological domain  description:Extracellular
type:transmembrane region  description:Helical
type:topological domain  description:Cytoplasmic
type:domain  description:Ig-like C2-type 1
type:domain  description:Ig-like C2-type 2
type:domain  description:Ig-like C2-type 3
type:domain  description:Protein kinase
type:nucleotide phosphate-binding region  description:ATP
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Poly-Asp
type:compositionally biased region  description:Poly-Ser
type:active site  description:Proton acceptor
type:binding site  description:ATP
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:modified residue  description:Phosphotyrosine; by autocatalysis
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:glycosylation site  description:N-linked (GlcNAc...) asparagine
type:disulfide bond  description:None
type:disulfide bond  description:None
type:disulfide bond  description:None
====== NO.2204protein ======
type:initiator methionine  description:Removed
type:chain  description:Vitamin D(3) 25-hydroxylase
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2205protein ======
type:signal peptide  description:None
type:chain  description:Fibroblast growth factor 23
type:chain  description:Fibroblast growth factor 23 N-terminal peptide
type:chain  description:Fibroblast growth factor 23 C-terminal peptide
type:site  description:Cleavage; by proprotein convertases
type:glycosylation site  description:O-linked (GalNAc) threonine
type:disulfide bond  description:None
type:sequence variant  description:In HFTC2; only the C-terminal fragment is secreted, whereas the intact protein is retained in the Golgi complex; dbSNP:rs104894342.
type:sequence variant  description:In HFTC2; dbSNP:rs104894343.
type:sequence variant  description:In HFTC2; full-length and N-terminal fragments are barely detectable, whereas a C-terminal fragment with the same molecular weight as that from wild-type can be detected; dbSNP:rs104894344.
type:sequence variant  description:In HFTC2; dbSNP:rs772964687.
type:sequence variant  description:In ADHR; partially resistant to cleavage by furin; dbSNP:rs104894347.
type:sequence variant  description:In ADHR; C-terminal processing is abolished; reduced proteolysis by PHEX; resistant to cleavage by furin; dbSNP:rs193922702.
type:sequence variant  description:In ADHR; C-terminal processing is abolished; dbSNP:rs28937882.
type:sequence variant  description:In dbSNP:rs13312793.
type:sequence variant  description:In dbSNP:rs7955866.
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:turn  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
====== NO.2206protein ======
type:signal peptide  description:None
type:chain  description:24-hydroxycholesterol 7-alpha-hydroxylase
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
type:sequence variant  description:Polymorphism; 60% decrease of 7-alpha hydroxylase activity; dbSNP:rs12192544.
type:sequence variant  description:Polymorphism associated with elevated serum (24S)-hydroxycholesterol levels; 30% decrease of 7-alpha hydroxylase activity; dbSNP:rs2277119.
type:sequence variant  description:Polymorphism; 10% decrease of 7-alpha hydroxylase activity; dbSNP:rs17856332.
type:sequence variant  description:Polymorphism associated with elevated serum (24S)-hydroxycholesterol levels; impairs 7-alpha hydroxylase activity; dbSNP:rs7761731.
type:sequence variant  description:Impairs 7-alpha hydroxylase activity; dbSNP:rs41273654.
====== NO.2207protein ======
type:chain  description:Cytochrome P450 1A1
type:region of interest  description:Mitochondrial targeting signal
type:metal ion-binding site  description:Iron (heme axial ligand)
type:binding site  description:Substrate
type:glycosylation site  description:O-linked (GlcNAc) serine
====== NO.2208protein ======
type:transit peptide  description:Mitochondrion
type:chain  description:Cholesterol side-chain cleavage enzyme, mitochondrial
type:metal ion-binding site  description:Iron (heme axial ligand)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In AICSR; reduced activity; dbSNP:rs121912813.
type:sequence variant  description:In AICSR; no loss of activity; dbSNP:rs121912811.
type:sequence variant  description:In AICSR; markedly reduced activity; dbSNP:rs387906601.
type:sequence variant  description:In AICSR; complete loss of activity.
type:sequence variant  description:In dbSNP:rs6161.
type:sequence variant  description:In AICSR; loss of activity; dbSNP:rs72547508.
type:sequence variant  description:In AICSR; markedly reduced activity; dbSNP:rs121912812.
type:sequence variant  description:In AICSR; complete loss of activity; dbSNP:rs121912814.
type:sequence conflict  description:In Ref. 1; AAA52162.
type:sequence conflict  description:In Ref. 2; CAA28965.
type:sequence conflict  description:In Ref. 9; AAA36404.
type:sequence conflict  description:In Ref. 1; AAA52162 and 9; AAA36404.
type:sequence conflict  description:In Ref. 3; BAG51810.
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:strand  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:strand  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:strand  description:None
type:strand  description:None
type:strand  description:None
====== NO.2209protein ======
type:chain  description:Probable cytochrome P450 517A4
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2210protein ======
type:chain  description:Probable cytochrome P450 519B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2211protein ======
type:chain  description:Bromodomain adjacent to zinc finger domain protein 1A
type:domain  description:WAC
type:domain  description:DDT
type:domain  description:Bromo
type:zinc finger region  description:PHD-type
type:region of interest  description:Required for interaction with NCOR1
type:region of interest  description:Required for association with the CHRAC1/POLE3 complex
type:region of interest  description:Interaction with SMARCA5
type:coiled-coil region  description:None
type:coiled-coil region  description:None
type:compositionally biased region  description:Poly-Glu
type:compositionally biased region  description:Glu-rich
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphothreonine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1133285.
type:sequence variant  description:In dbSNP:rs1044140.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 6; AAF28995.
type:sequence conflict  description:In Ref. 6; AAF28995.
type:sequence conflict  description:In Ref. 6; AAF28995.
type:sequence conflict  description:In Ref. 6; AAF28995.
type:sequence conflict  description:In Ref. 1; AAF70601.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 3; BAA89209.
type:sequence conflict  description:In Ref. 1; AAF70601 and 7; CAB43261.
type:helix  description:None
type:helix  description:None
type:turn  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
type:helix  description:None
====== NO.2212protein ======
type:chain  description:Probable cytochrome P450 515B1
type:transmembrane region  description:Helical
type:metal ion-binding site  description:Iron (heme axial ligand)
====== NO.2213protein ======
type:chain  description:Centromere protein R
type:region of interest  description:DD1
type:coiled-coil region  description:None
type:short sequence motif  description:LXXLL motif
type:short sequence motif  description:Nuclear localization signal
type:short sequence motif  description:LXXIL motif
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:modified residue  description:Phosphoserine
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:cross-link  description:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
type:splice variant  description:In isoform 5.
type:splice variant  description:In isoform 4.
type:splice variant  description:In isoform 3.
type:splice variant  description:In isoform 2.
type:sequence variant  description:In dbSNP:rs1058057.
type:mutagenesis site  description:Decreased interaction with nuclear receptors.
type:mutagenesis site  description:Loss of repressor function.
type:mutagenesis site  description:Abolishes localization to nucleus.
type:mutagenesis site  description:Abolishes localization to nucleus.
type:mutagenesis site  description:Abolishes dimerization, but not interactions with nuclear receptors; when associated with R-96.
type:mutagenesis site  description:Abolishes dimerization, but not interactions with nuclear receptors; when associated with R-89.
type:mutagenesis site  description:Abolishes interaction with nuclear receptors.
====== NO.2214protein ======
